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“You start out as a single cell derived from the coupling of a sperm and an egg; this divides in two, 
then four, then eight, and so on … The mere existence of such a cell should be one of the great 
astonishments of the earth. People ought to be walking around all day, all through their waking hours 
calling to each other in endless wonderment, talking of nothing except that cell.”   
— Lewis Thomas (1979), the Medusa and the snail 
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 BIOLOGICAL INTRODUCTION 
1.1. Human embryonic stem cells 
 A definition 
Human embryonic stem cells (hESC) are distinguished from other cell types by two main properties. First, 
their prolonged proliferation potential: hESC can be cultured in vitro and expanded in number 
indefinitely while maintaining the undifferentiated state characteristic of the blastocyst’s cells from which 
they are derived. Second, both in vivo and in vitro they have the remarkable capacity to develop into all 
different cell types of the human body. 
 Derivation of an hESC line and appropriate culture conditions 
Human ESC lines are derived from the blastocyst’s inner cell mass (ICM), generated by in vitro 
fertilization. Such embryos that are left unused can be donated for research purposes. Once the 
blastocyst stage is reached five days after fertilization, cells of the ICM are transferred from the pre-
implantation stage embryo into a plastic laboratory culture dish. In the original protocol of J. Thomson, 
the culture dish was coated with a feeder layer of mouse embryonic fibroblasts (MEFs) (Figure 1.1) [1]. 
Nevertheless, nowadays hESC can also be cultured in feeder-free conditions [2].  
In case MEFs are used as feeder layer, they are first mitotically inactivated with e.g. mitomycin C, in order 
not to overgrow the ESC. This is a potent chemotherapeutic agent that acts through DNA crosslinking, 
to inhibit DNA synthesis and cell division. These feeder cells are used because they support ESC 
proliferation and prevent spontaneous differentiation. The latter is accomplished by secretion of growth 
factors such as basic fibroblast growth factor (bFGF or FGF-2), transforming growth factor β, activin A, 
extracellular matrix proteins and antagonists of the bone morphogenetic protein (BMP) signaling 
pathway [3].  
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Figure 1.1 Establishing a hESC culture on a MEF feeder layer [4] 
To generate hESC, cells derived from the blastocyst’s inner ICM are cultured in a multi-step process.  
 ESC differentiation: from totipotent to unipotent 
Stem cells can differentiate into any of the hundreds of cell types in the human body. Yet, different 
potency levels are found throughout this differentiation process, whereby cells become more and more 
specialized at each step (Figure 1.2). The singe-cell zygote is totipotent and thus capable of forming 
both embryonic and extra-embryonic tissues. Five days after fertilization the human blastocyst is formed. 
The ICM and the ESC derived thereof are pluripotent. These cells can still differentiate into germ cells 
and any of the three germ layers: endoderm (lungs, liver and pancreas) , exoderm (nervous system and 
epidermal tissue) and mesoderm (heart, blood, muscle and bone) [5][6]. These three germ layers are the 
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embryonic source of all cells of the body. Upon further differentiation, cells become multipotent and can 
develop only in a limited range of cells within a tissue type, thereby differentiating towards oligopotent 
cells. These so-called progenitor cells can give rise to only a few cell types of a particular lineage. For 
example, a lymphoid stem cell is an example thereof: it can give rise to blood cells of the lymphatic 
system (T, B and NK cells), but can no longer develop into any kind of blood cell like the multipotent 
bone marrow stem cells can. The least potent precursor cells are called unipotent. These cells still have 
unlimited reproductive capacities but can only give rise to one specific cell type. For example, most 
epithelial tissues can renew damaged cells throughout adult life due to the presence of unipotent stem 
cells [7].  
 
Figure 1.2 Differentiation of an embryonic stem cell 
 
 Characterization of hESC 
Numerous hESC lines have been derived worldwide since the first derivatization in 1998 by Thomson [1]. 
Since all these hESC lines are genetically different and moreover cultured in diverse conditions, it’s not 
surprising that they are mutually divergent in morphology, growth dynamics and tendency to 
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differentiate spontaneously. Nevertheless, it remains crucial to be able to define the characteristics of a 
“true” hESC. This profiling can be done using 4 different types of markers: extracellular cell-surface 
markers, intracellular markers (e.g. transcription factors), general protein profile and epigenetic features 
[8].  
Extracellular markers have proven to be a powerful tool for distinguishing undifferentiated stem cells 
from their differentiated counterpart. It is interesting to know that some markers such as SSEA-1 are 
expressed only in mouse ESC, while other markers such as SSEA-3 and SSEA-4 are specific for hESC [9]. 
Besides these extracellular markers, monitoring the gene expression of specific markers is often used as 
an intracellular marker for hESC, thereby highlighting pathways unique for hESC. The expression pattern 
of genes coding for the transcription factors Nanog and Oct4 are typical markers of pluripotency [10]. A 
third way to define pluripotency is by the protein content. Van Hoof et al. [11] compared the proteomes 
of undifferentiated hESCs with their derivatives formed after 12 days of undirected “spontaneous” 
differentiation into a heterogeneous population. More than 700 proteins were identified as being 
present in undifferentiated cells only. Among these were several proteins that at the time were not 
previously known to be enriched in or specific for ESCs, such as: Top2A, Mcm4, Kpna2, and Sall4. 
Although both mass spectrometry (MS) based proteomics and stem cell research are upcoming fields, it 
is still difficult to obtain sufficient tissue to combine genomic and quantitative proteomics data. A final 
way of defining stemness is by using epigenetic markers, such as the chromatin state, which will be 
discussed in more detail in section 1.5.2. 
1.2. Induced pluripotent stem cells: maximize your pluripotential 
Although cell fates during development are neither restrictive nor irreversible, many assumed terminally 
differentiated cells had lost the potential of producing other cell types. Yamanaka and co-workers 
proved otherwise when they established the first induced pluripotent stem cells (iPSC) from mouse 
fibroblasts [12] in 2006. These iPSC are pluripotent cells generated from adult somatic cells by means of 
transfecting only four transcriptional factors: OCT4, SOX2, c-MYC and KLF4. Just six years later, this 
groundbreaking discovery would get him to win the Nobel Prize in Physiology or Medicine. In 2007, the 
same group published a study where iPSC were derived that could generate viable chimeras when 
injected in embryos, in contrast to the first generation iPSC. This is important since the formation of 
viable chimeras is considered a crucial characteristic for pluripotent stem cells. Therefore, they had to 
use Nanog as a marker to select for pluripotent stem cells instead of Fbx 15. At the same time, Thomson 
et al. achieved to create human iPSC out of human fibroblasts by means of a slightly different cocktail: 
OCT4, SOX2, c-MYC and LIN28 [13].  
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Despite the enormous potential for future applications in regenerative medicine, safety is the major issue 
burdening the clinical implementation of iPSC. Conventional reprogramming strategies rely on the stable 
integration of transgenes but coordinately introduce the risk of mutations being inserted into the target 
cell’s genome [14]. Hence, several nonintegrating reprogramming techniques have been developed to 
circumvent the risk of spontaneous tumor formation and to improve the quality of the generated iPSC, 
including the almost complete removal of the integrated viral DNA or alternatively, the use of 
nonintegrating viruses [15,16]. Furthermore, genome engineering is expected to further improve iPSC 
quality [17]. These virus-independent reprogramming methods are based on DNA, protein, or 
messenger RNA (mRNA) expression [18–20]. 
1.3. Stem cell states: PICMI as the connecting link between naïve and primed pluripotency 
Embryonic cells are pluripotent for only a short window of time in the embryo, nevertheless it has been 
shown that pluripotency is not a fixed state. Two phases of pluripotency can be defined: naïve – in the 
blastocyst and primed – in the post implantation epiblast [21–23].  
In theory, hESC should share more features with mouse ESCs (mESC), since both these cells are derived 
from similar stages in embryo development. Instead, hESCs - as well as human iPSC - appear to share 
defining features with  mouse epiblast stem cells (mEpiSCs), such as a flattened morphology and 
epigenetic silencing of one of the two female X chromosmes, amongst other things (Table 1.1). 
Nonetheless, both pluripotent states share a common gene expression signature which encompasses 
the core pluripotency network including Oct4, Sox2 and Nanog. Of relevance, detailed analysis of the 
morphological changes of the human ICM during the hESC derivation process revealed the formation 
of an obligatory transient structure, coined as the post-inner cell mass intermediate or PICMI, which 
expresses both early and late epiblast cell markers [24–26]. Further investigations on the characteristics 
of the PICMI, will help to get a more clear understanding of the human pluripotent states. 
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Table 1.1 Comparison of pluripotent stem cell types based on commonly recognized cell properties [27] 
Properties mESC 
NAIVE 
mEpiSC 
PRIMED 
hESC 
PRIMED 
Origin ICM Epiblast ICM 
Morphology Domed Flattened Flattened 
Clonogenicity High efficiecy Low efficiency Low efficiency 
Single cell 
clonogenicity 
Yes No No 
Passaging Insensitive Sensitive Sensitive 
Chimerism High efficiency Very low efficiency N/A 
Growth factor 
dependence 
LIF and BMP4 bFGF and Activin bFGF and Activin 
Female X inactivation XaXa XaXi XaXi 
Markers Oct4, Sox2, Nanog, 
Ssea-1, Rex-1, Fgf4, 
Tert, klf2, Klf4, Stella, … 
Oct4, Sox2, Nanog, 
Ssea-1, Fgf5, … 
OCT4, SOX2, NANOG, 
SSEA-3/4, TRA-1-60, 
TRA-1-81, REX-1, TERT, 
STELLA, … 
 
1.4. The ethical dilemma of human stem cell research 
Few people doubt the medical potential of human stem cell research. Hence, the main controversy 
surrounding stem cell research is not whether we should use stem cells for research and therapeutic 
purposes, but rather about what sort of stem cells we should use and how we should obtain them.  
As with all other newcomers in the medical field, stem cell research deals with issues such as proving the 
effectiveness, minimizing the risks, personal questions about donation and consent, and social issues 
like the price tag being too high for patients or health services. Nonetheless, for the majority of people, 
the most difficult dilemmas arise regarding the downstream effects of hESC research (Table 1.2). Either 
one supports this and accepts the embryo destruction that comes along with it, or either one opposes 
and thereby accepts potential benefits of this research will be foregone [28]. Many people however, fall 
somewhere in between these opposite points of view. They see the human need and hope for new 
treatments, but at the same time believe a human embryo is more than just a clump of cells. 
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Table 1.2 Ethical issues at different phases of stem cell research [29] 
Phase of research Ethical issues 
Donation of biological materials Informed and voluntary consent 
Research with hESC Destruction of embryos 
Creation of embryos specifically for research purposes 
Payment to oocyte donors 
Medical risks of oocyte retrieval 
Protecting reproductive interest of women in infertility 
treatment 
Use of stem cell lines derived at another 
institution 
Conflicting legal and ethical standards 
Stem cell clinical trials Risks and benefits of experimental intervention 
Informed consent 
 
In order to form an opinion, one can ask himself: “What moral status does the human embryo have?“. 
Some people believe that an embryo is a person with equal moral status as a baby or an adult. They feel 
we should not judge the embryo by its state of development but by what it will become. The opposite 
view says that the embryo becomes a person in the moral sense only at a later stage of development 
than fertilization. Some are even convinced that hESC research is a moral duty of humanity, if it provides 
a potential means to find treatments for otherwise serious and incurable suffering. But many other 
people believe neither of these radically opposed views do justice to the complexity of the developing 
embryo and hold a middle ground. They believe that the early embryo has a special status as potential 
human being but that it is acceptable to use it for research purposes given there is good scientific 
justification, careful oversight and informed consent from the couple donating the embryo for research 
[29,30].  
Does the dilemma get any easier if we move on from the theoretical discussion to a concrete example? 
Even though the first steps in that direction are made, cell replacement therapies based on hESC have a 
long way to go. But what if the use of hESC could reduce the use of animals for testing? Human stem 
cells and their derivatives could provide virtually unlimited sources of tissue to test drugs and chemicals 
for toxicity [31]. That way, the use of animals can be limited and gained insights can lead to improved 
human prediction models. On the other hand, can we replace one ethically controversial process (using 
animals) by another (using hESC)? If one disapproves of using animals to test cosmetics, can the use of 
cells derived from human embryos be approved instead?  
As the ample use of question marks used in this section illustrates, hESC research raises some complex 
moral and social issues. As a result, not only the public but also the funders of such research expect 
scientists to be able to show they are aware of, and understand, the ethical and social dimensions of 
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their work. The ethical issues thus need to be considered, along with the scientific challenges to ensure 
stem cell research is carried out in the appropriate manner.  
1.5. Epigenetics 
 A definition 
All cells in an animal originate from the same cell and therefore hold the same genetic material. Yet, e.g. 
a brain cell and a liver cell use this genetic information in a different way. This means there is a regulating 
mechanism on top of genetics, called epigenetics in which “epi” is the Greek prefix for “above”. When 
looking up the word “epigenetics”, one will find several definitions coming to the same conclusion: “An 
epigenetic trait is a stably heritable phenotype resulting from changes in a chromosome without 
alterations in the DNA sequence itself” [32,33]. 
The epigenome consists out of several epigenetic marks that tell genes to switch on or off, to speak 
loudly or whisper. It is through these epigenetic marks that extracellular and environmental factors like 
diet, stress and medication can make an imprint on our genes, that is passed on through cell division 
and from one generation to the next. The discovery that acquired characteristics can be inherited is a 
relatively new concept. During most of the 20th century we had a deal with biology: whatever choices we 
made causing obesity or hasten death, we could always rely on our genes. Our children would take a 
fresh start, the genetic slate would be wiped clean. Nowadays it is half time in the big “nature versus 
nurture” play-off and the answer lies somewhere in between. Our health, personality and other 
characteristics are based largely on the genes we inherited, but daily life habits and environment can 
result in epigenetic changes, altering gene expression. This also explains the differences between 
genetically identical twins. Some of the strongest evidence for transgenerational inheritance in humans 
comes from the survivors of the Dutch Hunger Winter (November 1944 – spring 1945) during which the 
population was trying to survive on only about 30% of the normal daily calorie intake. Monitoring of the 
pregnant women revealed that not only the birth weight of their own child was influenced by 
malnutrition, but the birth weight of their grand children as well. But make no mistake, epigenetics might 
be a new revolution, it’s not evolution nor does it dispel the main ideas of Darwinism. An epigenetic 
response can be inherited through many generations, but once the environmental pressure is removed 
it will eventually fade and the DNA code will return to its original programming. 
Waddington, who is given credit for coining the term “epigenetics”, created a metaphore for how gene 
regulation modulates development: the epigenetic landscape, as displayed in Figure 1.3 [34]. In this 
metaphore a marble rolling down a hill toward the lowest point represents the process of cellular 
decision making during differentiation and development. While still of great value in the context of 
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normal development, the Waddington model falls short of accommodating recent breakthroughs in cell 
reprogramming. The breakthrough of iPSC and advances in direct cell fate conversion suggest that 
somatic and pluripotent cell fates can be interconverted without transiting through distinct hierarchies 
[35]. The term epigenetics and its different components will be further discussed in section 1.5.2. 
 
Figure 1.3 Waddington’s epigenetic landscape [35] 
A: Marbles rolling down a specific groove represent the lineage commitment of pluripotent stem cells during cell 
development. B: An iPSC is symbolized by a marble rolling from the bottom of the hill back to the top. Thereafter 
it can be redifferentiated in another specific somatic cell type. C: During transdifferentiation, cell fates can be 
directly interconverted. 
 Unraveling the epigenetic layers 
The total length of the DNA in a single diploid human cell is approximately 2 m, but even so, it must fit 
into a cell’s nucleus that is roughly 10 µm in diameter. To accomplish this, the structural organization of 
DNA into eukaryotic chromatin involves several orders of compaction. Nucleosomes are the basic DNA 
packaging elements, formed by DNA wrapped around small histone proteins [36]. Epigenetic effects can 
take place at the chromatin, the DNA as well as the histone level. Furthermore, there are also RNA-based 
epigenetic mechanisms. All these different epigenetic mechanisms are shown in Figure 1.4 and will be 
described in the following paragraphs. 
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Figure 1.4 Epigenetic mechanisms 
The different mechanisms involved in epigenetics can be divided into 4 main groups. A: DNA methylation will 
hamper gene expression. B: PTMs on a histone tail can both induce or repress transcription, depending on the type 
of modification and the amino residue it is placed on. C: ATP-dependent chromatin-remodeling complexes regulate 
transcription by either translocating, ejecting or restructuring nucleosomes. D: Many of the non-coding RNAs can 
interact with translation of mRNA into a protein.  
 DNA methylation 
Methylation at the 5’ site of cytosine (5-mC) at CpG dinucleotides - also known as DNA methylation - is 
a major player in the process of epigenetic inheritance. DNA methylation of the mammalian genome is 
a repressive mark, which is directed and preserved by the actions of a DNA methyl transferase (DNMT) 
family – also called “writers” (Figure 1.5). The effect itself is established by recruitment of so-called 
“readers”, the methyl-CpG-binding domain or by blocking the binding of transcriptional factors [37].  
Until recently DNA methylation was thought of as stable and irreversible, as the removal of the methyl 
group of the 5’ site of cytosine is a thermodynamically unfavorable event. Nowadays it is known that 
DNA demethylation can occur, and this in two different ways: passively during DNA replication or actively 
through enzymatic activities. Passive DNA demethylation involves DNMTs being denied access to the 
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newly replicated DNA, which results in an unmethylated status. Active DNA demethylation on the other 
hand can be exerted via one out of the two currently known ways of operating. First, activation-induced 
cytidine deaminase has been shown to play a key role in genome-wide demethylation of mouse 
primordial germ cells [38]. Second, several research groups demonstrated the capacity of Ten-11 
translocation (TET) family proteins to convert 5-mC to 5-hydroxymethylcytosine (5-hmC), 5-
formylcytosine (5-fC) and 5-carboxylcytosine (5-caC), resulting in base excision repair, in the absence of 
cell division [39,40].  
 
Figure 1.5 DNA methylation [41] 
The DNMT family of enzymes catalyzes the transfer of a methyl group to DNA by using S-adenosyl methionine 
(SAM) as the methyl donor. 
 RNA based epigenetic mechanisms 
Genome wide studies have revealed that even though only 1-2% of the human genome encodes for 
proteins, still up to 90% is transcribed [42]. Hence, this results in a large pool of non-coding RNAs 
(ncRNAs) which underlie an additional set of epigenetic mechanisms.  
These ncRNAs can be classified into two main groups: infrastructural ncRNAs and regulatory ncRNAs. 
Ribosomal, transfer, small nuclear, and small nucleolar RNAs belong to the group of infrastructural 
ncRNAs. Regulatory ncRNAs can be divided into microRNAs (miRNAs), Piwi-interacting RNAs (piRNAs), 
small interfering RNAs (siRNAs) and long non-coding RNAs (lncRNAs) [43,44]. 
MiRNA are small RNAs (< 200 bp) that target mRNA in order to regulate gene expression. It has been 
postulated that they regulate the expression of 50% of all genes in a cell at posttranscriptional level [45]. 
In stem cells, it is shown that miRNAs are involved in controlling self-renewal and differentiation, by 
affecting DNA methylation processes [46]. SiRNAs can modulate gene silencing using the sequence 
complementary to the target mRNA, piRNAs on the other hand induce chromatin remodeling and 
transposon silencing by interacting with Piwi proteins. The majority of the ncRNAs belong to the group 
of lncRNAs, which comprise all ncRNAs of >200 bp in length. Among the most well described examples 
are the two lnRNAs Xist (17 kb) and its antisense transcript Tsix (40 kb) involved in X chromosome 
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inactivation, for which they ensure that only one of the two X chromosomes in females is expressed 
during development [43,44,46].  
Familial traits, including physiological and developmental processes are not always transmitted 
according to the Mendelian rules. As part of the epigenetic machinery, the non-coding RNA might be 
another player involved in this process. In order to be heritable, RNAs must be present within ova or 
spermatozoa, or in both [47]. Several studies have shown that a complex and diverse set of RNAs is 
present within gametes of males and females, as well as in early embryos [48–52]. However, in order to 
correctly estimate the effect sizes of RNA heritability a lot more research is still needed. 
 Chromatin based remodeling 
ATP-dependent chromatin remodeling complexes provide a means to package the same genetic 
material in two different chromatin states: euchromatin and heterochromatin. Euchromatin is the 
transcriptionally active state, whereas heterochromatin is the highly compacted form where only low 
levels of transcriptional activity are found. Together, the different subfamilies of chromatin-remodeling 
enzymes disrupt the chromatin interactions which allows for sliding the histone octamer across the DNA, 
changing the conformation of nucleosomal DNA and changing the composition of the histone octamer 
[53–55].  
 Posttranslational histone modifications 
Since some posttranslational modifications (PTMs) on histones are inheritable during cell division, they 
are generally considered to be a major type of epigenetic marks [56]. In this section several topics 
concerning these histone PTMs will be discussed: composition of the nucleosome, main classification of 
histone PTMs, biological mechanism of histone PTMs and an overview of the main modifications. 
As described above, in all eukaryotes, the genome is tightly associated with histone proteins in order to 
form chromatin, whose fundamental subunit is the nucleosome (Figure 1.6) [36]. Chromatin is essential 
for the compaction of genomic DNA but also represents a physical barrier to control DNA accessibility 
and gene expression. Each nucleosome is made up of four different types of core histones, which have 
been very well evolutionarily conserved [57]. Two H3:H4 dimers form a tetramer, which then binds to 
two H2A:H2B dimers in order to form an octamer. Due to the high abundance of lysine (K) and arginine 
(R), the alkaline histones are positively charged at physiological pH. DNA on the other hand has a 
negative charge coming from its phosphate group, therefore 146 bp of DNA can easily wrap around a 
histone octamer by mainly electrostatic forces. The nucleosomes, in turn, are held together by H1 linker 
histones [58]. 
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Figure 1.6 Condensed folding of DNA into a chromosome 
The DNA double helix is wrapped around the core histone octamer (H2A, H2B, H3 and H4: two each) and forms a 
nucleosome. These fundamental subunits are packed together into chromatin. Chromatin is then further organized 
into a chromosome, located in the nucleus [59]. 
When looking at the structure of a nucleosome, one can see that the histone N-tails protrude out of the 
nucleosome, making them more susceptible for PTMs. Nevertheless, PTMs can also be found within the 
globular domain and even at the C-terminal tail of H2A and H2B [60]. Three different types of histone 
modifications can be distinguished. First, the addition of a functional group or protein to a specific amino 
acid (Aa). Examples thereof are K methylation, acetylation and ubiquitination amongst others. However, 
these PTMs represent only a small part of all the possible modifications, as probably some of them are 
yet to be discovered. Tan et al. published in 2011 a list of 67 new histone marks, which increased the 
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number of known histone modifications by 70% [61]. Second, the chemical or structural nature of the 
Aa residue itself can be altered by e.g. citrullination which is the posttranslational conversion 
(deimination) of an R residue within a protein to the non-coded Aa citrulline. An example of structural 
change is proline isomerization [62]. More drastic structural changes such as histone clipping are 
considered the third type of histone PTMs. The latter will be discussed more elaborately in Chapter 4. 
The combinatorial complexity of all different PTMs is often referred to as “the histone code” and extends 
the information potential of the genetic code [63,64].  
Histone PTMs are thought to regulate chromatin structure and function by two main mechanisms. First, 
as a result of neutralizing the histones’ charge state or through internucleosomal interactions, the 
higher-order structure of chromatin can be reformed, thereby influencing the access of DNA-binding 
proteins, such as transcription factors. Additionally, histone PTMs can function either by recruiting PTM-
specific binding proteins (“readers”) and their associated binding partners (“effectors”) or by inhibiting 
the binding of a protein to the chromatin. Installing and removing of the histone PTMs themselves is 
regulated by a diverse group of enzymes, called “writers” and “erasers” respectively. 
The PTM induced changes in interaction between chromatin and its binding factors is translated into a 
biological outcome [65]. Interestingly, the same histone PTMs can correlate with transcriptional 
activation or repression depending on the type and localization of the modification. Twenty types of 
histone PTMs have been reported (Figure 1.7) but only the main modifications will be discussed 
hereafter. 
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Figure 1.7 Structure of histone PTMs [66] 
 
Acetylation (Ac) on K neutralizes the charge of the basic histone proteins and thereby interferes with the 
histone-DNA interaction. DNA becomes thus more accessible for DNA transcriptors, leading to increased 
gene expression. It is one of the most widely studied PTMs and is catalyzed by a group of enzymes called 
”histone acetyltransferases”. Deacetylation on the other hand is catalyzed by “histone deacetylases” and 
results in gene silencing [67,68]. Acetylation increases the weight of a histone peptide by ~42 Da per 
acetyl moiety. 
Lysine or arginine methylation (me) is a covalent modification that represents the addition of a methyl 
group from the donor SAM to the side-chain nitrogen residue. Although there is a pKa shift, methylation 
does not change the charge on histone proteins at physiological pH and hence its electrostatic 
interaction with DNA is not affected. It will mainly serve as an anchor site that can be recognized via 
specific binding domains. Thereby, methylation can be related to activation, elongation, or repression of 
gene expression dependent on the site and extent of methylation [67,69,70]. For example, H3K4me, me2 
and me3 associate with transcriptional activation [71–73], whereas methylation on H3K27 leads to 
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transcriptional repression [74]. Histone arginine methylation is strongly associated with gene activation 
[67]. Methylation increases the weight of a histone peptide by ~14 Da. 
Another important modification that occurs on histones is phosphorylation (ph) on serine (S), threonine 
(T) or tyrosine (Y) that is mediated by various specific protein kinases. Phosphatases on the other hand 
mediate the removal of a phosphate group. Just as acetylation, a phosphate group generates an overall 
negative charge on these residues, thereby interfering with DNA-histone interactions. Each phosphate 
group adds ~95 Da to the histone’s molecular weight. Little is known about the relationship between 
histone phosphorylation and gene expression. Nevertheless, it is an important modification since histone 
phosphorylation participates in many cross talk events with other histone modifications. For instance, 
H3S28ph enables the demethylation and further acetylation of the neighbouring H3K27. Beside its role 
in chromosomal condensation and transcription, phosphorylation of H2A.X is a universal and 
instantaneous cellular response to the DNA damage [67,68,70].  
Ubiquitination is a bulky modification (76 Aa protein molecule) on the small histone peptides. Each 
ubiquitin group adds approximately 8.5 kDa and in case of polyubiquitination multiple ubiquitin 
monomers are attached to a single lysine, thereby forming a polymer. Ubiquitination typically marks 
proteins for proteasomal degradation via the 26S proteasome but in case of histones it provides other 
signals important for gene regulation [67,69,70]. Three possible mechanisms were proposed for how 
histone ubiquitination affects transcription. First, due to its large size ubiquitin may affect chromatin 
folding and DNA accessibility. Second, the ubiquitin moiety may function as an anchor site for the 
recruitment of various regulatory molecules. Finaly, ubiquitination may also influence other histone 
modifications, thereby affecting transcription indirectly. For example, in euchromatin, ubiquitination 
would activate the transcription by enabling the methylation of H3K4 and facilitating the transcriptional 
elongation [70,75]. 
Like ubiquitylation, sumoylation is a very large modification (~100 Aa). It was demonstrated that 
sumoylation can take place on all four core histones. Sumoylation can also compete with other lysine-
targeted modifications, including acetylation or ubiquitylation, and thereby can switch transcription from 
the active to the repressed state [68,70,76,77].  
ADP-ribosylation is defined by the addition of poly (ADP-ribose) units specifically at the lysine residues. 
It plays an important role in DNA break repair mechanisms but also influences transcription. The latter 
is probably established through crosstalk with other histone modifications. For example, mono-ADP-
ribosylation on H4 seems to occur preferentially when H4 is hyperacetylated [67,68,70].  
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 Histone variants 
Next to the four canonical histone proteins, many histone variant forms exist in different organisms. 
Histone variants differ in certain residues or regions of their Aa sequence compared to their canonical 
counterparts (Table 1.3) [78,79]. These variants can be expressed throughout the cell cycle, which 
suggests they have other functions to fulfill next to DNA compaction and are usually present as single 
copy genes. Since there are so many different variants and therefore combinatorial possibilities the 
question arises whether these structural variations induce differences in function and localization of the 
nucleosomal structure [80]. In general, H2B variants have tissue-specific functions, for example in the 
testes of both vertebrates and invertebrates [81–83]. The first H4 isoform has recently been identified in 
human fat cells [79]. H3 en H2A variants have a broad range of possible functions during development 
and differentiation, and some variants can switch places with pre-existing histones. Several groups 
reported the role of histone H3.3 in transcriptional activation [84,85].  
Table 1.3 Overview of known histone variants [55,78–82]. 
Canonical histone Histone variants 
H1 H1.0 H1.1 H1.2 H1.3 H1.4 H1.5 H1X 
H2A H2A.X H2A.Z H2A-BDB MacroH2A 
H2B hTSH2B H2BFWT TH2B 
H3 H3.1 H3.2 H3.3 H3.t CENP-A 
H4 H4.B 
  
“Men are only so good as their technical developments allow them to be.” 
― George Orwell 
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 TECHNICAL BACKGROUND 
2.1. The importance of proteomics 
Proteomics is an emerging field in molecular biology (Figure 2.1) that deals with the systematic large 
scale analysis of proteins. The proteome is referred to as “all proteins expressed in a given organism, 
tissue, organ or cell culture under defined conditions”.  
Despite the great technological breakthroughs in the genomics field, such as next generation 
sequencing in 2005, the need for proteomics still remains. Nucleic acids, while undoubtedly vital 
molecules in a cell, are mainly information carriers. Therefore they can only tell us about protein function 
indirectly, while proteins are the actual functional molecules in the cell. Moreover, as RNA can have 
alternative splicing products and proteins can be modified in many different ways, over a million different 
proteoforms exist, in contrast to the ~20.300 protein-coding genes identified. Thus, much of the 
complexity created by our biological machinery originates at the level of protein variation rather than 
genome variation [86,87].  
Proteins are omnipresent in all organisms as hormones, enzymes, antibodies, transporters, receptors, 
etc. and are thus involved in almost every biological function. A comprehensive analysis of the proteins 
in a cell provides a unique global perspective on how these molecules interact and cooperate. In 
addition, proteins are the primary targets of most drugs and therefore are the main targets for 
developing new ones.  
The ever-ongoing developments in data generation and data interpretation lead towards new 
technologies in the field of proteomics based on liquid chromatography coupled mass spectrometry 
(LCMS) [88]. Nevertheless, important hurdles must be overcome at every stage of the process, from 
sample preparation through data analysis. One major drawback of proteomics is the lack of an 
amplification method equivalent to the polymerase chain reaction (PCR), for the analysis of very scarce 
proteins. The complexity of the proteome and the broad dynamic range of protein concentrations 
hamper adequate protein mapping and quantification, considering that the typical dynamic range of 
LCMS detection is 4-6 orders of magnitude, while in biological samples the protein concentration can 
span 12 orders of magnitude (from mg/ml to fg/ml). For this and other reasons, complete coverage of 
the proteome cannot yet be obtained and information about splice variants, isoforms and PTMs is often 
missing [87,88]. Technology gradually moves past these technical limitations, but the transition from 
bench to bedside remains challenging. Multiple MS strategies are used these days to unravel molecular 
mechanisms, but the applications are mainly limited to the discovery phase. Next to this so called 
discovery proteomics, targeted proteomics - in which researchers focus their experiments on the subset 
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of proteins important to their line of inquiry - has been steadily gaining attraction over the last few years 
[89]. In targeted proteomics experiments, selected reaction monitoring acquisition has the ability to 
increase the sensitivity and specificity of the analysis, also in complex samples. Finally, new initiatives are 
essential to promote the efficient sharing and integration of the proteomics data. In another 15 years it 
might thus be that cell biology students will have to be as familiar with MS as they currently are with 
microscopes (Figure 2.1) [90].  
 
Figure 2.1 Normalized trend in publication (dark color) and citation numbers (light color) for the topics 
'proteomics' (blue), ‘MS’ (green) and ‘LCMS’ (orange) over the past 15 years [91] 
 
2.2. Strategies for protein separation 
MS driven proteomics requires methods for the separation of protein mixtures into their individual 
components, and this for two major reasons. First, during most experiments proteins are obtained via 
cell lysis or out of complex biological samples, such as tissues. In an eukaryotic cell at least 50.000 – 
100.000 different proteoforms may easily be present when taking PTMs into account, resulting in an 
enormous complexity at the proteome level. Second, most mass spectrometers can only analyze a 
limited amount of peptides co-eluting from the LC system. Currently, no LCMS platform can handle such 
complexity. 
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Selective methods aim to isolate individual proteins by exploiting their very specific properties such as 
binding specificity or biochemical function, e.g. affinity based chromatography to enrich for a certain 
PTM. Even though these methods are definitely very useful, the following paragraphs will mainly focus 
on nonselective isolation methods used in this work: sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) and LC. These methods aim to fractionate a complex protein mixture in such 
a manner that all individual proteins and peptides derived from them, or at least a substantial fraction 
thereof, are readily available for subsequent analysis. The underlying principle is always the application 
of physical or chemical differences between proteins which will lead to different behavior in a particular 
environment. The two major requirements for such separation strategies are the need for high resolution 
and high throughput.  
 SDS-PAGE 
The purpose of SDS-PAGE is to separate proteins according to their size, and thus molecular weight, 
irrespective of charge. This is accomplished by the addition of SDS to the sample, prior to the separation 
process in a polyacrylamide gel. Due to the exposure of denatured proteins to the negatively charged 
SDS, the latter will bind stoichiometrically with the polypeptide backbone. This implies that larger 
proteins will bind more SDS than smaller ones. As a result all protein-SDS- complexes have the same 
charge density and the relative differences in mass between proteins are maintained. The actual 
separation takes place by using an electric field to pull the proteins through the gel. The gel enhances 
the size-dependent separation by sieving the proteins as they migrate through it. The speed at which 
this takes place is dependent on the size of the protein itself as well as the gel polyacrylamide 
concentration. The latter determines the pore size of the gel: the higher the gel concentration, the 
smaller the gel pores will be, and thus the harder it will be for (larger) proteins to move through. Smaller 
proteins will migrate faster through the gel pores. In order to estimate the mass of the proteins in the 
sample, a series of protein markers with known masses can be included in one of the lanes. 
 LC 
Chromatography is a separation technique that was invented in 1906 by a Russian-Italian botanist during 
his efforts to separate plant pigment, hence the name chromatography (Greek: chroma = color; grafien 
= writing). Nowadays, chromatography is known as any of the various techniques available for the 
qualitative or quantitative separation of a mixture’s components, characterized by the use of a fixed 
stationary phase and a free moving mobile phase. Chromatography comes in all different sorts and 
types, including paper chromatography, thin layer chromatography, gas chromatography and liquid 
chromatography. They all depend on the same underlying principle: the sample mixture is dissolved in 
a fluid called the mobile phase. As the mobile phase moves over the stationary phase, the components 
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can interact with both the solvent molecules and those of the stationary matrix. The separation is then 
based on their differing affinity for each phase. Molecules with the least interaction with the stationary 
phase move the quickest, since they tend to stay in the mobile phase, and vice versa (Figure 2.2).  
In proteomics, LC is an indispensable tool because of its high versatility, high throughput, high resolution 
and compatibility with MS. Moreover, unlike gel electrophoresis, LC is suitable for the separation of both 
peptides and proteins. Another advantage of LC is the broad selection of stationary and mobile phases: 
alternative LC methods can be based on different separation principles such as size, affinity, charge or 
hydrophobicity. In this work reversed phase LC (RP-LC) was used, whereby peptides are separated by 
their hydrophobic interaction with the non-polar groups bound on a stationary phase such as C4 or C18 
alkyl groups. The mobile phase composition is usually water, or a water-miscible organic sovent 
(methanol, acetonitrile) which is forced through the column under high pressure (RP-HPLC). Gradient 
elution is achieved by gradually increasing the amount of organic modifier in the mobile phase, which 
promotes desorption of the least hydrophobic molecules first. More hydrophobic peptides are eluted 
slower than the hydrophilic ones. 
 
Figure 2.2 Protein purification by column chromatography 
A sample (brown) is fractionated by means of column chromatography. The red fraction shows 
the highest affinity for the mobile phase and is eluted first. The blue component on the other 
hand is retained longer on column due to stronger interactions with the stationary phase.  
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2.3. MS based proteomics 
A mass spectrometer is an analytical instrument that discriminates ions in the gas phase, based on their 
mass to charge ratio (m/z), with high sensitivity and specificity. This thesis will focus on the use of MS to 
investigate the proteome (Figure 2.3), more specific the histone proteome. MS is also applied in other 
fields, such as metabolomics, glycomics, lipidomics and small molecule analysis. One of the most popular 
hybrid designs combines two important mass analyzers: a quadrupole (Q) coupled to a time-of-flight 
(TOF) mass analyzer. The different units of such a Q-TOF instrument will be discussed below. 
Briefly, during tandem MS the m/z ratio of a peptide is measured, whereupon it gets separated from all 
other ions by a mass analyzer. These targeted peptides then become fragmented in a collision cell and 
the so-generated fragment ions are measured by a detector. This paragraph will also briefly discuss the 
different methodologies for data interpretation, followed by an overview of the strategies available for 
quantitative proteomics.  
 
Figure 2.3 A typical proteomics experiment [92].  
After the digestion of proteins into peptides, the complex mixture gets separated by HPLC prior to MS analysis. 
Briefly, peptides are ionized using ESI, all peptides are acquired in a full spectrum MS scan, followed by the selection 
of a specific precursor to be fragmented and generate a MSMS spectrum. The data are then processed to be 
identified, quantified or both.  
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 Ionization 
The development of soft ionization techniques in the late eighties made it possible to achieve ionization 
of peptides and other molecules without significant fragmentation; resulting in the possibility to analyze 
peptides via MS. Two such methods have been widely adopted in proteomics and were rewarded a 
Nobel Prize in 2002: electrospray ionization (ESI) and matrix assisted laser desorption ionization (MALDI). 
Whereas MALDI-MS is a very sensitive method, it is mainly used for simple peptide mixtures, given that 
it cannot be easily coupled to an LC instrument. LC ESI-MS is more suited for the analysis of complex 
peptide mixtures and will therefore be discussed in more detail below.  
ESI was introduced by Fenn in 1984 [93], which has transformed the field of MS ever-since. In the mid-
nineties Wilm et al. introduced nano ESI and thereby allowed for the characterization of low 
concentration peptides due to improved sensitivity [94]. Here, peptides are dissolved in an 
aqueous/organic solution and forced through a narrow needle, held at high voltage (1500-3500 V). A 
fine spray of charged droplets emerges from the needle tip and is directed into the vacuum chamber of 
the mass spectrometer through a small orfice. A drying gas (often nitrogen) facilitates the evaporation 
of the solvent and thereby reduces the size of the droplets. The imbalance between surface tension and 
electrostatic repulsion finally causes a Coulomb explosion generating the ions in the gas phase (Figure 
2.4). These multiply charged peptides are then drawn into the vacuum of the mass spectrometer, forming 
an ion beam.  
 
Figure 2.4 Schematic representation of the electrospray ionization process [95] 
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 Mass analyzers 
The mass analyzers are the beating heart of a mass spectrometer since they can both separate as well 
as analyze the ions based on their m/z ratio. In a Q-TOF instrument the Q can be used as a lens or a 
selector, depending on the acquisition mode, and the TOF is the actual mass analyzer (Figure 2.5). 
A quadrupole consists out of four parallel metal rods: one pair with a positive electric potential and one 
pair with a negative potential. By alternating the radiofrequency voltage set in the two pairs of rods, ions 
are attracted in an alternating way to the active electrode. Since the two dimensional oscillation is 
dependent on the m/z ratio, only ions with a specific m/z ratio will get a stable directory and thus be 
able to pass through the Q. Changing the voltages alters which m/z ratio can get through without 
crashing into one of the rods. Quadrupoles are easy-to-use, cover a large mass range and are thus ideally 
suited to act as a mass filter, lens or analyzer. 
Unlike Q instruments, no electric field is required to separate ions in a TOF instrument. It exploits the 
fact that in any mixture of ions carrying the same charge, light ions will be able to travel faster compared 
to the heavier ones. As the distance of the ions from pusher to detector is fixed, it measures the flight 
time taken by an ion, and thus its velocity, and accordingly its m/z ratio. Crucial however is that all ions 
possess an identical kinetic energy at the onset of the measurement, since this also affects the time-of-
flight. To compensate for the variation in kinetic energy a reflectron is often used at the end of the field-
free region to reflect and focus incoming ions with slightly different kinetic energies. 
 
Figure 2.5 Schematic of the Waters Micromass Q-TOF Ultima ESI-MS (z-spray) [95] 
 
Throughout this work two ESI-Q-TOF mass spectrometers were used: TripleTOF 5600 (Sciex) and Synapt 
G2Si (Waters) (Figure 2.6). Both mass spectrometers are state of the art technology and display some 
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unique features. The TripleTOF 5600 system combines high-sensitivity detection and high resolution 
with fast acquisition speeds, and stable mass accuracy. Moreover, the instrument enables MSMSALL with 
SWATH acquisition [96]. In the Waters’ Synapt G2Si, the quadrupole is supplemented by traveling wave 
technology (T-wave) which allows ion mobility separation. This separartion technique separates peaks 
according to their collisional cross section, specified by the charge, size and shape of the peptide. For 
example, peptide ions with multiple charge states can be separated as peptide ions with a higher charge 
state experience a higher electric field, resulting in a higher drift velocity and lower drift time. Along with 
the TripleTOF, this instrument can also perform data independent acquisition by means of HDMSE [97]. 
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Figure 2.6 Representation of the mass spectrometers available in the Laboratory of Pharmaceutical 
Biotechnology: (A) TripleTOF 5600 and (B) Synapt G2Si [96,98] 
 
 Fragmentation of peptide ions 
By fragmenting peptides, additional information is provided concerning their sequence and PTMs. 
During collision induced dissociation (CID), an intact peptide ion will be fragmented by colliding them 
with a stream of inert gas molecules such as argon. The generated fragments will be measured by the 
second mass analyzer and finally be measured by the detector.  
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The most informative fragments are those in which fragmentation has occurred along the peptide 
backbone. Two types of peptide fragments arise, each subdivided in three different classes (Figure 2.7.A): 
the a, b and c ions are fragments that retain the original N-terminus; while the x, y and z ions are 
fragments that retain the peptide C-terminus. In CID-mediated tandem MS (MSMS), interpretation 
generally involves the arrangement of b- or y-series ions in order of increasing mass (Figure 2.7.B). The 
y-ion series is often most informative because the charge most often remains on the C-terminal basic 
residue in a typical proteomics experiment wherein trypsin is used as the proteolytic enzyme to generate 
the peptides.  
Electron-capture dissociation (ECD) and Electron-transfer dissociation (ETD) both induce complementary 
fragmentation of multiple protonated peptides by transferring electrons to them. This addition of an 
electron creates a radical intermediate that almost immediately decays into fragments. The observed 
fragment ion types for ECD and ETD are predominantly c and z ions [99]. These fragmentation strategies 
provide an alternative sequence coverage and are useful in PTM research and top-down proteomics. 
 
Figure 2.7 MSMS for peptide sequencing and PTM detection [66,100,101] 
A: The Biemann nomenclature for peptide fragment ions. B: An MSMS spectrum 
example obtained by CID.  
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 Detection 
The final element of a mass spectrometer is the detector. Both the electron multiplier and the 
microchannel plate detector detect the current produced when an ion hits the surface. To increase the 
signal from a single electron, it gets amplified via secondary emission.  
Accurate quantitative results can only be obtained when working within the linear dynamic range of any 
given peptide, respectively. This linear dynamic range is the range over which the ion signal is directly 
proportional to the analyte concentration (Figure 2.8). The linear dynamic range as well as its 
corresponding limits of quantifications are peptide- and mass spectrometer dependent. The typical 
range is situated between 2 and 5 orders of magnitude [102]. 
 
Figure 2.8 Linear dynamic range and limits of quantification 
 
 Peptide identification 
All previous steps lead to the fragmentation of a precursor peptide and eventually result in a measured 
precursor ion m/z, a list of fragment ion m/z and intensities: the MSMS spectrum. Interpreting this 
spectrum and translating it into a peptide identification is the main goal in proteomics since it provides 
the main results of the experiment. Besides, peptide identification will also affect downstream data 
analysis such as quantification. Wrong peptide identifications will obviously lead to false biological 
conclusions. Four distinct strategies are commonly used in proteomics experiments for the identification 
of MSMS spectra: (i) de novo sequencing, (ii) sequence tag based approaches, (iii) spectral library 
searching and (iv) protein database searching.  
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De novo sequencing as well as sequence tag approaches aim to infer a full peptide sequence directly 
from the MSMS spectrum. De novo sequencing is based on the distance between subsequent fragment 
ion peaks, while sequence tag based approaches generate only a list of small sequences from the 
spectrum. If both the sequence tag and the precursor mass match in a database, the peptide is identified. 
During spectral database searching, spectra are compared to a spectral library of previously recorded 
and identified MSMS spectra. Protein database search algorithms on the other hand will use a database 
of theoretically created MSMS spectra for comparison. Figure 2.9 below gives an overview of the 
different steps that occur in these different peptide identification strategies.  
 
Figure 2.9 Overview of the various steps that occur in different peptide identification approaches [103] 
 
 Quantitative MS proteomics 
Sometimes it is enough to know what exactly is in your sample, but more often researchers are interested 
in the exact quantification of a specific protein or peptide pool. This can be in absolute numbers, or 
relative to another sample. Since dynamic changes of histone marks are associated with many cellular 
processes such as transcription and DNA damage, it becomes important to quantify the changes in 
histone marks between two or more samples. Figure 2.10 gives an overview of all different methods and 
the ones used most frequently are discussed in more detail below. 
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Figure 2.10 Quantitative proteomics: an overview  
A: Chart representing the different strategies for quantitative proteomics. B: Workflows of the main quantification 
methods. Boxes in yellow and blue represent two different experimental conditions.  
 Metabolic labeling 
Metabolic labeling requires the introduction of isotopic labels directly in the medium of a cell culture 
during cell growth and replication. Mann and co-workers introduced the most popular metabolic 
labeling strategy in the proteomics community: stable isotope labeling by amino acids in cell culture 
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(SILAC) [104]. This approach uses heavy labeled essential amino acids (13C and 15N), usually R and/or K, 
which eventually become fully incorporated into the proteome. A second cell population is grown in 
parallel in normal medium and both samples are then analyzed in the same MS run. Relative 
quantification is performed on the MS level by comparing the ion intensities of each of the isotopic 
peaks corresponding to the same peptide. The main advantage of this technique is that labeled and 
unlabeled samples can be combined prior to sample processing, thereby reducing technical variation. 
The main disadvantage is that the heavy Aa themselves can get metabolized into other Aa, impairing 
accurate quantification [105,106]. In 2010, Geiger et al. introduced super SILAC, which is a mixture of 
several cell lines that serves as an internal spike-in standard [107]. 
Although metabolic labeling is mostly used for cultured samples, incorporating heavy labeled Aa has 
also been extended to whole model organisms, such as drosophila [108], chicken [109] and mice [110]. 
Yet, the high cost of the diet and the extensive time required for complete labeling limits its widespread 
in vivo application. 
 Chemical and enzymatic labeling 
While SILAC provides a powerful experimental strategy, metabolic labeling is not always a feasible 
option, for example when working with clinical samples. One way of overcoming this problem is chemical 
or enzymatic labeling. In general, protein extracts from the different samples that ought to be compared, 
are chemically labeled during or post digestion and subsequently analyzed in the same MS run. 
Quantification can occur at the MS (ICAT, dimethyl labeling, 18O labeling) as well as the MSMS level 
(iTRAQ, TMT), and the main possible techniques are discussed hereafter. 
Isotope-coded affinity tags (ICAT) reagents consist of three functional elements: a reactive thiol group 
for derivatising the reduced cysteine residues, an isotopically coded linker and an affinity tag to enrich 
the labeled peptides [111]. A major disadvantage however of the ICAT technology is the fact that it limits 
quantification to cysteine containing peptides, which is one of the least abundant Aa in the proteome. 
Dimethyl labeling is an alternative method, based on the chemical labeling of primary amines (peptide 
N-termini and the ε-amino group of K residues) with light or heavy (13C, 2H) formaldehyde [112], thereby 
labeling every peptide after trypsin digestion. Even though dimethyl labeling is probably the least 
expensive and most straight-forward stable isotope labeling strategy it has not been extensively used 
and validated in the proteomics community. This might be partly due to the fact that deuterated 
peptides show a small but significant shift in retention time in RP-LC compared to their non-deuterated 
counterparts which can cause substantial quantification errors in quantitative proteomics [113]. 
Alternatively, the stable heavy isotope label can be introduced into the peptide during enzymatic 
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digestion and the accompanying reaction with H2
18O [114]. Proteolysis results in the incorporation of up 
to two 18O atom into the C-terminus of each proteolytically generated peptide. Although 18O labeling 
has the potential of being the ideal chemical labeling technique, it has not become a preferred method. 
Incomplete incorporation and the overlap of the isotopic envelope resulting from the small mass shift 
that is introduced are the most likely reasons for this.  
The strategies previously mentioned are all based on the mass difference generated between 
differentially labeled peptides. In order not to increase the complexity of the MS spectra too much, many 
experiment setups are limited to binary (2-plex) or ternary (3-plex) set of reagents. Yet, the use of isobaric 
tags for relative and absolute quantification (iTRAQ) [115] and tandem mass tags (TMT) based methods 
[116] allows for the relative quantification of multiple samples at the tandem MS stage. In these 
techniques the samples are first digested, whereupon both N-termini and lysine side chains of peptides 
are labeled with a different isobaric mass reagent in such a way that all derivatized peptides are isobaric 
and chromatographically indistinguishable. However, when subjected to CID, the different reporter ions 
typical for each label are generated. The ratios of the different tags at the MSMS level are then used as 
a quantitative read-out for the relative peptide abundance and thus serve as a surrogate measurement 
for the protein from which they derive. The main advantages lie in the possibility to do a multiplex 
analyses in the same LCMS run, thereby limiting the effect of technical variability. However, challenges 
still remain, such as the underestimation of the fold change and the inherent problems with precision 
and accuracy [117–119]. As for today isobaric labels are still a valued technique, but the high cost in 
combination with these drawbacks pave the way for label free quantitation strategies.  
 Label free quantitation 
Label free quantification does not require expensive labelling, nor the additional sample preparation 
steps that can result in experimental variability. Furthermore, the technique has become more reliable 
as a result of the constantly improving LC-MS equipment. This quantification strategy is based on the 
observation that the electrospray process gives rise to a signal response that is linearly correlated with 
the increasing concentration of the peptide. Label free approaches can be divided into two main groups 
by the way the abundance of a peptide is measured: (i) spectral counting and (ii) peak measurements. 
In the first group the total number of peptide spectra matching is taken as an indicator of the protein 
abundance [120]. Yet, this may lead to a bias in favor of large and more abundant proteins. Most label 
free analysis methods however rely on the direct evaluation of peak measurements (ion intensity and 
peak area) for relative quantification. The LCMS analysis of samples to be compared is then carried out 
separately and only at the final stage LC chromatograms are overlaid and compared at the MS or MSMS 
level. Although this method is relatively straightforward, several considerations must be taken into 
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account to ensure accurate and reproducible quantitation. Potential sources of technical variation (and 
thus experimental error) are unequal sample loading and run-to-run variation in the LCMS process, 
amongst others.  
Label free quantitation by measurement of peptide fragment signal intensity at the MSMS level was 
rarely used up to now due to the stochastic nature of data dependent acquisition (DDA). However, data 
independent acquisition (DIA) has the potential to make large scale MSMS quantitation a more viable 
alternative to label free MS quantitation. In 2012 an approach was developed, named “Sequential 
Window Acquisition of all THeoretical Mass Spectra” (SWATH) [121], whereby complex mass spectra of 
a predefined mass range are queried for the presence of specific peptides. The latter is done by using 
libraries of qualified peptide spectra, in combination with their accompanying retention time. In the 
second approach, named MSE, the collision energy is alternated between low and elevated energy scans. 
In the low energy scans the intact precursors are measured, in the corresponding high energy scan all 
these peptide ions are subjected to CID without isolation of a specific precursor. Afterwards it is possible 
to align the precursor and the corresponding fragments for identification as well as quantification 
[122,123].  
 Spiked standard 
In 2003, Gygi and his team introduced an innovative strategy used for targeted quantitative proteomic 
analyses: Protein Absolute Quantitation (AQUA) [124]. In contrast to the previously described methods, 
AQUA enables absolute protein quantitation instead of relative quantification, using stable isotope 
labeled peptides (mostly 13C and 15N). An AQUA peptide, which is a synthetic peptide corresponding to 
a peptide of interest, is spiked into a sample containing the native peptide. Both peptides will behave 
exactly the same during the following sample preparation and LCMS process (elution, ionization) and 
thus remain indistinguishable until the MS level where quantification becomes possible by comparing 
the signal intensity of both the spikes and sample peptide. 
2.4. MS for histone analysis 
Over the last decades, histone modification analysis has been mainly conducted using site specific 
antibody-based techniques such as Western blotting, immunofluorescence and chromatin 
immunoprecipitation, among others [125]. While these techniques are very useful, drawbacks such as 
highs costs, cross-reactivity, epitope occlusion and the need for prior knowledge make the discovery of 
new PTMs difficult. Hence, it is no surprise that the significant increases in mass accuracy and resolution 
of mass spectrometers have brought these instruments to the forefront as an analytical strategy to detect 
histone PTMs (hPTMs).  
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The same procedure as described in section 2.3 can be used for identification and localization of PTM 
sites. Each PTM will alter the molecular weight of the Aa it is located on. This can then be taken into 
account while interpreting the MS and MSMS spectra for identification. For example acetylation on lysine 
will result in a mass increase of 42.0106 Da, compared to an unmodified lysine reside. Nevertheless, the 
physical properties of histones, together with the large number of PTMs and variants make identification 
of histone PTMs a laborious task. The major difficulties arise prior to and post MS acquisition: during 
sample preparation and data analysis. Both these topics will be discussed below. First, we focus on three 
major strategies for sample preparation (Figure 2.11) namely bottom-up, middle down and top down 
approaches, and draw up some pros and cons for each strategy (section 2.4.1 till 2.4.3). Next, we provide 
some insights into the hurdles during interpretation of the MSMS spectra (section 2.4.4). Finally, since 
MS methods enable simultaneous detection and quantification, we elaborate further on the latter in 
section 2.4.5. 
  
 
Figure 2.11 Comparison of peptide 
centric versus protein centric MS 
strategies for the analysis of histone 
PTMs [126] 
A: During bottom-up analysis, histones are 
digested by a protease such as Arg-C or 
chemically derivatized prior to trypsin 
digest. The resulting peptides are then 
subjected to LCMS analysis using CID. This 
fragmentation technique generates b- and 
y-ions, which permits for the exact 
localization of a PTM. B: The middle down 
approach is also a peptide centric approach, 
but in contrast with the bottom-up 
approach other enzymes (such as Glu-C) are 
used for digestion. This results in larger 
peptides, compared to bottom-up. In the 
illustrated example, the full MS spectrum 
corresponding to peptide 1–50 is reported. 
The peak corresponding to 8+ charge state 
is then isolated and subjected to Electron 
Capture Dissociation (ECD) fragmentation. 
C: In the top down approach, a purified 
intact histone is analyzed in MS mode. In 
the example, the modified form of H3.1 is 
reported (middle panel) and the zoomed 
region of the ECD spectrum, corresponding 
to 18+ charge state of H3.1, is shown 
(bottom panel).
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 Bottom-up histone analysis 
Bottom-up is the most widespread strategy for both identification and quantification of histone PTMs 
(Figure 2.11). Since the N-terminus of histone proteins are highly enriched in basic residues like lysine 
and arginine a regular bottom-up MS approach is a challenge. Standard proteases such as trypsin will 
cleave after every basic residue and therefore generate small hydrophilic peptides with insufficient 
chromatographic retention. Moreover, the presence of frequent modifications on lysine residus will 
reduce digestion efficiency. Two approaches can be used to overcome these problems. (i) The use of 
Arg-C enzyme or Glu-C could partly circumvent this problem, but they both have their limitations. Arg-
C only cleaves at arginine but lacks efficiency and specificity resulting in poor MS analysis [127]. Glu-C 
on the other hand cuts at the C-termini of glutamic acid and aspartic acid residues which are less 
common Aa in histones, generating large and multiply charged peptides whose MSMS spectra are 
difficult to interpret. (ii) A solution can be found in chemical derivatization of histones on lysine and 
monomethylated lysine, followed by trypsin digestion [128]. The benefits of trypsin concerning efficiency 
and specificity remain, but larger peptides (6-20 Aa) ending on only arginine are formed. Moreover, the 
addition of a hydrophobic group on lysine increases retention time.  
Several lysine derivatization strategies have been developed over the years. One of the most adopted 
protocols applies propionic anhydride for derivatization (Figure 2.12) [128]. Nevertheless, also other 
derivatization methods are used. For example, Liao et al. published a paper using the propionic acid N-
hydroxysuccinimide ester instead of the anhydride [129]. The Smith group designed a method that uses 
deuterated acetic anhydride to acetylate all free and monomethylated lysine residues [130,131].  
 
Figure 2.12 Chemical derivatization of lysine residus by propionic anhydride [66] 
When propionylating histones prior to trypsin digestion, all free amine groups on the N-termini and the ε-amino 
group on free or endogenously monomethylated lysines will be blocked by the chemical propionyl group. When 
the N-terminus or a lysine residue is covered by an endogenous modification other than monomethylation, a 
propionyl group can no longer bind because the residue is blocked by that modification itself. Consequently, trypsin 
can no longer cleave after these derivatized lysine residues but results in proteolysis only C-terminal to arginine 
residues, mimicking an Arg-C digestion, but with the efficiency and reproducibility of trypsin. By propionylation post 
digestion, all newly generated N-termini will be propionylated as well. 
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The advantage of a bottom-up MS strategy lies in its high sensitivity and less complicated data analysis, 
compared to the middle down and top down approaches. Despite the many applications of bottom-up 
histone analysis, some limitations emerge as well. First, since bottom-up commonly uses CID for 
fragmentation, labile PTMs such as phosphorylation tend to be lost. Also, random backbone cleavage of 
the peptide backbone can be hindered due to the great amount of basic residues that prevent random 
protonation. Finally, because digestion results in short peptides (6-20 Aa) connectivity between long 
distance PTMs is lost and it is hard to assign PTMs to specific variants ([126,132]. Alternatively, to 
overcome these drawbacks, larger histone domains or intact histone proteins can be analyzed with 
respectively the middle down or top down strategy [133]. Pros and cons are listed in Table 2.1. 
 Middle down histone analysis 
As the name implies, the middle down approach is a compromise between bottom-up and top down 
strategies (Figure 2.11). It is still a peptide centric strategy, but it differs in the size of the peptides 
generated (>2 kDa). To obtain these larger peptides a protease other than trypsin must be used. In fact, 
AspN and GluC are often used since they cleave less frequently occurring Aa [126,134,135].  
The main advantage of this strategy is the possibility to examine coexistence of multiple PTMs. For 
example, when using Glu-C the entire H3 N-tail is cleaved since the first glutamic acid is at position 50. 
This N-terminal part contains most PTMs decorating this histone, which can then be related to each 
other. Moreover, ETD as a fragmentation strategy is better suited to preserve labile PTMs than CID and 
results in even backbone fragmentation. On the other hand, the fragmentation efficiency of this 
fragmentation technique is low. Another caveat of middle down MS is the decreased sensitivity (relative 
to bottom-up analysis), even though it is still remarkably higher than top down approaches. This can be 
explained by the fact that the MS signal is diluted by the different charge states of a larger peptide ion 
on the one hand, and by the increasing number of possible PTM combinations on the other. 
Furthermore, there is a need for specialized software to identify the complex combinatorial networks of 
histone PTMs and the algorithms used herefor are still in their infancy (Table 2.1) [136–138]. 
 Top down histone analysis 
Histones are rather small proteins (11-21 kDa) and therefore very suitable for top down MS analysis 
[139]. There is no digestion step required in this technique and complete proteins can be analyzed by 
the mass spectrometer (Figure 2.11). The primary advantage lies in the fact that all PTM crosslinks remain 
available for analysis, and thus can provide information about the stoichiometry of all modifications. 
Also, variant specific PTMs can be distinguished more easily. Yet, the same drawbacks as for middle 
down analysis remain: incomplete fragmentation, sensitivity drops, prefractionation is often required to 
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enable analysis of all the different proteoforms and instrument as well as software requirements are 
more advanced in terms of mass resolution and mass accuracy to deconvolute the very complex MSMS 
spectra (Table 2.1) [66,126,132,134,135].  
Table 2.1 Pros and cons of different MS strategies for histone analysis [134] 
MS strategy Scope Advantages Disadvantages 
Bottom-up Small peptide 
fragments 
Best sensitivity Lose connectivity of most PTMS 
 Easiest analysis Generally paired with CID 
  Labile PTMs lost 
  Non random backbone cleavage 
Middle down Medium peptide 
fragments (~50 Aa) 
Better connectivity than bottom-
up peptides 
Complicated data analysis 
 Better sensitivity than top down Lose connectivity of some PTMs 
 Retain labile PTMs Less sensitive than bottom-up 
 Even backbone cleavage Low fragmentation efficiency of 
ETD 
Top down Entire proteins Complete connectivity of PTMs Difficult data analysis 
 Paired with ETD Worst sensitivity 
 Retain labile PTMs Low fragmentation efficiency of 
ETD 
 Even backbone cleavage  
 
 Interpreting MS data during histone analysis 
Many search engines have been developed to quickly and accurately analyze large volumes of 
proteomics data. Popular softwares like SEQUEST, Mascot and Andromeda align experimental MSMS 
spectra with theoretical peptide fragmentation patterns [140,141]. Yet, identification of PTM bearing 
peptides, and histones in particular, is more challenging than that of the unmodified forms. This is 
because search alghoritms have to take into account the diversity of multiply modified forms that might 
exist. A database search with many PTMs will result in low search speed and an increased number of 
false positives. Besides, identifying new PTMs poses a challenge when performing a database search, 
since the new PTM will most probably induce an unknown mass shift. Finally, next to the identification 
of a PTM, correct localization is a struggle as well. In the paragraphs below, we discuss some of the 
efforts that have been made over the years in order to overcome these data analysis issues.  
(i) Several alghortims have been described with a procedure called “non restricted sequence alignment” 
[142–146]. These algorithms enable identification of a mass shift - caused by a novel PTM or mutation - 
by assuming that the mass difference in the MS spectrum can be localized to certain residues through 
comprehensive MSMS spectra alignment. Still, these methods suffer from ambiguous alignment and 
noisy background which makes manual validation inevitable [66]. (ii) Fu and co-workers proposed a 
method to estimate the individual PTM false discovery rate (FDR) from the global FDR [147]. (iii) Yuan 
et al. developed a strategy, named iterative search for identifying PTMs (ISPTM), for tackling this 
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challenge. In this approach unmodified spectra are identified in basic search, afterwards the leftover 
unidentified spectra are analyzed by iterative searches of many PTMs using a small number of them 
(usually two) in each search [148]. (iv) The group of Garcia thought of a strategy to evaluate search 
engines on identifying histone PTMs [149]. Hereby, histone data are searched with separate 
modifications and filtered for confident results (FDR <1%). Next, redundant identifications between 
different searches with low scores are discarded in order that only confident identifications remain. The 
authors put some of the more well known search engines to this test and found that two search engines, 
pFind and Mascot, identify most of the confident results at a reasonable speed. (v) Last but not least, 
also the technical improvements in mass spectrometers can facilitate database searching. Thanks to the 
higher mass accuracy of MS and MSMS spectra, the number of peptide and protein candidates gets 
limited, which reduces the search space [150]. 
Even though the previous paragraph illustrates identification of PTMs is a laborious task, this is even 
more true for determining the exact localization thereof on the peptide backbone. To accurately map a 
PTM’s localization, different tools have been developed. (i) Ascore measures the probability of correct 
PTM localization based on the presence and intensity of site-determining ions in MSMS spectra. While 
this subjective measure will vary from dataset to dataset, an Ascore of >20 is generally a "good" Ascore, 
with a site being localized with >99% certainty [151]. Maxquant/Anderomeda adopts a similar strategy 
for PTM scoring [152]. (ii) Another method for scoring the PTM-localization probability is the Mascot 
Delta Score or MD-score [153]. Here, the Mascot ion-score difference between peptide identification 
with different site locations are compared. The bigger the difference, the better. A MD-score of 10 means 
probabilities of 91% and 9% for two PTM localizations (based on the same spectrum). As the name 
suggests, this scoring method is only available when using Mascot as a software tool. (iii) In addition to 
these tools, many other scoring modules or softwares have been developed over the years, including: 
Phospho Score [154], phosphorylation localization score in Inspect [155], SLoMo [156], PhosphoRS [157], 
Phosphinator [158], SLIP score in protein Prospector [159], ModLS and D-score [160].  
 Quantification of posttranslational histone modifications 
Histones are involved in many cellular processes such as transcription and DNA damage repair. The 
dynamic changes of PTMs play an important role herein. Hence, many research groups want to quantify 
changes of histone marks between two or more samples. The various strategies mentioned in section 
2.3.6 can also be used for measurement of histone modifications, variants and turnover [161–169]. Since 
chemical labeling with dimethyl also labels primary amines, this is often replaced by isotopic propionic 
anhydride (e.g., H10 vs D10 or 
12C6 vs 
13C6) to label two pools of proteolytic peptides. In the following 
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paragraphs we will further discuss the most popular methods for determing the stoichiometry of histone 
marks.  
(i) First is absolute quantification of modification states. For this, synthetic, isotopically labeled peptides 
can be used as internal standard for both relative and absolute quantification [124,170]. The peptides 
are synthetized with the same sequence (and PTMs) as the peptide of interest, but isotopically encoded. 
Briefly, relative quantification is obtained when the intensity of each native modified peptide is compared 
with that of the internal standard. Absolute quantification can be achieved by making a calibration curve 
of the ion intensity versus the concentration of the peptide standard. (ii) Next is isotopic labeling in vitro 
by chemical derivatization. Analysis of iTRAQ data at the peptide level surfaced e.g. an interesting 
aberrant proteolytic product of a histone protein: clipping of the histone H2A C-tail [171]. Nevertheless, 
both TMT and iTRAQ have been mainly employed on chromatin for protein level profiling, with no focus 
on PTM changes [172–174]. (iii) Further, in vivo metabolic labeling has emerged as a powerful tool for 
accurate peptide/protein quantification. Even though SILAC is preferentially used to profile protein 
levels, it has also been successfully applied to identify and quantify hPTMs [163,164,175,176]. Zee et al. 
even used the SILAC approach to measure the turnover of both hPTMs and variants [177]. A variation of 
SILAC, known as heavy methyl SILAC (hmSILAC), is used for identification of methylation at K and R. In 
this approach, “heavy” methionine is added to methionine depleted media. From there, all proteins 
(histone as well as non-histone) will be enzymatically methylated by a heavy methyl group. The presence 
of a specific light and heavy peak pair in the MS spectrum can then be used for high confidence 
identification of a methyl group and subsequent quantification [178]. A drawback of SILAC is that the 
approach is limited to a comparison of no more than three functional states in a single experiment 
(unlabeled, 13C6- and 
13C6 
15N4-labeled Aa). Also, some samples - such as clinical samples - are not 
amenable to metabolic labeling as they contain no actively dividing cells to incorporate the isotopic 
label. This limitation was overcome by Mann and co-workers through the introduction of super SILAC 
[107]. In this approach, a standard heavy labeled proteome mixture is spiked into clinical samples, 
generating a universal reference for quantification. In order to use this strategy for quantifying hPTMs, 
a comprehensive set of heavy labeled histone peptides (containing virtually all known hPTMs) should 
however be generated as a universal reference. (iv) Lastly, label free quantification can be used for the 
relative quantification of histone PTMs. This technique enables determination of dynamic changes 
among dozens or even hundreds of samples and is cost-effective. Currently, most label-free 
quantification experiments are based on the calculation of the peak areas of the modified-peptide parent 
ions after standard DDA acquisition. In this type of analysis, the MS signal of all different modified 
peptides and their corresponding unmodified counterparts are considered. Specifically, the peak areas 
of the unmodified and all differentially modified forms of a histone residue of interest (e.g., H3K9 residue) 
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are summed and designated as 100%, and an individual form of a histone peptide is calculated as a 
fraction of the summed peak areas [179]. Recently however, label free quantitation methods based on 
DIA have been developed: HDMSE and SWATH [121,180]. The latter has been implemented by Sidoli et 
al. to monitor the dynamic changes in histone marks during differentiation of hESCs and mouse 
trophoblast stem cells. A general concern for label free quantitation is the variation in MS detection 
efficiency, induced by PTMs. This is partially due to the difference in ionization efficiency of peptides 
with the same sequence but a different PTM. This can be overcome by applying correction factors 
generated by spiking in synthetic histone peptide standards (internal correction) or by using information 
derived from independent MS analysis of those standard synthetic histone peptide mixtures (external 
correction). Nevertheless, due to the combinatorial versatility of hPTMs on the one hand and the high 
cost on the other, synthesis of all these peptides is not feasible [181].  
 
 
  
“In the beginning there was nothing, which exploded.” 
― Terry Pratchett 
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 OUTLINE AND AIMS OF THIS THESIS 
For over a decade, scientists have had access to a reference human genome: the complete set of genes 
in our cells. It is hard to think of any branch of human biology that has not benefited from the elucidation 
of the human genome sequence, given that it forms the foundation for understanding how variation in 
the genetic code can affect human health. But despite the technological improvements and biological 
discoveries, much remains to be understood about how genetic information is used by the individual 
cells in our body. This is where epigenetics comes in. Operating “on top” of the genome, epigenetic 
mechanisms collectively help in regulating gene expression and variations thereof without altering the 
primary DNA sequence. Metaphorically, the many different cell types throughout the body (found within 
brain, bone, heart, skin, etc.) represent different readers of that same three billion letter DNA 
encyclopedia, each highlighting their favorite parts, dog-earing certain pages, annotating interesting 
paragraphs, and crossing out things they find dull or uninteresting. This thesis focuses on one specific 
part of epigenomics that has remained relatively understudied compared to e.g. DNA methylation: 
histone PTMs. Nevertheless, these modifications also participate in gene expression regulation by 
influencing genome accessibility and/or recruitment of other effector proteins involved in transcription. 
We approach this matter from a biological (Chapter 4) as well as a technical point of view (Chapter 5 
and Chapter 6). The biological background was already described in Chapter 1; whilst Chapter 2 
summed up the most important techniques used throughout this work.  
Our first aim was to gain more insight in the importance of histone PTMs and histone clipping in 
particular. One very relevant model to study epigenetics are human embryonic stem cells (hESC). 
Differentiation of these hESCs provides a unique opportunity to study the regulatory mechanisms that 
facilitate cellular transitions in a human context. In order to achieve this goal, several questions were put 
forward: (i) “What is the biological relevance of histone clipping in hESC?” (ii) “Where does this 
clipping take place?” and (iii) “Which enzyme mediated this process?”. As described in Chapter 4, 
we were able to show for the first time that histone H3 clipping takes place in hESC, in contrast to 
completely differentiated Raji cells that do not show any clipping. We could pinpoint several cleavage 
sites and characterize the enzyme responsible to be a serine protease. Nevertheless, we have no 
conclusive evidence for the epigenetic relevance (or biological relevance whatsoever) of this process. 
Many theoretical approaches can explain how H3 clipping could be involved in several processes linked 
to gene expression. Yet, the question still remains as to whether H3 proteolysis correlates directly to or 
causes such processes. In the first part of Chapter 7 we elaborate further on this issue and put forward 
a proposal for categorization of histone proteolysis into complete degradation and specific clipping. 
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Our second objective was to improve both identification and quantification of histone PTMs through 
bottom-up MS. Chemical derivatization (mostly propionylation) prior to trypsin digestion is required to 
generate sufficient peptides of adequate length. Unfortunately, this additional step during sample 
preparation goes with a lot of technical variation, obscuring biological changes of epigenetic relevance. 
Therfore, the main research question is: “Do current propionylation protocols meet the technical 
standards needed for proper identification and quantification of histone PTMs?”. In Chapter 5 we 
disclose several pitfalls in propionylation that can hinder identifcation as well as quantification and make 
some suggestions for streamlined data analysis. We try to tackle each of these pitfalls more in depth in 
Chapter 6 and put forward a propionylation method of choice for future MS analysis. General conclusion 
towards different propionylation strategies can be found in the second part of Chapter 7.  
 
  
“If you try and take a cat apart to see how it works, the first thing you have on your hands is a non-
working cat.”  
― Douglas Adams 
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 HISTONE CLIPPING IN HUMAN EMBRYONIC STEM CELLS 
4.1. Abstract 
Histone PTMs are essential features in epigenetic regulatory networks. One of these modifications has 
remained largely understudied: regulated histone proteolysis. In analogy to the histone H3 clipping 
during early mouse ESC differentiation, we report for the first time that also in hESC this phenomenon 
takes place in the two different analyzed cell lines. Employing complementary techniques, different 
cleavage sites could be identified, namely A21, R26 and residue 31. The enzyme responsible for this 
cleavage is found to be a serine protease. The formation of cleaved H3 follows a considerably variable 
pattern, depending on the timeframe, culture conditions and culture media applied. Contrary to earlier 
findings on H3 clipping, our results disconnect the link between declining Oct4 expression and H3 
cleavage.  
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4.2. Background 
In all eukaryotes, DNA is tightly associated with histone proteins in order to form chromatin, of which 
the fundamental subunit is the nucleosome [36]. Each nucleosome consists of four different core histone 
types (H2A, H2B, H3 and H4), which have been very well evolutionarily conserved. Chromatin structure 
is essential for compaction of genomic DNA but also represents a physical barrier to control DNA 
accessibility and gene expression.  
In ESC the delicate balance of self-renewal and differentiation into specific lineages is determined by 
many lineage-restricted promoters that are associated with highly combinatorial histone PTM patterns 
which may determine their selective priming of gene expression during lineage commitment. Together 
with DNA methylation, ATP-dependent chromatin remodeling, RNA interference, ncRNA and 
incorporation of histone variants, these properties form the “epigenetic signature” [55].  
Not only ESC differentiation but also other biological contexts are characterized by a continuous 
interplay of installation and removal of histone PTMs. To accomplish the latter, several mechanisms can 
be at play. Apart from enzymatic elimination of modifications [55,68] and histone exchange [55,182,183], 
also regulated proteolytic histone cleavage has been suggested to play such role [184,185]. 
Duncan et al. showed that H3 is proteolytically cleaved at its N-terminus during early differentiation of 
mouse ESC (mESC) and they provide evidence for the regulatory capacity of covalent modifications 
herein [184]. Cathepsin L was found to cleave histone H3, with alanine 21 being the primary site of 
cleavage [184,186]. This truncated H3 form is detected during the first days of both monolayer 
differentiation (with and without retinoic acid (RA) induction) and embryonic body (EB) formation. Similar 
clipping events of H3 associated with other cellular processes including viral infection [187,188], aging 
[189,190] and sporulation [191] have also been reported. Additionally, protease activity towards H3 was 
also found in chicken liver and Tetrahymena micronuclei [192–195]. Although the molecular 
consequences of any histone clipping event are yet to be defined, these data seem to suggest an 
evolutionary conserved process.  
Here, we show for the first time that histone H3 clipping also occurs in human ESC lines (hESC) in addition 
to mESC. Several cleavage sites were assigned and the clipping enzyme was characterized as a serine 
protease. The manifestation of this proteolytic event can theoretically have an impact on several levels 
such as pluripotency and differentiation. Our results indicate that H3 cleavage can indeed be 
accompanied by a loss of Oct4 expression but does not exclusively occur in this condition. Hence, a 
direct correlation between these two processes cannot be claimed.  
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4.3. Methods 
Cell culture 
Two hESC lines were used: the UGENT2 cell line (XX), created in-house and the WA01 Oct4-eGFP knock-
in reporter cell line (XY), obtained from WiCell [196]. Both cell lines were cultured (5 % O2 and 5 % CO2 
at 37 °C) on a feeder layer of Mitomycin C inactivated MEF. Cells were passaged every 4 to 6 days, using 
1 % collagenase type IV and glass beads. Culture medium consisted of knock-out DMEM supplemented 
with 2 mM L-glutamine, 1 % non-essential Aa, 20 % knock-out serum replacement, 4 ng/ml bFGF, 
100 U/ml penicillin and 100 µg/ml streptomycin. 
Feeder-free cultures were maintained on a Vitronectin XF coating (Primorigen), in combination with 
Essential 8 medium (E8, Life Technologies). Cultures were split every 2 to 3 days by means of EDTA-
passaging.  
Differentiation was induced by omitting bFGF from the medium and by adding RA to the culture medium 
at a final concentration of 2 µM. 
THP-I cells were maintained in suspension culture in completed RPMI consisting of RPMI medium 
supplemented with 2 mM L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin and 10 % fetal 
bovine serum (37 °C, 5 % CO2). Medium was replenished or refreshed totally every other day. 
Differentiation was induced by addition of 1 µM RA. 
Raji cells (suspension) were cultured in completed DMEM consisting of DMEM medium supplemented 
with 2 mM L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin and 10 % fetal bovine serum (37 °C, 
5 % CO2). Medium was replenished or refreshed totally every other day. 
Cell cycle synchronization 
Raji and THP-I cells were synchronized by means of a double thymidine block. A first blocking was 
reached by exposure to an excessive amount of thymidine (2 mM) overnight. After this incubation period 
the cells were released again for 7 to 8 hours by washing off the thymidine. Subsequently a second 
overnight thymidine block was applied, after which the cells were synchronized at the early S phase. 
Propidium iodide staining 
The results of the cell cycle synchronization can be monitored with flow cytometry. To this end, the cells 
were stained with propidium iodide (PI) (ex. 488 nm, em. 617 nm). Prior to staining, the cells were fixated 
in ethanol at 4 °C during at least 2 hours. After washing the cells with phosphate buffered saline (PBS), 
staining was performed in the dark during 30 min (50 µg/ml PI and 10 µg/ml RNase in PBS).  
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Flow cytometry 
Oct4-eGFP or PI levels were monitored after cell isolation and resuspension in flow buffer (1 % BSA, 
0.1 % NaN3 in PBS) with an FC500 (Beckman Coulter) using the CXP analysis software. 
Fluorescence microscopy 
Fluorescence microscopy images of eGFP expression (ex. 485 nm, em. 515 nm, exposure time 5000 ms) 
were acquired on an Axiovert 200M inverted fluorescence microscope equipped with the Axiovision 
multichannel fluorescence module and an AxioCam MRM camera (Carl Zeiss). Colonies (without auto-
fluorescent medium) were screened at 10x magnification using a Carl Zeiss short distance Plan-Acromat 
objective and visualized using Zeiss filter set n° 38 (BP 470/40, FT 495, BP 525/50). For larger colonies, 
several images were stitched by use of Photoshop CS4 on TIFF images (Adobe).  
Acid histone extraction 
Cells were isolated using 0.25 % trypsin-EDTA. After a washing step, cells were resuspended in Triton 
extraction buffer (TEB; 0.5 % Triton X 100 and 0.02 % NaN3 in PBS) at a cell density of 1x10
7 cells/ml, and 
incubated for 10 min on ice. Subsequently the cells were centrifuged at 1500 rpm for 10 min at 4 °C, and 
resuspended in half the volume of TEB. After centrifuging again, the cells were resuspended in 0.2 N HCl 
at a cell density of 4x107 cells/ml and incubated overnight at 4 °C, after which the supernatant containing 
the histones, was isolated. Protease inhibitors (Roche, 11836170001) were freshly added to each buffer 
for every experiment, unless stated otherwise. Protein concentration of the extracts was measured by 
Bradford/Coomassie assay. 
Direct boiling in Laemmli buffer 
Direct boiling in SDS-loading dye for protein isolation was performed. Human ESC were directly boiled 
(3 min at 100 °C) after harvesting with trypsin, in 2X Laemmli buffer (4 % SDS, 20 % glycerol and 10 % 
β-mercaptoethanol in 50 mM Tris (pH 6.8)).  
Gel electrophoresis and Western blotting  
Per sample the required amount of histone extract was vacuum-dried and dissolved in 2X Laemmli 
buffer, separated on a 15 % Tris-HCl gel (BioRad Laboratories) and tank-blotted on a nitrocellulose or a 
PVDF membrane. The membrane was incubated overnight at room temperature with the appropriate 
antibody. The following antibodies were purchased from commercial vendors: a C-terminus directed 
histone H3 Ab (1:1000; Abcam, ab10799), an N-terminus directed histone H3 Ab (1:1000; Merck Millipore, 
05-499) and an antibody specific for the H3 N-terminus when cleaved after A21 (H3.cs1 Ab; 1:1000; 
Active Motif, 39573) anti-cathepsin L catalytic domain antibody (1:1000; Abcam, ab49984), anti-
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cathepsin L mature domain antibody (1:500; Abcam, ab58991), anti-cathepsin V antibody (1:1000; 
Abcam, ab49982), anti-neutrophil elastase antibody (1:500; Abcam, ab21595). All blots were detected by 
chemiluminescence using a Versadoc imaging system (BioRad Laboratories). Biotinylated histone H3 (as 
described below) was specifically visualized using HRP-conjugated avidin (45 min incubation; 1:100000; 
eBioscience, 18-4100-94). When needed, blots were stripped by incubating at 50 °C for 4 to 6 hours in 
stripping buffer containing 2 % SDS, 0.1 M β-mercaptoethanol, 0.05 M Tris (pH 6.8).  
In-gel digest of propionylated histones  
Vacuum-dried histones were propionylated as described [197] and separated by gel electrophoresis. 
Sypro Ruby (Invitrogen) stained gel pieces were cut out and subsequent in-gel digestion was performed 
as described before [198], with only a slight modification to the protocol: 25 mM ammonium bicarbonate 
(ABC) buffer was used and the alkylating agent applied was iodoacetamide (100 mM). After peptide 
extraction out of the gel pieces, samples were vacuum-dried and a second round of propionylation was 
completed to propionylate the newly generated N-termini. 
Reverse transcription – quantitative PCR 
RNA isolation, cDNA preparation and reverse transcription – quantitative PCR (RT-qPCR) analysis were 
performed as described before [199]. In short, cells were suspended in Trizol after isolation and stored 
at -80 °C. After reverse transcription (SuperScript II kit, Invitrogen), qPCR analysis was performed for 
pluripotency gene POU5F1 (Taqman assay Hs01895061_u1) with normalization to an optimized pool of 
3 reference loci, namely B2M (RTPrimerDB ID #2), RPL13A (#6) and AluSq (Forward: 
CATGGTGAAACCCCGTCTCTA – Reverse: GCCTCAGCCTCCCGAGTAG) (all SYBR Green assays). The 
additional TaqMan assays used were: cathepsin L (Hs00377632_m1), cathepsin V (H100426731_m1), 
neutrophil elastase (Hs00975992_g1 and Hs00975994_g1), all purchased from Life Technologies. 
 Histone biotinylation 
One mg of purified histone H3, isolated from calf thymus (Roche), was biotinylated using the EZ-Link 
Sulfo-NHS-Biotinylation kit (Thermo Scientific, 21425), according to the manufacturer’s conditions. After 
the biotinylation reaction, the excess of biotin-label was removed by addition of 5 % hydroxylamine 
(HA)-solution in a concentration of 6 µl HA per 100 µl sample. 
N-terminal sequence analysis 
A histone extract taken one day after induction of differentiation and known to contain clipped H3 (cH3) 
as validated by Western blotting, was blotted onto PVDF and proteins were visualized using Ponceau S 
staining. Subsequently the cleaved area was cut and subjected to Edman degradation, which was 
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outsourced to Eurosequence (Groningen, The Netherlands) and performed according to standard 
procedures.  
MS method 
Propionylated peptides were dissolved in 0.1 % formic acid in water (buffer A) and separated on a 
PepMap 100 (C18) column (I.D. 75 µm, length 25 cm, particle size 5 µm) by use of a U3000 LC-system 
(Dionex) at a flow rate of 300 nl/min. Elution was performed with 80 % acetonitrile/0.1 % formic acid 
(buffer B) using a gradient of 10 % to 60 % buffer B in 60 min. A Q-TOF Premier mass spectrometer 
(Waters) with nano-ESI source was operated in the data-dependent mode, with a resolution of 10.000. 
Survey MS scans were acquired (m/z 425-1300) and up to 7 precursors (m/z 50-2300) with charge state 
2+, 3+ or 4+ exceeding the signal threshold were isolated for fragmentation by collision induced 
dissociation, using the collision energy profile as suggested by the manufacturer. An inclusion list 
contained precursor m/z value 574.3 since preliminary experiments suggested that this is a cleavage site 
fragment. 
MS data analysis 
Database searching was performed against a custom-made database containing human histone 
sequences obtained from the National Center for Biotechnology (NCBI) database, using a Mascot 2.3 in 
house server (Matrix Science). Mass error tolerances for the precursor ions and its fragment ions were 
set at 0.35 Da and 0.45 Da respectively. Enzyme semi-specificity was set to Arg-C, allowing for up to two 
missed cleavage sites. Variable modifications included acetylation, dimethylation and propionylation on 
lysine, methylation and dimethylation on arginine and oxidation of methionine. Lysine monomethylation 
was searched as the sum of propionylation and methylation since monomethylated lysine residues can 
still be propionylated. N-terminal propionylation and carbamidomethylation of cysteine residues were 
set as fixed modifications. Redundant peptides were filtered including only the highest scoring match 
under the highest scoring protein containing that match. Low confidence identifications were excluded 
using an expectancy value cut-off of 0.05. Nevertheless all of the used spectra were additionally manually 
validated using Mascot Distiller software (Matrix Science).  
Nuclear extraction and protease inhibitor experiments 
Nuclear extracts (NE) were prepared using the commercially available Episeeker Nuclear Extraction Kit 
(Abcam, ab113474), omitting protease inhibitors during extraction. Calf H3 (1 µg) and NE (0.5 µg) were 
incubated together in buffer (150 mM NaCl, 2 mM β-mercaptoethanol, 0.1 mM EDTA, 10 % glycerol and 
25 mM Tris-HCl (pH 7.5)) at 37 °C for 1 hour, after which the assay was inactivated by incubation at 99 °C 
for 10 min. All samples were analyzed by Western blotting.  
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The protocol applied for isolating the nuclear fraction of THP-I cells used in the first step a hypotonic 
lysis buffer (10 mM Tris (pH 8), 1 mM KCl, 1.5 mM MgCl2, 1 mM dithiothreitol, PIC), in which the cells 
were incubated for 30 min at 4 °C. After centrifugation (10 min, 4 °C, 2000 rpm), the isolated nuclei were 
resuspended in R1-buffer (40 mM Tris, supplemented with tributylphosphine, phosphatase inhibitors, 
PIC and endonuclease) and sonicated for 10 min.  
For the inhibition assay the following commercially available inhibitors were used (Figure 4.11): 4-(2-
Aminoethyl)-benzenesulfonyl fluoride hydrochloride (AEBSF, Sigma-Aldrich, 76307), E64 (Sigma-Aldrich, 
E3132), EDTA (Sigma-Aldrich, E5134), Bestatin (Sigma-Aldrich, B8385), Pepstatin A (Sigma-Aldrich, 
P5318), protease inhibitor cocktail tablets (PIC, Roche, 11836170001) and three specific cathepsin L 
inhibitors (I (219421), III (219427) and CAA0225 (219502), purchased from Calbiochem. Inhibitors were 
pre-incubated with the NE for 15 min at 37 °C prior to addition of the H3 substrate. Their inhibitory 
capacity was validated and concentrations yielding aspecific inhibition were excluded from the assay. 
In vitro enzymatic incubation assays 
Recombinant active cathepsin L was purchased from Abcam (ab81780). Recombinant pro-cathepsin V 
was obtained from Enzo Life Sciences (BML-SE554-0010) and could be activated by pre-incubating the 
proenzyme in assay buffer for 5 to 30 min. The pH 5.5 buffer consisted of 10 mM HEPES, 10 mM KCl, 
1.5 mM MgCl2, 0.34 M sucrose, 10 % glycerol and 5 mM β-mercaptoethanol. The pH 7.5 buffer was 
composed of 25 mM Tris-HCl, 150 mM NaCl, 0.1 mM EDTA, 10 % glycerol and 2 mM β-mercaptoethanol. 
Incubations were performed at 37 °C for 1 hour. 
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4.4. Results 
 Feeder-Free cultured hESC show continuous histone H3 cleavage during differentiation  
To verify whether the histone H3 N-tail is cleaved during hESC differentiation in analogy to mESC [184], 
two hESC lines were monitored: an Oct4-eGFP reporter hESC cell line that expresses eGFP under the 
control of the Oct4 promoter and a non-reporter cell line UGENT2. Both cell lines were cultured in 
feeder-free conditions during 5 days after induction of differentiation by addition of 2 µM RA to the 
culture medium, in the absence of bFGF. Cells were isolated every 24h and histone extracts were 
prepared. 
The differentiation status during the experiments was validated for both cell lines. Morphologically each 
cell line displayed clear traits of differentiation, resulting in more lengthened cells and loss of round 
colony shape (data not shown). To further validate the efficiency of differentiation, Oct4-eGFP reporter 
cells were directly monitored by both flow cytometry and fluorescence microscopy [200]. Flow data 
showed a clear drop in eGFP signal through time (Figure 4.1A), and microscopy imaging visualized a 
sustained but definite reduction in eGFP throughout the hESC colonies (Figure 4.1B). To monitor loss of 
pluripotency in the conventional non-reporter stem cell line (UGENT2), RT-qPCR analysis of the 
pluripotency gene POU5F1 encoding for the transcription factor Oct4, coordinately confirmed 
differentiation in these cells (Figure 4.1C).  
HISTONE CLIPPING IN HUMAN EMBRYONIC STEM CELLS 
65 
 
 
Figure 4.1 Histone H3 cleavage in hESC under feeder-free culture conditions. 
Human ESC samples were collected during five days after differentiation induction with RA. Differentiation was 
confirmed by A: flow cytometry Oct4-eGFP analysis for the Oct4-eGFP cell line. In addition, B: fluorescence 
microscopy data affirmed a drastic drop in Oct4-eGFP signal when comparing an undifferentiated colony (Und) and 
a colony after three days of differentiation (scale bars represent 200 µm). Also C: RT-qPCR analysis illustrated the 
decrease in POU5F1 expression (encoding for Oct4) over time for the UGENT2 cell line (mean and standard deviation 
of 2 replicates). D: Western blot analysis (2 µg histone extract per sample) using a C-terminal H3 antibody reveals 
N-terminal H3 clipping (cleaved H3 indicated with an asterisk) in both the Oct4-eGFP reporter (upper image) and 
UGENT2 cell line (lower image).  
Samples were monitored for histone H3 cleavage by means of Western blotting analysis, using an H3 C-
terminally directed antibody. For both cell lines, lower molecular weight bands of histone H3 (indicated 
with an asterisk) were visualized at each time point throughout the differentiation experiment, indicating 
N-terminal cleavage of H3 (Figure 4.1D).  
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 Continuous histone H3 cleavage in the Oct4-eGFP reporter hESC line is not related to the 
Oct4 expression level 
The results above differ substantially from the data reported for differentiating mESC, which display a 
pattern with upcoming cH3, reaching a maximum intensity after 4 days, and decreasing again towards 
the end of the experiment [184]. The continuous H3 clipping found in feeder-free cultured hESC could 
be best explained by assuming that the timeframe was not extended enough to demonstrate the 
disappearance of cH3. The cH3 pattern might also be influenced by the speed and heterogeneity of 
differentiation, as also shown by Duncan et al., where spontaneous and RA induced differentiation and 
EB formation all lead to different cleavage patterns in terms of timescale. Therefore we repeated the 
experiment with the Oct4-eGFP reporter cell line, monitoring the hESC in feeder-free culture for a longer 
period of time (14 days), and subjected them to three different methods of differentiation to vary the 
speed at which they lose stemness throughout this timeframe: (i) in their undifferentiated status by 
culturing the cells in E8 medium, (ii) inducing spontaneous differentiation by omitting bFGF from the 
culture medium and (iii) enforcing directed differentiation by addition of RA. Morphological changes 
were observed using light microscopy (data not shown), global Oct4 expression and differentiation were 
monitored using flow cytometry. According to the flow plots shown in Figure 4.2A, the three used culture 
conditions indeed differ greatly in their (non)maintenance of stemness throughout the experiment. 
When analyzing the hESC, it is clear that E8 medium promoted the undifferentiated status in contrast to 
both differentiation methods which led to a decreased Oct4 expression. While spontaneous 
differentiation divided the culture system into two groups with loss of the Gaussian distribution in the 
flow histogram, RA induced a collective decrease in Oct4 expression of all cells resulting in a preserved 
Gaussian distribution shifting towards lower fluorescence. Also, differentiation induced by RA occurred 
much faster and a minimal Oct4 expression was reached after 12 days of differentiation while 
spontaneous differentiation continued at a slower pace and did not reach a minimum limit in Oct4 
expression after 14 days of differentiation.  
Despite the clear differences in Oct4 expression as described above, all time points in each culture 
condition appeared to display clear N-terminal H3 clipping when monitored with Western blotting 
(Figure 4.2B).  
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Figure 4.2 H3 cleavage in feeder-free cultured hESC under application of different culture media within an 
extended time frame. 
The Oct4-eGFP reporter cell line was cultured for 14 days in different conditions: (i) maintaining the pluripotent 
state in E8 medium, (ii) differentiating spontaneously (in the absence of bFGF) and (iii) differentiating after RA 
induction. A: Flow cytometry analysis displays a definite reduction in Oct4-eGFP levels under differentiation-allowing 
circumstances. The flow histogram plots show a variable shift in Oct4-eGFP signal under differentiating conditions: 
whilst the signal in RA-stimulated cells decreases collectively for the total population, the spontaneously 
differentiating cells are divided into two groups with different paces of differentiation. All data shown on the flow 
histogram depict data from the undifferentiated stage until day 14 of differentiation, with the most anterior graph 
representing the Oct4-eGFP signal from undifferentiated cells, and the graph most at the back illustrating day 14. 
B: Western blot images (2 µg samples, C-terminal H3 antibody) show continuous cH3 formation in hESC, regardless 
of the hESC culture condition.  
 Histone H3 clipping in hESC is not an in vitro artifact  
To exclude the possibility that this continuous histone H3 cleavage in a feeder-free culturing system is 
actually an in vitro artifact induced during extraction, we spiked biotinylated calf histone H3 during hESC 
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histone extraction at day 1 of differentiation for subsequent avidin-HRP detection on Western blot. We 
initially confirmed that indeed the biotinylated histone H3 still is susceptible to proteolytical degradation 
(Figure 4.3A). 
After spiking biotinylated calf H3 during extraction, a lower band was detected on the Western blot from 
the histone extracts only when using the C-terminal H3 antibody. This band was absent when 
immunoblotting was done using avidin-HRP, which specifically highlights the biotinylated fraction 
(Figure 4.3B). This implies that the histone H3 cleavage was indeed already present during culturing and 
that the truncated form was not created during extraction. Moreover, when the extraction was performed 
both with and without protease inhibitor cocktail (PIC), no difference between these samples was found, 
confirming that no additional cleavage was induced during extraction. Although we verified the 
enzymatic susceptibility of biotinylated H3,we also repeated this experiment by using non biotinylated 
calf H3. Here, we added an excessive amount of calf H3 to the buffers during the extraction procedure. 
Since western blot analysis can not distinguish between this calf H3 in and endogenous H3, we compared 
intensities of the lower cH3 band between the samples with or without spike in (data not shown). The 
relative abundance of clipped H3 was clearly lower in the HE spiked with calf H3, suggesting no 
additional proteolysis in vitro. Although we cannot exclude that this was due to an inhibitory effect of 
the excess calf H3 towards the clipping of the endogenous H3, this result at least suggests that the 
added calf H3 was probably not clipped to a notable amount during extraction and did not contribute 
to the cH3 content in the hESC samples  
 
Figure 4.3 Histone H3 cleavage is not an in vitro artifact. 
A: The digestion of purified calf H3 and biotinylated calf H3 with both trypsin or GluC was compared, and Sypro 
Ruby staining after SDS-PAGE illustrated the analogous susceptibility of both samples. B: Comparison of spiked 
biotinylated H3 (Biot-H3) with the H3 content extracted from hESC shows that only the latter undergoes truncation. 
As both immunoblotting images demonstrate, including the PIC (-PIC versus +PIC) during the extraction procedure 
does not influence the outcome. Per lane 2 µg sample was loaded. C: Illustrates the comparison of two different 
extraction protocols: TEB/HCl extraction (left, 2 µg sample) versus direct boiling in Laemmli buffer (right, 5 µl 
loaded). Western blotting analysis shows no difference in cH3 content between those protocols. 
In addition, the TEB/HCl extraction protocol was compared with direct boiling of the hESC after 
harvesting. Directly boiling in Laemmli buffer diminishes the steps of the extraction procedure and thus 
the steps in which cH3 can be artificially formed. For this experimental set-up, Oct4-eGFP reporter hESC 
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were differentiated with 2 µM RA for 24h. After this the hESC were harvested and split into two to carry 
out both protocols simultaneously on the same starting material. As can be seen in Figure 4.3C, both 
protocols result in the same Western blotting image containing cH3.  
Finally, besides the experiments to exclude possible unwanted in vitro clipping activity during the histone 
extraction protocol, we also briefly looked into whether or not the other core histones are processed 
during our hESC experiments. In the MS data obtained in search for the clipping sites (Results 4.4.4), we 
could not find any evidence for other clipped histone forms. Additionally, we analyzed several samples 
from differentiating hESC by means of Sypro Ruby staining after SDS-PAGE to visualize possible 
additional protein bands indicative of other degradation products. Again, no obvious changes in histone 
patterns were found, except for that of histone H3 (Figure 4.4). Although this is evidently not stringent 
enough to affirm their absence, it does add to the evidence for the specificity of this clipping event.  
Taking all these data together, we conclude that the detected H3 fragments must have been generated 
prior to the extraction procedure in our experiments. Nevertheless, undisputable confirmation hereof 
could only be attained by detecting the specific fragment in intact cells, e.g. by live-cell 
immunofluorescence staining with the H3.cs1 antibody. Yet, we consider the evidence outlined here 
adequate to imply a biological origin of the cH3 fragments in differentiating hESC. 
 
Figure 4.4 No general histone clipping in hESC. 
Sypro Ruby staining after SDS-PAGE (upper panel) shows no notable changes in any other core histone content 
other than histone H3. Specific western blotting analysis (lower panel) with the C-terminal H3 antibody clearly 
showed the cH3 content. Samples were obtained from a differentiation (2 µM RA) experiment performed on Oct4-
eGFP reporter cells (MEF culture) during 5 days. The input for each lane was 3 µg histone extract. 
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 Similar histone H3 cleavage sites are found in mouse and human ESC  
To verify if this H3 truncation event has any parallel to the clipping event reported in mESC, we next set 
out to identify the cleavage site(s). 
Applying the antibody directed against the C-terminus of H3, cH3 is visualized, in some cases as multiple 
bands. As opposed to the C-terminal antibody, immunoblotting with an antibody directed against the 
N-terminal end of histone H3 detected no cH3 for both the Oct4-eGFP reporter and UGENT2 cell line 
(Figure 4.5A and B). Only the band of intact histone H3 was seen, indicating N-terminal cleavage. When 
using the C-terminal antibody, the distance of the most intense cH3 band to the intact H3 form, implies 
a loss of approximately 3 kDa, which roughly corresponds to about 30 Aa. Using the histone H3.cs1 
antibody that was developed to specifically detect H3 truncated after A21 [184], a weak signal was 
detected for samples of the Oct4-eGFP cell line, suggesting A21 as a possible target site also in hESC. 
  
 
Figure 4.5 H3 cleavage in feeder-free cultured hESC under application of different culture media within an extended time frame. 
The application of differentially directed antibodies for immunoblotting (antibody epitopes displayed in A) illustrates that the cleavage is situated N-terminally, and proposes 
alanine 21 as one of the possible cleavage sites (B). C: MS analysis after propionylation of different hESC samples (Day 1, day 2, day 3 and day 6 of differentiation) also reveals 
residue 31 as a site of cleavage. D: An additional site, arginine 26, was annotated by Edman degradation.
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Apart from the most prominent A21, Duncan et al. found additional histone H3 cleavage sites in mESC, 
so we pursued further investigation of the presence of any other possible cleavage site(s) in hESC. A 
specific MS approach for histone analysis was therefore optimized which is subsequently described in 
more detail. A regular bottom-up approach using trypsin would cleave after each lysine (K) or arginine 
(R) (except when followed by a proline), resulting in unidentifiably small peptides because of the 
abundant presence of these basic Aa in histones. We thus propionylated the histones prior to digestion, 
which modifies all free primary amine groups (the N-termini and the ε-amino group of unmodified and 
monomethylated K). Of note, when the N-terminus or a lysine residue is covered by an endogenous 
modification other than monomethylation, this residue cannot be propionylated but is also blocked from 
proteolytical digestion by that modification itself. Consequently, trypsin now only cleaves C-terminal to 
arginine residues mimicking an Arg-C digestion for histone H3, resulting in larger, identifiable peptides 
[128]. By post-digestion propionylation all newly generated N-termini are subsequently being 
propionylated as well. The specific cleavage sites present in cultured hESC can then be detected as 
peptides containing a non-arginine C-terminus or which start N-terminally with an Aa not neighboring 
an arginine. Spectra corresponding to such so-called semi-Arg-C peptides were additionally manually 
validated. 
Hence we separated propionylated histone extractions of the feeder-free cultured Oct4-eGFP reporter 
cell line at four different time points after RA induction (D1, D2, D3 and D6) on SDS-PAGE (Figure 4.5C). 
This way, multiple molecular weight bands could be cut out for subsequent in-gel digestion using 
trypsin. After a second round of propionylation, samples were analyzed by RP-LC and ESI-MSMS. Of all 
identified histone H3 peptides, 100 % ended C-terminally with R and 94.4 % had an N-terminus adjoining 
an R, confirming successful propionylation. 
First, to confirm the N-terminal histone H3 cleavage by MS we monitored the presence or absence of an 
N-terminal histone H3 peptide in the intact H3 and the cH3 gel bands. The peptide K[9]STGGKAPR 
starting after R[8] covers the N-terminus of histone H3 and was only identified in the H3 bands and not 
the cH3 (Figure 4.5C), in contrast to the globular histone H3 peptides and the C-terminal 
V[117]TIMPKDIQLAR which were present in both. Two differentially modified semi-Arg-C peptides both 
started at residue 32 which N-terminally does not flank an R: T[32]GGVKpropKpropPHR and T[32]GGVKpropKme-
propPHR (Figure 4.6). Since these spectra correspond to the peptide generated by cleavage after Aa 31 
and this residue itself is not represented in the spectrum, it is impossible to define whether Aa 31 is an 
alanine or serine, coming from the H3.1/H3.2 or the H3.3 isoform respectively. At each of the four 
different time points A[31] or S[31] clipping was identified in the gel pieces containing cH3, but not intact 
H3. Of note, using this MS method no cleavage at an arginine residue can be detected, since the protocol 
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itself introduces clipping after arginine during digestion. Indeed, by applying Edman degradation, we 
also assigned R26 as a cleavage site (Figure 4.5D). Since the Aa at position 31 is identified by Edman 
degradation as an alanine this cleaved form is derived from the H3.1 and/or H3.2 isoforms.  
In conclusion, both Western blotting and MS confirmed N-terminal cleavage with an intact C-terminus, 
and the latter assigned Aa 31 as a cleavage site for histone H3 without isoform specification. N-terminal 
sequence analysis added R26 as a cleavage site, at least for the H3.1 and/or H3.2 isoforms. 
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Figure 4.6 Manual validation of cleaved H3 peptides. 
Validation of the MSMS spectrum representing A: T[32]GGVKpropKpropPHR and B: T[32]GGVKpropKme-propPHR 
respectively. Matching fragments are displayed in red. 
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 When grown on MEF hESC cleave H3 in an identical temporal window compared to 
mESC 
Since mESC differentiation showed various temporal clipping patterns depending on the differentiation 
protocol applied, we further extended the different culture conditions to also include the more classical 
culture system on a MEF feeder layer. Although these MEF are mitotically inactivated prior to cell 
culturing, cH3 formation derived from MEF cannot be excluded. Thus, RA was first added to a culture 
consisting only of a confluent layer of MEF, without hESC present. No cleavage was detected by 
immunoblotting (Figure 4.7). 
 
Figure 4.7 MEFs display no histone H3 cleavage. 
When incubating a culture consisting only of MEF with RA for 5 days, no cH3 could be detected. 
When RA was added to hESC cultured on MEF, both morphological assessment of the differentiated 
status, and flow cytometry as well as RT-qPCR confirmed a decrease in Oct4 level as differentiation 
proceeded for the Oct4-eGFP reporter and UGENT2 cell line respectively (Figure 4.8A and B). Of note, as 
seen by fluorescence microscopy within one colony patches or ‘islets’ of undifferentiated cells became 
apparent, indicating heterogeneous stemness within colonies (Figure 4.8C). Remarkably, this Oct4 
expression pattern is clearly different from what was seen when growing hESC feeder-free, which showed 
a diffuse expression pattern in the abovementioned experiments. 
Surprisingly, when analyzing these histone extracts with Western blotting, a more ‘mouse-like’ pattern 
of H3 cleavage becomes visible: on day 2 of differentiation cH3 appears, attains a maximum on day 4 
and fades considerably on the last day of the experiment. This pattern was visualized for both cell lines, 
again confirming the cleavage capability of both the reporter and non-reporter cell line (Figure 4.8D).  
Also here the N-terminal nature of the H3 cleavage was double-checked using the N-terminally directed 
antibody, which visualized only the band of intact histone H3. In addition, a clear signal was detected 
using the H3.cs1 antibody for the UGENT2 sample, once more pointing out A21 as a possible cleavage 
site (Figure 4.8E). 
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Figure 4.8 A different H3 cleavage pattern is seen in MEF cultured hESC. 
Aside from the application of feeder-free culture, additional differentiation experiments with hESC cultured on a 
MEF feeder layer were conducted. The differentiated status is again confirmed by A: flow cytometry and B: RT-qPCR 
(mean and standard deviation of 2 replicates). C: Fluorescence microscopy analysis indicates differentiation 
heterogeneity among colonies, as within each colony several ‘islets’ of concentrated Oct4-eGFP expression were 
seen (scale bars represent 200 µm). D: Western blotting analysis reveals that when hESC are cultured on MEF, a 
cleavage pattern is shown that resembles more to the mESC results. E: Also, the N-terminal orientation of the 
cleavage and A21 as a possible cleavage site is confirmed by application of the N-terminal and H3.cs1 antibody 
respectively. 
In order to better understand the biological turnover of this H3 clipping event in MEF-cultured hESC, the 
initial differentiation experiments were also repeated both in a more narrow time frame and over a more 
extended time period. For this experiment two cell lines were combined (UGENT1 and UGENT2). Figure 
4.9 shows both UGENT1 and UGENT2 display a pattern of upcoming and decreasing H3 proteolysis. This 
pattern generated by harvesting cells every 4 hours, is even more undulating than the one obtained by 
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daily sampling of the same cell line (Figure 4.8) and is in stark contrast with the continuous cleavage 
found in feeder-free cultured hESC.  
 
Figure 4.9 Undulating pattern of H3 clipping in MEF cultured hESC. 
A: The initial differentiation experiment showed cleavage for both the G1 and the G2 cell line, with upcoming cH3 
on day 2 and fading again on day 4 of differentiation. B: When increasing the time resolution on day 3, 4 and 5 of 
differentiation, western blotting analysis shows a ‘wave’ pattern of upcoming and decreasing clipping. C: The same 
result is obtained on a larger time scale when the experiment was extended up to 12 days. Also for B and C samples 
from both cell lines were used, as indicated on the blot image. Respectively 3 µg (B) and 2 µg (C) histone extract 
were loaded per lane. The time points of sample collection are indicated on all images (“x hours/days” after onset 
of differentiation).  
 H3 proteolysis is not cell cycle related 
Both this undulating pattern (section 4.4.5) as well as the synchronizing effect of RA on the stem cell 
cycle directed us towards the assumption that this H3 clipping event might be cell cycle related. We 
hypothesized that the histone clipping event takes place during the S phase, in which the DNA is 
duplicated and the histone content is remodeled accordingly. As the chromatin structure is loosened 
upon replication, it becomes more susceptible for proteases, which might fulfil specific as well as 
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aspecific enzymatic activity. To investigate this we performed a cell synchronization experiment with a 
Burkitt’s lymphoma Raji cell line. Treatment with double thymidine results in a G1/S-phase arrested cell 
population. The use of PI staining in combination with flow cytometry allows progression of the cells 
through the cell cycle to be monitored (Figure 4.10 A). The terminally differentiated raji cells showed no 
clipping activity, disregarding whether they are synchronized or not (Figure 4.10 B). Of note, the 
progenitor THP-I cell line (acute monocytic leukemia) is capable of H3 proteolysis. However, this clipping 
potential seems to be unrelated to differentiation, as the addition of RA did not induce any changes. 
These results are in accordance with the results in section 4.4.2 that indicate Oct4 expression, and 
therfore differentiation, does not seem to be a major requirement for histone clipping. Also here, cell 
cycle synchronization did not alter the constant pattern of clipping, even though the obtained THP-I 
results were not as consistent as other cell lines.  
 
Figure 4.10 Histone H3 clipping in synchronized Raji cells and an (un)differentiating progenitor THP-I cell 
line  
A: Validation of cell cycle synchronization. Flow plots after PI staining show a clear shift in population distribution 
after release from the thymidine block, compared to the steady profile of the control samples. B: No cH3 was 
observed in Raji cells in western blotting analysis, neither in unsynchronized or synchronized conditions (T0 = 
starting point right after release of second thymidine block, other time points indicate number of hours after 
release). THP-I cells on the other hand are capable of H3 clipping, but the addition of RA does not influence the 
clipping pattern (Time points given are the number of hours after onset of differentiation).  
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 Histone H3 clipping activity in hESC is exerted by a serine protease 
In order to identify the clipping enzyme, we conducted different calf H3 incubation assays, whether or 
not with the application of various protease inhibitors. To this end, we prepared a nuclear extract (NE) 
from Oct4-eGFP hESC for which histone H3 cleavage was confirmed in the corresponding histone extract, 
and validated it to be capable of calf H3 proteolysis. Endogenous H3 was not detectable in the amount 
of NE used in these experiments. 
In a first experiment we compared the incubation of H3 with hESC NE after immunoblotting with the 
three different antibodies described before. This confirmed that the cleavage pattern induced by the NE 
is similar to what was seen in the histone extract of Oct4-eGFP hESC: the cleavage is exclusively of N-
terminal nature and there is no detection of A21 as a possible cleavage site (Figure 4.11A).  
 
Figure 4.11 The histone H3 clipping activity in hESC is exerted by a serine protease. 
A: In order to investigate the responsible cleavage enzyme, incubation assays were set up in which 1 µg calf histone 
H3 was incubated with 0.5 µg hESC NE. The NE was prepared from the Oct4-eGFP cell line and contains N-terminal 
histone H3 cleavage activity, as was confirmed in the corresponding histone extracts (data not shown). 
Immunoblotting analysis of the incubation product displays several cH3 fragments, with confirmed N-terminal 
origin. A21 could not be confirmed as a cleavage site (H3.cs1 Ab). The list of all inhibitors included, with their targets, 
the applied concentrations and their outcome in the inhibition assay is displayed in panel B. C: Western blotting 
analysis points out that only when using a serine protease inhibitor the cleavage activity of the NE can be inhibited. 
The latter is confirmed by the additional inhibitory effect of the PIC, targeting mainly serine and cysteine proteases. 
In the following inhibition assay, several inhibitors were included (Figure 4.11B), comprising both general 
inhibitors for a certain protease enzyme class and specific inhibitors for cathepsin L, in parallel to the 
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mESC results, where cathepsin L was identified as the responsible clipping enzyme. Western blotting 
analysis pointed out that only AEBSF, a serine protease inhibitor, could establish inhibition of the 
cleavage, whereas all other inhibitors could not demonstrate any notable effect on the incubation. Also 
the PIC was able to inhibit the proteolytic activity on histone H3. The specific inhibitors for cathepsin L 
were not able to diminish the cleavage (Figure 4.11C). 
4.5. Discussion 
Histone clipping was reported for the first time even before these proteins received their current 
nomenclature [201,202]. Surprisingly however, these truncation events are still greatly understudied. Yet, 
from a practical point of view, techniques such as chromatin-immunoprecipitation run the risk of not 
detecting the substantial influence that histone clipping might have on their outcome. All techniques 
employing specific antibodies to the H3 N-terminus in general or to modifications thereof in particular, 
will fail in case of H3 proteolytic cleavage. Also MS-based (quantitative) comparisons of e.g. H3K4 and 
H3K27 methylations devaluate when dealing with samples where clipped histones are present. 
Histone clipping has been reported in several distinct biological systems [187–190,192–195], entailing 
different biological settings and thus potential roles of this PTM. However, only recently it was admitted 
into the epigenetic landscape with the discovery of transient histone H3 clipping in differentiating mESC 
[184] and sporulating yeast [191]. The evolutionarily conserved sequence of histone proteins has been 
suggested to underlie the surprising occurrence of A21 clipping in both mouse and yeast, and we thus 
set out to verify whether the H3 clipping that accompanies mESC differentiation also takes place during 
hESC differentiation.  
Duncan and colleagues monitored cH3 levels under several differentiation protocols in mESC, namely 
spontaneous monolayer differentiation after withdrawal of leukemia inhibitory factor (LIF), induced 
differentiation with RA and EB formation. Depending on the protocol applied, a different cH3 pattern 
was visualized. Where RA induction leads to an undulating pattern of upcoming and decreasing H3 
clipping centered around day 2 and 3 of differentiation, EB formation displayed a faster migrating H3 
band which peaked between day 8 and 12 but did not disappear completely after 14 days. 
Here, we report that indeed histone H3 N-terminal clipping occurs in differentiating hESC and that its 
temporal appearance is equally influenced by the culture conditions. In feeder-free conditions, the two 
hESC lines tested (UGENT2 and WA01 Oct4-eGFP) show a continuous cH3 pattern after RA induced 
differentiation, resembling the results of EB formation in mESC. In contrast, when switching to culturing 
hESC on a feeder layer of MEF, both these cell lines obtain a pattern of upcoming cleavage appearing 
on day 1, reaching a maximum intensity at day 4 and fading again at the last day of the experiment, 
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similar to the temporal pattern described for RA induced mESC differentiation. Together, this suggests 
that within both human and mouse, the specific control over histone H3 cleavage during differentiation 
is profoundly influenced by experimental culture conditions applied. Although the cleavage event in 
mESC and hESC is appreciably similar, caution should be taken when functionally comparing these 
events, not in the least because hESC resemble more mouse epiblast stem cells than regular mESC. The 
latter are considered to represent a more homogeneous and naïve pluripotent state compared to hESC, 
which are designated to be in a heterogeneous and primed pluripotent condition and thus probably 
reflect a more developed state [21,24,203]. In contrast to Duncan et al., we could not find any clear 
correlation between the progression of differentiation and histone H3 clipping. The pluripotency status 
was monitored in this report by following Oct4 levels, i.e. specifically with an Oct4-eGFP reporter cell 
line. When monitoring three different differentiation methodologies, H3 cleavage seemed to be 
unaffected, while the Oct4 status was found to be influenced in the predicted way: a decrease in 
expression following (induced) differentiation. Considering the open and highly dynamic state of 
pluripotent hESC chromatin, this might not be such a surprise [55]. In line with this, on a Sypro Ruby 
stained SDS-PAGE gel we also observed some reduction in H4 band intensity at some time points (data 
not shown). Whether this indeed is a clipping event remains to be determined. Of note, when Duncan 
et al. inhibited cathepsin L, H3 clipping was abrogated while Oct4 expression still decreased, adding yet 
another argument against a direct link between Oct4 expression levels and histone clipping. 
Histone H3 cleavage is not in vitro generated during the experiment as visualized here by the use of 
biotinylated and non biotinylated histone H3 during the extraction procedure. Also, protease inhibitors 
did not seem to influence the cH3 intensity, whether or not they are present. Moreover, both TEB/HCl 
extraction and direct boiling in SDS-PAGE Laemmli yields the same results, further supporting the 
endogenous formation of cH3. The fact that MEF themselves do not display any clipping, but can 
completely change the temporal appearance of cH3 in differentiating hESC, further argues in favor of a 
biologically regulated process. We also verified the occurrence of H3 clipping in a human, terminally 
differentiated cell line (Burkitt’s lymphoma Raji cells) and these cells did not form any clipped histone 
H3.  
If not generated in vitro, the link between cell cycle and this clipping event was investigated. First, 
synchronization was induced in terminally differentiated Raji cells by means of a double thymidine block, 
but no cH3 was seen. The cell cycle as such is thus not responsible for H3 proteolysis. Moreover, also 
the progenitor THP-I cell line was included and clipping was monitored after stimulation with RA and 
when subjected to cell cycle synchronization. Even though these results were not as consisitent as other 
cell lines, they show that THP-I cells are capable of H3 cleavage, with or without RA induction. However, 
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cell cycle synchronization did not alter the constant pattern of proteolysis found in these cells. Taken 
together, these findings suggest that clipping is not directly related to cell cycle, yet some degree of 
differentiation capacity is required for it to occur.  
Many different histone H3 cleavage sites have been reported in the past, even within one study. In 
differentiating mESC [184], A21 is the primary site of cleavage, though multiple other sites were also 
found at T22, K23, A24, R26 and K27. By the use of Western blotting, Edman degradation and MS 
respectively, we confirmed two of those cleavage sites in hESC, namely A21 and R26, and assigned 
residue 31 as an additional new cleavage site in hESC. Unfortunately, with the techniques applied, no 
definite distinction could be made between the H3.1/H3.2 or H3.3 isoform cleavage respectively. 
Nevertheless, we expect H3.1 or H3.2 to be the cleaved isoform, since A31 is followed by threonine just 
as A21, which can thus be suspected to be susceptible to a similar enzyme activity.  
It is worth noting that despite the many hurdles that need to be overcome when using MS for the 
analysis of histone H3, several arguments add up to the likelihood of this newly identified cleavage site 
at residue 31. First, the annotated peptide was N-terminally propionylated, indicating no in-source decay 
causing this fragment to appear. Second, elution time patterns of the precursor and its cleaved form are 
distinct, further arguing against in-source formation of the cleaved fragment out of the intact precursor. 
Third, by first separating the histones with SDS-PAGE, the location of annotated histone H3 and its 
cleaved form in the gel allows to project the peptide data back onto the precursor proteins: the N-
terminally cleaved fragment could only be annotated in lower MW (cH3) gel bands, in contrast to the N-
terminal peptide itself which was found only in the highest MW (intact H3) fraction. Finally, all spectra 
corresponding to a cleaved peptide were manually validated by an expert before taken into account. On 
the other hand, more cleavage sites are expected to be present which cannot be identified by MS, as 
seen for the A21 and R26 sites detected by a specific antibody and Edman degradation respectively. This 
can be explained by the limited possibilities of MS to annotate small peptides with high reliability. When 
a cleavage site is found to be close to an arginine, which is cleaved during digestion, the resulting 
peptides will consist of too little Aa to be identified reliably. As a result not all possible cleavage sites 
can theoretically be identified by MS but their existence should not be disregarded.  
Only few of the published histone clipping reports actually also categorize the protease responsible for 
this event (reviewed in [204]). Duncan and colleagues (2008) assigned the cleavage to cathepsin L, a 
lysosomal cysteine protease, whilst glutamate dehydrogenase has been brought forward by Mandal et 
al. (2013). Santos-Rosa et al. (2009) who originally published the yeast clipping event, could only 
categorize the enzyme as a serine protease. It was just recently that Xue and colleagues [205] found that 
the vacuolar protein Prb1 (Cerevisin) is required for the N-terminal H3 clipping in Saccharomyces 
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cerevisiae. Finally, the Foot-and-Mouth disease virus (FMDV) expresses the so-called protease 3C, a 
cysteine protease, in the host cells which mediates clipping of host histone H3 at leucine 20 [187,188]. 
The incubation assays performed here with the application of different inhibitors point out that the 
clipping enzyme is a serine protease, since apart from AEBSF none of the inhibitors for other protease 
classes could establish any effect on the incubation. This was confirmed by the fact that the PIC, which 
inhibits mainly serine and cysteine proteases, was also able to inactivate the clipping activity. We also 
included three specific inhibitors for cathepsin L, in analogy to the clipping in mESC, but no decrease in 
cleavage was seen due to these inhibitors. However, caution should be taken in the search for the 
responsible enzyme. As also others already suggested [184,191], enzyme redundancy and overlapping 
functions could impede its identification. 
Despite the great epigenetic promise of such radical PTM, histone clipping and more specifically its 
biological potential and the mechanisms by which it could exert its transcriptional effects, remain 
surprisingly understudied. Since the two landmark discoveries of H3 clipping in mouse and yeast in 2008 
and 2009 respectively, four major mechanisms have been formulated by which histone proteolysis can 
influence gene expression programs [185]. 
First, in yeast, a direct regulatory role of gene expression has been attributed to the removal of the N-
tail and its repressive marks at promoter regions [191]. As such, histone H3 cleavage clears repressive 
marks massively, hence allowing for gene expression activation. Second, cH3 might provide a new 
binding site for protein complexes that could not be bound before clipping, thus fulfilling an active role 
in protein recruitment. On the other hand, also a passive regulatory role should be considered if other 
proteins are no longer able to bind the shortened histone H3 [185,191]. Third, Santos-Rosa and 
colleagues [191] also proposed nucleosome eviction and histone replacement as another framework in 
which clipping might regulate gene expression, as they report that H3 clipping precedes nucleosome 
eviction and subsequent gene induction. Finally, the N-terminal peptide itself might establish its 
translation regulation by binding its own mRNA [185]. Which of these mechanisms, if any, is at play in 
(differentiating) hESC remains to be elucidated. 
In short, based on previous findings and theoretical background, H3 clipping could be involved in several 
processes linked to gene expression control and differentiation. But the question still remains as to 
whether H3 proteolysis correlates directly with or causes such processes. Further studies will hopefully 
help elucidate the role of this new epigenetic mark in hESC and their differentiation process. 
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4.6. Conclusions 
As a member of the epigenetic network, regulated histone proteolysis has been occasionally described 
earlier in diverse biological settings, yet being largely understudied. Histone H3 clipping and histone 
proteolysis in general might skew experimental findings substantially, both from a biological and a 
technical point of view. In this report we show for the first time that this PTM is also present in human 
ESC, and is mediated by a serine protease. The temporal pattern of cleaved H3 is highly dependent on 
the culture protocol applied, as seen for both cell lines used in this report. Although in first instance we 
also detected the clipping upon early stem cell differentiation, we found that the clipping process is not 
necessarily accompanied by a decrease in Oct4 expression, as also undifferentiated hESC can contain 
cleaved H3 fragments. Thus, more research is needed to fully elucidate the potential biological role(s) of 
histone H3 cleavage. 
 
  
“An expert is a person who has made all the mistakes that can be made in a very narrow field.”  
― Niels Bohr 
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 PITFALLS IN HISTONE PROPIONYLATION DURING BOTTOM-UP MASS SPECTROMETRY 
ANALYSIS 
5.1. Abstract 
Despite their important role in regulating gene expression, hPTMs modifications remain technically 
challenging to analyze. For identification by bottom-up MS, propionylation is required prior to and 
following trypsin digestion. Hereby, more hydrophobic peptides are generated enabling RP-HPLC 
separation. When histone dynamics are studied in a quantitative manner, specificity and efficiency of 
this chemical derivatization are crucial. Therefore we examined eight different protocols, including two 
different propionylation reagents. This revealed amidation (up to 70%) and methylation (up to 9%) of 
carboxyl groups as a side reaction. Moreover, incomplete (up to 85%) as well as aspecific propionylation 
(up to 63%) can occur, depending on the protocol. These results highlight the possible pitfalls and 
implications for data analysis when doing bottom-up MS on histones. 
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5.2. Background 
Histones are subjected to a diverse array of PTMs, thereby regulating the accessibility of the underlying 
DNA, effecting both physiology and disease [63,206]. MS has become a powerful tool to simultaneously 
identify and quantify these PTMs. Nevertheless, sample preparation for bottom-up MS strategies is 
complicated by the requirement of chemical derivatization such as propionylation prior to and following 
trypsin digestion (Figure 5.1.A) [128]. This step modifies all free primary amine groups (the N-termini 
and the ε-amino group of unmodified and monomethylated lysine (K)), hence changing the tryptic into 
Arg-C specificity and resulting in larger (6-20 Aa), more hydrophobic and readily identifiable peptides. 
However, in order to optimize identification and study histone dynamics in a quantitative way, this 
propionylation reaction has to be specific as well as efficient. Only then, accuracy and reproducibility can 
be guaranteed. Propionylation specificity of histones can be hampered by the high abundance of 
hydroxyl containing residues (serine (S), threonine (T) and tyrosine (Y)) which can be aspecifically 
propionylated in addition to the primary amines, hereafter referred to as “overpropionylation”. On the 
other hand, an efficient reaction implies that all free primary amine groups should react, leaving no 
peptides “underpropionylated”. Finally, unanticipated side-reactions can hinder the peptide annotation 
rate and bias quantification.  
Based on the protocols most often used in current literature we developed 4 different propionylation 
methods (A to D) comprising two different types of propionylation agents, several buffer types and 
incubation temperatures (Figure 5.1.B) [128,179,198,207,208]. The methods using propionic anhydride 
were performed with a single as well as a double round of propionylation pre- and post-digestion, to 
monitor the advantage of an extra round of propionylation. For similar reasons method D was carried 
out using two different concentrations of NHS-propionate. Each protocol was performed in triplicate on 
10 µg bovine histones and subsequently 1 µg of each sample was analyzed by MS, using a label-free 
information-dependent acquisition strategy on a TripleTOF 5600 (Sciex). In a first targeted data analysis 
step on this dataset, eight different manually validated peptides were monitored throughout all eight 
methods to gain a first insight into the conversion rate, specificity and efficiency of each propionylation 
protocol. In the subsequent untargeted evaluation strategy, a PCA analysis (Progenesis QI, NonLinear 
Dynamics, Waters) on all MS precursor intensities present, 11.247 in total, was performed in order to 
verify clustering (and thus reproducibility) of the experimental conditions and to check for outliers 
without prior knowledge of these peptides’ identity. For each cluster of methods MS precursors were 
selected that were significantly (p-value ≤ 0.0001) most abundant (highest mean) within this cluster. 
Each group of extracted MS precursors was then subjected to consecutive rounds of searches to define 
the occurrence of any unanticipated side-reactions (Figure 5.1.A).
  
 
Figure 5.1 Propionylation workflow and overview of the different protocols 
A: Propionylation is carried out prior to (      ) as well as post digestion (      ), followed by LCMSMS analysis. During the first propionylation reaction K, monomethylated K and the 
protein N-terminus become derivatized. After digestion the newly generated peptide N-termini get propionylated as well. The generated LCMSMS data was analyzed using two 
approaches: (i) left box: a targeted approach, defining the conversion rate based on identified peptides (ii) right box: an untargeted approach, based on differential MS precursor 
intensities in between methods. The first strategy can be used to determine efficiency and specificity of the protocol, the latter is used to monitor for unexpected side reactions 
that differ in between protocols. B: Table representing the differences between the propionylation methods. The 4 different methods vary in propionylation reagent, buffer and 
reaction temperature. Methods A to C are performed with a single (1x) as well as a double (2x) round of propionylation before and after digestion, marked as method X.1 and X.2 
respectively. Method D is carried out with a 150 times molar excess (method D.1) and a 600 x molar excess (method D.2) of NHS-propionate to the bovine histones.
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5.3. Methods 
An additional overview of all propionylation methods used and mentioned throughout this work is given 
in Chapter 11 (Addendum). 
Propionylation method A 
Twenty µL propionylation reagent (propionic anhydride:methanol 1:3 (v/v)) was added to 10 µg vacuum-
dried bovine histones (Roche), immediately followed by the addition of 15 µL ammonium hydroxide. The 
reaction was incubated at room temperature for 30 min and evaporated in a SpeedVac to remove any 
volatile remnants. In method A.2 a second round of propionylation was performed prior to trypsin 
digestion, in contrast to method A.1 where propionylated proteins were immediately reconstituted for 
digestion. To propionylate the newly generated N-termini, propionylation was also carried out after 
enzymatic digestion, with the same protocol as before digestion.  
Propionylation method B and C 
Bovine histones (10 µg) were resuspended in 15 µL H2O and diluted with 15 µL 100 mM 
ammoniumbicarbonate (ABC). After adding 10 µL ammonium hydroxide to the sample, propionylation 
reagent (propionic anhydride:methanol 1:3 (v/v)) was prepared and 10 µL immediately added to the 
histone sample. If needed, an extra amount of ammonium hydroxide or glacial acetic acid was added to 
keep an ideal pH of 8. Reactions were maintained at 37°C (method B) or 51°C (method C) for 15 min and 
vacuum-dried, whereupon samples of method B.2 and C.2 were subjected to a second round of 
propionylation, in contrast to method B.1 and C.1 where propionylated proteins were immediately 
reconstituted for digestion. To propionylate the newly generated N-termini propionylation was also 
carried out after enzymatic digestion, with the same protocol as before digestion.  
Propionylation method D 
Bovine histones (10 µg) were resuspended in 50 mM triethylammoniumbicarbonate (TEAB). A NHS-
propionate stock solution (100 mM water: ACN, 1:1 (v/v)) was added to a final concentration of 10 mM 
whereby the molar excess to the bovine histones was 150x and 600x for methods D.1 and D.2, 
respectively. Samples were incubated during 1h at 30°C, followed by the addition of the same amount 
of NHS-propionate stock solution to reach a final concentration of 20 mM and again incubation for 1h 
at 30°C. To revert propionylated serine, threonine and tyrosine, HA was added to the sample (4 times 
the molar excess of HA to the NHS ester) and incubated for 10 min at 30°C. The pH was lowered to 3 by 
adding the required amount of 1% formic acid. Samples were thoroughly dried in a SpeedVac and 
digested with trypsin, whereupon the newly generated N-termini were also propionylated using the 
same protocol as before digestion. 
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Trypsin digestion 
Trypsin digestion was identical in all protocols except for the buffer used: in all methods 50 mM ABC 
was applied, except for method D where 50 mM TEAB was used. In each case, dried out, propionylated 
histones were reconstituted in the respective buffers, supplemented with 1 mM CaCl2, 5% ACN and 
digested overnight at 37°C with trypsin (Promega) at a histone/enzyme ratio of 20:1 [198]. 
LCMSMS 
One microgram propionylated peptides were dissolved in 0.1% formic acid in water (buffer A) without 
any preceding clean up steps, and separated on a PepMap 100 (C18) column (I.D. 75 µm, length 25 cm, 
particle size 5 µm) by means of trap-elute injection. An U3000 LC-system (Dionex) was used at a flow 
rate of 300 nL/min. Elution was performed with 80% acetonitrile/0.1% formic acid (buffer B) using a 
gradient of 4% to 55% buffer B in 60 min. Quality control samples (QC) contain equal amounts of each 
sample and 1 µg in total. A TripleTOF 5600 (Sciex) was used for information dependent analysis, using a 
nano-ESI source in positive ion mode. Survey MS scans were acquired (m/z 400-1250) and up to 20 
precursors (m/z 65-2000) with charge state 2+, 3+ or 4+ exceeding the signal threshold (750 counts per 
second) were isolated for fragmentation by collision induced dissociation, using the dynamic collision 
energy profile as suggested by the manufacturer. 
Data analysis 
Targeted as well as untargeted data analysis was performed on triplicate runs of each protocol. In this 
data set 87% of the MS precursors have a power > 0.8, justifying the sample size of 3 replicates to find 
a significant difference between groups. 
Database searching was performed against a bovine database obtained from the National Center for 
Biotechnology (NCBI) database, merged with the contaminant database included in the Sciex software 
containing prevalent contaminations such as keratin and trypsin. During the targeted approach, 
generated wiff-files (each method performed in triplicate) were thoroughly searched using Protein Pilot 
4.5 (Sciex), implementing the following special factors: purified histones, propionylation pre-digestion 
and propionylation post-digestion. Enzyme specificity was set to Arg-C and an FDR analysis was 
performed. The data were exported to Excel and filtered using 5% distinct peptide local FDR as cut-off 
value. The different peptide forms of eight peptides (underpropionylated, desired, overpropionylated) 
were isolated and XICs of these forms throughout all runs were made using PiekView 1.2. To confirm 
correct annotation and localization of the propionyl groups, the same dataset was also searched using 
a Mascot 2.5 in house server (Matrix Science) and only spectra assigned to the same peptide by both 
ProteinPilot and Mascot were taken into account. Mascot parameters were the following: mass error 
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tolerances for the precursor ions and its fragment ions were set at 15 ppm and 0.01 Da respectively, 
enzyme semi-specificity was set to Arg-C, allowing for up to two missed cleavage sites. Variable 
modifications included acetylation, dimethylation, trimethylation and propionylation on lysine (K), 
methylation and dimethylation on arginine (R) and oxidation of methionine. Lysine monomethylation 
was searched as the sum of propionylation and methylation since monomethylated lysine residues can 
still be propionylated. Propionylation was set as a variable modification at the N-terminus, serine (S), 
threonine (T) and tyrosine (Y). Only peptides with an expectancy value < 0.01 were considered correctly 
annotated. Moreover, all spectra used for peptide identification were manually validated. Most peptides 
were covered throughout the whole Y-ion series, enclosing the Aa susceptible for propionylation, which 
implies correct localization of the propionyl group. We support this with a representative example in 
Figure 5.6. MSMS spectra of peptide YQKSTELLIR are depicted. For this peptide three possible 
propionylation sites (K, S and T) are located next to each other, thereby increasing the risk of incorrect 
localization. 
The propionylation conversion rate was calculated as follows: XIC desired products / (XIC desired 
products + XIC underpropionylated products + XIC overpropionylated products).  
The untargeted approach was carried out using Progenesis QI software (Nonlinear Dynamics, Waters). 
After alignment of the runs, the MS precursors were filtered, based on retention time (Rt 15-75 min) and 
charge state (2+-5+) and the data were normalized to all precursors. A multivariate statistical analysis 
was performed on all 11.247 MS precursors, without any prior peptide identification. The Principal 
Component Analysis (PCA) in Progenesis uses MS precursor abundance levels across runs to determine 
the principle axes of abundance variation. Transforming and plotting the abundance data in principle 
component space separates the samples according to abundance variation. PCA analysis was carried out 
to check for outliers and see if experimental conditions group together. The MSMS spectra of the 
differential precursors, significantly most abundant in a cluster of methods (ANOVA p-value < 0.0001; 
q-value < 2e-6) were exported as an MGF peaklist and searched using a Mascot 2.5 in-house server 
(Matrix Science). An error tolerant search against a bovine histone database containing prevalent 
contaminants was performed, with propionylation of lysine and the N-terminus as variable 
modifications. Mass error tolerances for the precursor ions and its fragment ions were set at 15 ppm and 
0.05 Da respectively. Enzyme specificity was set to Arg-C, allowing for up to two missed cleavage sites 
and results were filtered for confident hits using a 0.01 expectancy cutoff. The most abundant 
modification was identified for each separate *.mgf file using the “modification statistics” functionality 
of the 2.5 Mascot server. Next, the relative abundance of this specific modification was calculated for 
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each cluster separately by dividing the total number of error tolerant modification matches by the 
number of peptide matches above identity threshold. 
5.4. Results 
First we compared the average propionylation conversion rate of 8 different peptides in the triplicate 
runs of each protocol. The chosen peptides are both non-modified as well as biologically modified and 
originate from histone H3 and H4. Since acetylation on peptide KQLATKAAR results in two isobaric co-
eluting forms (H3K18Ac and H3K23Ac) that cannot be distinguished on MS level, we here refer to these 
isobaric species as KQLATKAAR+Ac. To determine this conversion rate for a specific peptide, the peak 
area of the extracted ion chromatogram (XIC) for the desired product was divided by the sum of the 
peak areas representing the total pool of this peptide: the desired form, overreacted products 
(overpropionylated) and incomplete products (underpropionylated) Figure 5.2.A and Figure 5.2.B). 
Method A.2 performs best for all eight peptides with an average conversion rate between 93 and 100%. 
Methods B and C on the other hand have average conversion rates lower than 70% for 7 out of 8 
peptides (Figure 5.2.C). The one outlier with a conversion rate of 99% in these protocols coordinately 
introduces the notion of sequence-dependent propionylation efficiency. This phenomenon can also be 
seen in the methods using NHS chemistry, where the conversion rate is over 80%, except for the peptides 
DAVTYTEHAKR and K(Me)SAPATGGVKKPHR where it stays below 65%.  
The low conversion rates of methods B to D can either be due to aspecific overpropionylation, inefficient 
propionylation or a combination of both. Hence, we calculated the average contribution of 
overpropionylation as well as underpropionyation for all peptides in each protocol based on XICs. When 
using NHS-chemistry, overpropionylation is the main reason for a low conversion rate, with a peak of up 
to 60% overpropionylation of peptides DAVTYTEHAKR and K(Me)SAPATGGVKKPHR (Figure 5.3.A). 
Methods B and C on the other hand mainly suffer from underpropionylation due to incomplete reaction, 
thereby hampering conversion (Figure 5.3.B). Method A.2 is both specific and efficient for all peptides, 
which explains the high conversion rate mentioned before.  
  
 
Figure 5.2 Targeted data analysis 
A: Formula to determine the conversion rate of a peptide, based on XICs of identified forms. B: Composite representation of the XICs of five different forms of peptide 
DNIQGITKPAIR, generated after the propionylation (pr) workflow: underpropionylated products (           ), desired products (   ), overpropionylated products (   ). This clearly 
illustrates the increasing retention that is induced by propionylation. C: Radar chart representing the average conversion rate for eight targeted peptides. Each peptide is located 
on one angle of the radar chart and each method is represented by another color. The conversion rate for each peptide using the different methods is shown on the radius, 
whereby a conversion rate of 0 is located in the center, increasing outwards.
  
 
Figure 5.3 
Radar chart showing the average contribution of over- (A) and underpropionylation (B). DP = desired product; UP = underpropionylated product; OP = overpropionylated product 
for the eight targeted peptides in each protocol. (C) Graph showing the fold change in conversion rate when a double round of propionylation is carried out prior to and post 
digestion, as opposed to a single propionylation.
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Next we focused on the effect of a second round of propionylation prior to as well as post digestion on 
the conversion rate. Therefore we calculated the average increase in conversion rate for all six peptides 
when using method X.2 instead of method X.1 (Figure 5.3.C). These results indicate that a second round 
of propionylation increases the conversion rate by lowering underpropionylation without any increase 
in overpropionylation. This effect is most notable for method B and C with an increase of the conversion 
rate by a factor of 1.55 for the protocol at 37°C and up to a factor 1.82 for the protocol at 51°C. When 
using method A an increase by only a factor of 1.10 was observed. This can be explained by the high 
conversion rate that was already found when performing one propionylation round. Of interest, technical 
variation of propionylation in between triplicates as well as sequence-dependent propionylation in 
between the peptides subjected to the same protocol, lowered considerably when performing a second 
round of propionylation (Table 5.1). Especially method A.2 thus shows little sequence-dependent 
propionylation at all, with average conversion rate in between 93 and 99% for all six peptides as opposed 
to 79 to 99% when only one round of propionylation was applied (method A.1). Thus, a second round 
of propionylation increases the conversion rate and thereby lowers technical variation as well as 
sequence-dependent propionylation whereby method A.2 emerges as the best candidate protocol for 
subsequent quantitative MS analysis.  
Table 5.1 
Each propionylation method was performed in triplicate. The average propionylation conversion rate is 
shown for each targeted peptide, together with the standard deviation. 
Peptide conversion rate 
Peptide 
Method A.1 Method A.2 Method B.1 Method B.2 Method C.1 Method C.2 Method D.1 Method D.2 
Average SD Average SD Average SD Average SD Average SD Average SD Average SD Average SD 
DAVTYTEHAKR 0,85 0,08 0,95 0,04 0,32 0,12 0,50 0,08 0,31 0,03 0,54 0,01 0,44 0,04 0,65 0,07 
ISGLIYEETR 0,80 0,13 0,93 0,02 0,21 0,07 0,41 0,13 0,18 0,08 0,43 0,08 0,87 0,02 0,83 0,02 
GVLKVFLENVIR 0,95 0,03 0,95 0,05 0,42 0,27 0,67 0,08 0,52 0,16 0,67 0,08 1,00 0,00 1,00 0,00 
DNIQGITKPAIR 0,79 0,19 0,96 0,03 0,17 0,08 0,31 0,13 0,15 0,06 0,37 0,06 0,88 0,02 0,91 0,02 
YQKSTELLIR 0,76 0,11 0,94 0,02 0,17 0,06 0,27 0,04 0,16 0,08 0,38 0,03 0,83 0,08 0,84 0,04 
YRPGTVALR 1,00 0,00 0,99 0,00 0,99 0,00 0,99 0,00 1,00 0,00 1,00 0,00 0,88 0,05 0,86 0,02 
KQLATKAAR+Ac 0,98 0,01 1,00 0,01 0,51 0,12 0,68 0,08 0,54 0,06 0,70 0,06 0,90 0,04 0,91 0,03 
K(Me)SAPATGGVKKPHR 0,91 0,03 0,97 0,02 0,29 0,10 0,49 0,11 0,27 0,06 0,53 0,08 0,37 0,06 0,48 0,04 
 
While of obvious value in finding the best possible sample preparation protocol, these analyses are all 
based on preceding peptide identification, and are therefore targeted. Nevertheless, it is possible that 
unanticipated side reactions occur, thereby generating peptides which remain unidentified using 
standard search parameters. In order to search for these unanticipated side reactions a “quantify-then-
identify” strategy was applied under the form of an “MS precursor intensity based” PCA (Progenesis QI, 
Nonlinear Dynamics, Waters) on the total of 11.247 MS precursors, (Figure 5.4).  
 
  
Figure 5.4 Untargeted, 
precursor-based data 
analysis 
PCA was performed on MS 
precursor intensities from a 
label-free IDA analysis of 
triplicate experiments and 
four QC samples resulting in 
the clustering of method A, 
method D and methods B & 
C. Precursors with an ANOVA 
p-value ≤ 0.0001 and 
significantly most abundant 
for one cluster of methods 
were filtered. A 
representative abundance 
profile of a differential 
precursor is shown for each 
cluster (method A: blue; 
method B and C: red; method 
D: green). Identification of the 
MSMS spectra linked to these 
exported precursors 
confirmed that there is an 
enrichment of 
overpropionylated peptides 
in method D, and that 
underpropionylation is mainly found in methods B and C. A new modification was revealed to be enriched in method A: amidation of D, E and the C-terminus. This can result in a 
dispersion of precursor signal intensity over the generated peptide forms, illustrated by peptide ISGLIYEETR. The amino acids susceptible for amidation are highlighted in red and 
the different peptide forms are marked.
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Four quality control (QC) samples were included, next to the triplicate method samples, resulting in a 
total of 144.784 MSMS spectra generated over all different runs. QC samples are identical and contain 
equal amounts of each sample and 1 µg in total. Because they contain all possible precursors within one 
sample, they can be used as a precursor alignment template for the Progenesis QI software, which is 
very important here because considerable differences were induced by the different protocols. Since this 
PCA is carried out using MS precursors instead of identified peptides, no prior knowledge concerning 
annotation parameters is required. The aggregation of the different methods in this PCA analysis (87% 
of the MS precursors has a power > 0.8) shows three different clusters: method A, method B & C and 
method D with PC1 explaining 44% and PC2 19% of the variation. MSMS spectra from precursors that 
are significantly most abundant for a cluster of methods were extracted into a separate *.mgf file 
(ANOVA p-value < 0.0001; q-value < 2e-6), generating three clusters of MS precursors: most abundant 
in method A, most abundant in method B & C and most abundant in method D. These three separate 
*.mgf files (comprising 21.406, 37.736 and 36.141 MSMS spectra respectively) were then each subjected 
to an error tolerant search with both N-terminal and K-specific propionylation set as variable 
modification (Mascot 2.5, Matrix Science). The most occurring error tolerant modification was identified 
for each cluster, using the modification statistics (Figure 5.5).  
 
Figure 5.5 Graphs representing the relative abundance of a modification 
After PCA, the most occurring error tolerant modification was identified within all three “method clusters”. Next, we 
also monitored the presence of each of these modifications in the other clusters. Shown here is the relative 
percentage of annotated spectra that carry: (A) amidation of D, E and the C-terminus, (B) non-specific cleavage and 
(C) aspecific propionylation of S and T. 
Indeed, in vitro induced modification significantly outnumbered biologically relevant PTMs such as 
acetylation. Earlier findings of the targeted analysis were confirmed herein: (i) precursors that were most 
abundant in method D were mainly identified as overpropionylated (propionylation on S and T as the 
most identified error tolerant modification), (ii) precursors that were most abundant in method B and C 
mainly suffer from underpropionylation. The latter group thus also comprised “semi-ArgC” peptides, in 
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which the protein was “non-specifically” cleaved at a K because this amino acid was not sufficiently 
propionylated in the reaction prior to the trypsin digest. Surprisingly, the third group of differential 
precursors (iii) which were most abundant in method A, also shared a common PTM: amidation (-0.9840 
Da) on aspartic (D) and glutamic acid (E), as well as on the C-terminus. These identifications (MSMS 
spectra of both the amidated and non-amidated peptide form) are shown in Figure 5.6.  
Remarkably, the reactivity of carboxyl groups in method A is not only limited to amidation. Also 
methylation of D, E and C-terminus can occur when mixing propionic anhydride with methanol. Yet, this 
side reaction was not identified for method B and C even though methanol was used as well. In order to 
estimate the impact of these side reactions (amidation and methylation of COOH-groups) on 
quantification we calculated the relative abundance of both the amidated and carboxy methylated 
peptide form compared to its non-reacted counterpart (Figure 5.7).  
 
  
 
Figure 5.6 C-terminal amidation is a well-supported identification 
The upper panel shows the MSMS spectrum of propionylated peptide ISGLYEETR, its C-terminal amidated counterpart is depicted in the lower panel, displaying a 
complete y-ion series 0.98 Da below the original series.
  
 
Figure 5.7 Occurrence of unwanted amidation and methylation of carboxyl groups 
Amidation (A) and methylation (B) of a carboxyl groups can occur as a side reaction when using method A. Amidation is present on all peptides depicted, in contrast to the 
formation of a methylester which was identified for peptide ISGLIYEETR only.
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All 8 peptides used for targeted analysis were investigated, yet 2 peptides were not included in Figure 
5.7. Especially for peptide KQLATKAAR+Ac, accurate quantitation was impaired by the fact that the 
amidated form elutes first and its naturally occurring first isotope co-elutes with the non amidated 
peptide precursor mass, hindering XIC based quantification (Figure 5.8). For the other peptide, 
K(Me)SAPATGGVKKPHR, amidation nor methylation was identified. As shown in Figure 5.7, amidation at 
COOH occurs far more frequently and intense than methylation in this protocol. The latter was only 
detected for peptide ISGLIYEETR and no more than 9% was affected. Amidation on the other hand can 
convert up to 70% of a peptide in an amidated form, depending on the presence of D and E in the 
sequence. 
 
Figure 5.8 
Co-elution of peptide KQLATKAAR+Ac (m/z 570.83) (B) with its amidated counterpart (C) hampers 
correct quantitation by means of XIC (A). 
As shown here, each method has its own shortcomings. However, the most often used metric for 
studying biology is the relative abundance of PTMs in which the intensity of modified peptides are 
expressed relative to all peptides sharing that same sequence. Thus, we quantified the relative 
abundance of one such PTM, H3K23ac, within the bovine histone sample in all different protocols. 
Hereby we assumed the researcher to be blind to an unexpected side reaction, underpropionylation or 
overpropionylation. This was estimated as the percentage of peptide KQLATKAAR+Ac by all peptides 
sharing that same sequence (side reactions, underpropionylation or overpropionylation not taken into 
account). As shown in Table 5.2, estimations only vary slightly (between 28% and 35%). While this is 
reassuring for the conclusions on biology reported to date, it emphasizes the importance of calculating 
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the relative abundance in each run before comparing the samples, as opposed to directly comparing 
precursor intensities in between separate runs. Also, the standard deviation of the relative abundance in 
protocols using only a single round of propionylation cautions for the limited accuracy of estimation for 
these methods. Equally important however, abundant side reactions such as amidation not only reduce 
the signal of the in vivo relevant precursor ion, they also generate large amounts of uninformative new 
precursors that are being selected for MSMS during the DDA acquisition, as these new forms have a 
different retention time (Figure 5.4). It is therefore advisable to check for side reactions (amidation / 
methylation at COOH), underpropionylation or overpropionylation. These peptides can then be taken 
into account when reporting on the total amount of features detected and identified.  
Table 5.2 The relative abundance (%) of acetylation at H318-26 is 
shown as estimated by each protocol (average + SD) 
Estimated relative abundance of acetylation at H3 18-26 
Method Average abundance (%) SD (%) 
Method A.1 34% 8,34% 
Method A.2 28% 1,21% 
Method B.1 31% 4,44% 
Method B.2 31% 0,39% 
Method C.1 35% 0,53% 
Method C.2 31% 0,70% 
Method D.1 31% 0,91% 
Method D.2 33% 1,69% 
 
5.5. Conclusion 
In conclusion, this dataset pointed out that a second round of propionylation increases the conversion 
rate as well as the reproducibility of precursor quantification and is therefore strongly recommended. 
Nevertheless, several pitfalls in propionylating histones for bottom-up MS were disclosed: incomplete 
derivatization, aspecific propionylation and side reactions on carboxyl groups. Each of these events has 
its own implications during data analysis (Table 5.3). When focusing on identification of histones the 
following should be taken into account: using method A, amidation and methylation of COOH-groups 
should be added as a variable modification; method B and C will benefit from allowing non-specific 
cleavage at K (or using trypsin as enzyme in the search parameters with a high number of missed 
cleavages) and setting N-terminal propionylation as variable modification instead of fixed; adding 
propionylation on S, T and Y will increase identifications when using method D. For accurate 
quantification, we strongly recommend to use relative abundances, as these appear reproducible 
between different protocols and can thus be considered the most robust option. Amidation was only 
found as a side reaction thanks to an untargeted evaluation strategy based on a PCA on MS precursor 
intensities and identification of differential MS precursor abundance in between protocols. Therefore, 
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we would like to stress the importance of using such an approach and recommend including it when 
comparing or evaluating other protocols. 
Table 5.3 Table summarizing the pitfalls for each method and suggestions for data analysis 
Method Pitfall 
Suggestions for data analysis 
Peptide identification 
Quantification of histone 
modification 
Amino Acid Modification Variable Fixed 
A 
Amidation at COOH C-terminus/ D/ E Amidation x  
Use relative 
quantification within the 
same run 
Methylation at COOH C-terminus/ D/ E Methylation x  
/ N-terminus Propionylation  x 
B Underpropionylation 
N-terminus/ K/ 
Kme 
Propionylation x  
Use relative 
quantification within the 
same run 
K 
Non specific 
cleavage 
x  
C Underpropionylation 
N-terminus/ K/ 
Kme 
Propionylation x  
Use relative 
quantification within the 
same run 
K 
Non specific 
cleavage 
x  
D 
Overpropionylation S/ T/ Y Propionylation x  
Use relative 
quantification within the 
same run 
/ N-terminus Propionylation  x 
  
“The most exciting phrase to hear in science, the one that heralds new discoveries, is not ’Eureka!’ but 
‘That’s funny …’.” 
― Isaac Asimov 
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 EFFICIENT AND SPECIFIC CHEMICAL DERIVATIZATION OF HISTONES BY MEANS OF 
PROPIONIC ANHYDRIDE 
6.1. Introduction 
Histone proteins are essential elements for DNA packaging. Moreover, also the PTMs that are extremely 
abundant on these proteins, contribute in modeling chromatin structure and recruiting enzymes 
involved in gene regulation, DNA repair and chromosome condensation. Dysregulation of these 
processes has been intimately associated with the development of diseases such as cancer [209–213]. 
This fundamental aspect, together with the epigenetic inheritance of histone PTMs, underlines the 
importance of having biochemical techniques for their characterization. Over the past two decades, 
significant improvements in mass accuracy and resolution of mass spectrometers, have made LC-
coupled MS the strategy of choice for accurate quantification of protein PTMs. Still, the main hurdle to 
overcome when analyzing histone PTMs is the chemical derivatization of lysine residues prior to this MS 
analysis. When the technical variation is high and unpredictable, biological conclusion are dubious. In 
Chapter 5 we investigated the limitations and biases of the most widely adopted sample preparation 
protocols for histone propionylation. We notice that some protocols lead to incomplete derivatization, 
while others produce a variety of side products such as amidation, methylesterification and unwanted 
propionylation on S, T or Y. In this chapter, we further elaborate on these protocols and examine some 
new approaches, in order to address these previously described challenges during sample preparation. 
Several attempts were made to prevent amidation, under- or overpropionylation from happening. Still, 
most adjustments applied seemed to exchange one problem for another. Finally, reversing 
overpropionylation by adding hydroxylamine (HA) resulted in an effective protocol with efficient 
propionylation on primary amines and no unwanted side products remaining. We recommend using this 
method for future analysis of histones through bottom-up MS.  
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6.2. Methods 
An overview of all propionylation methods used and mentioned throughout this work is given in Chapter 
11 (Addendum). For all methods, at least 3 replicates were analyzed.  
Propionylation method A.reverse (method A.r)  
Ten µg bovine histones were vacuum dried, followed by the addition of 15 µL ammonium hydroxide. 
Next, 20 µL propionylation reagent (propionic anhydride:methanol 1:3 (v/v)) was added. The reaction 
was incubated at room temperature for 30 min and evaporated in a SpeedVac to remove any volatile 
remnants. A second round of propionylation was performed prior to trypsin digestion. To propionylate 
the newly generated N-termini, propionylation was also carried out after enzymatic digestion, with the 
same protocol as before digestion. 
Propionylation method A.together (method A.t)  
Twenty µL propionylation reagent (propionic anhydride:methanol 1:3 (v/v)) was mixed with 15 µL 
ammonium hydroxide, immediately followed by the addition of this mixture to a pellet of 10 µg vacuum-
dried bovine histones. The reaction was incubated at room temperature for 30 min and evaporated in a 
SpeedVac to remove any volatile remnants. A second round of propionylation was performed prior to 
trypsin digestion. To propionylate the newly generated N-termini, propionylation was also carried out 
after enzymatic digestion, with the same protocol as before digestion. 
Propionylation method A.no NH4OH (method A.n) 
Twenty µL propionylation reagent (propionic anhydride:methanol 1:3 (v/v)) added to a pellet of 10 µg 
vacuum-dried bovine histones, immediately followed by the addition of 20 µL water. The reaction was 
incubated at 37°C for 30 min and evaporated in a SpeedVac to remove any volatile remnants. A second 
round of propionylation was performed prior to trypsin digestion. To propionylate the newly generated 
N-termini, propionylation was also carried out after enzymatic digestion, with the same protocol as 
before digestion. 
Propionylation method B.separate (method B.s) 
Ten µg vacuum-dried bovine histones were dissolved in 10 µL of 50 mM ABC, immediately followed by 
10 µL methanol, 10 µL propionic anhydride. Finally, 20 µL ammonium hydroxide was added to reach a 
pH above 8. The reaction was incubated at room temperature for 30 min and evaporated in a SpeedVac 
to remove any volatile remnants. A second round of propionylation was performed prior to trypsin 
digestion. To propionylate the newly generated N-termini, propionylation was also carried out after 
enzymatic digestion, with the same protocol as before digestion. 
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Propionylation method E 
Fifty µL propionic acid was added to a pellet of 10 µg vacuum-dried bovine histones, immediately 
followed by the addition of 5 µL propionic anhydride. The reaction was incubated at room temperature 
for 6 hours and evaporated in a SpeedVac to remove any volatile remnants. A second round of 
propionylation was performed prior to trypsin digestion. To propionylate the newly generated N-termini, 
propionylation was also carried out after enzymatic digestion, with the same protocol as before 
digestion. 
Propionylation method F 
Fifteen µL 0.1 M ethanolamine was added to a pellet of 10 µg vacuum-dried bovine histones, 
immediately followed by the addition of 5 µL propionic anhydride. The reaction was incubated at room 
temperature for 30 min and evaporated in a SpeedVac to remove any volatile remnants. A second round 
of propionylation was performed prior to trypsin digestion. To propionylate the newly generated N-
termini, propionylation was also carried out after enzymatic digestion, with the same protocol as before 
digestion. 
Propionylation method G 
Fifteen µL 0.1 M triethanolamine was added to a pellet of 10 µg vacuum-dried bovine histones, 
immediately followed by the addition of 5 µL propionic anhydride. The reaction was incubated at room 
temperature for 30 min and evaporated in a SpeedVac to remove any volatile remnants. A second round 
of propionylation was performed prior to trypsin digestion. To propionylate the newly generated N-
termini, propionylation was also carried out after enzymatic digestion, with the same protocol as before 
digestion. 
Propionylation method H (original – 42x – 20x – 5x) 
Twenty µL 1 M TEAB was added to a pellet of 20 µg vacuum-dried bovine histones, immediately followed 
by the addition of 20 µL propionic anhydride reagent. Of importance, unlike previous methods, 
isopropylalcohol is used instead of methanol to prevent the formation of methylesters. Depending on 
which method used, the ratio (v/v) of propionic anhydride and isopropylalcohol differs: 1:3 for method 
H, 1:79 for method H 42x, 1:170 for method H 20x and 1:680 for method H 5x. Hereby 42x, 20x and 5x 
represent the molar excess of propionic anhydride compared to the amount of primary amines present 
in the sample. The reaction was incubated at room temperature for 30 min and afterwards 20 µL water 
was added for hydrolysis during 30 min at 37°C. Subsequently, the sample was evaporated in a SpeedVac 
to remove any volatile remnants. A second round of propionylation was performed prior to trypsin 
digestion for method H, but this step was left out in method H 42x, 20x and 5x. To propionylate the 
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newly generated N-termini, propionylation was also carried out after enzymatic digestion, with the same 
protocol as before digestion. 
Reversing overpropionylation through boiling 
Fifty µL of 50 mM ABC was added to a 5 µg of vacuum-dried bovine histones, which were propionylated 
using method H 42x. By means of a pH indicator strip the pH was checked and, if necessary, adjusted to 
8 using ammonium hydroxide. The reaction was incubated at 99°C for 1 h. After incubation, the solution 
was evaporated in a SpeedVac to remove any volatile remnants. 
Reversing overpropionylation by addition of hydroxylamine 
Fifty µL of 0.5 M hydroxylamine was added to 5 µg of vacuum-dried bovine histones, which were 
propionylated using method H 42x. Around 15 µL of ammonium hydroxide was added for an increase 
in pH to 12. The reaction was incubated at room temperature for 20 min. After incubation, the pH was 
lowered to 3 by adding 5% formic acid. Finally, the solution was evaporated in a SpeedVac to remove 
any volatile remnants. 
Trypsin digestion 
Trypsin digestion was identical in all protocols, apart from the buffer used: in all methods 50 mM ABC 
was applied, except for method H and derivatives, where 50 mM TEAB was used. In each case, dried out, 
propionylated histones were reconstituted in the respective buffers, supplemented with 1 mM CaCl2, 5 
% ACN and digested overnight at 37°C with trypsin (Promega) at a histone/enzyme ratio of 20:1 [198]. 
LCMSMS 
Because of technical issues, data acquisition was done by means of two different LCMS setups. Data 
analysis however was done in a similar way (see Data analysis) 
LCMS for samples A.n, B.s, F and G was performed using a nanoACQUITY UPLC system. An analytical 
column (100 µm x 100 mm nanoACQUITY UPLC 1.7 µm Peptide BEH) was used at a flow rate of 300 
nL/min and peptides were separated using the gradient as shown in Figure 6.1. A Synapt G2Si was used 
for high definition data dependent analysis, using a nano-ESI source in positive ion mode. Survey MS 
scans were acquired using a fixed scan time of 400 ms. Tandem mass spectra of up to 9 precursors with 
charge state 2+, 3+, 4+ or 5+ were generated using collision induced dissociation upon exceeding an 
intensity threshold of 2000 cps, using a collision energy ramp defined between two lines from 50 to 5000 
m/z: from 6/9 V (low mass, start/end) to up to 147/183 (high mass, start/end). MSMS scan time was set 
to 100 ms with an accumulated ion count ‘TIC stop parameter’ of 350 000 cps allowing a maximum 
accumulation time of 200 ms. After acquiring, masses from MSMS were excluded for 10 s. Wideband 
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enhancement was used to obtain a near-100% duty cycle on singly charged fragment ions. Lockspray of 
Glufibrinopeptide-B (m/z 785.8427) and leu-enkephalin (m/z 556.2771) was acquired at a scan frequency 
of 60 s. Data were lock-mass corrected post-acquisition. 
 
Figure 6.1 Gradient elution profile for the separation of propionylated histone peptides by RP-LC 
 
LCMS for all other samples was performed by means of an Eksigent LC system coupled to a TripleTOF 
5600. Peptides were separated using the gradient as shown in Figure 6.1. The mass spectrometer was 
applied with a ESI source in positive ion mode for DDA. Survey MS scans were acquired and up to 12 
precursors exceeding the signal threshold (750 cps) were selected (m/z 400-1250). 
Data analysis 
The abundance of different peptide forms (desired, amidated at COOH, methylated at COOH, under- 
and overpropionylated) of seven peptides were monitored using their XIC’s throughout all replicates. 
The conversion rate of each form was calculated as shown here for underpropionylation: 
𝑨𝒎𝒐𝒖𝒏𝒕 𝒐𝒇 𝒖𝒏𝒅𝒆𝒓𝒑𝒓𝒐𝒑𝒊𝒐𝒏𝒚𝒍𝒂𝒕𝒊𝒐𝒏
=
𝑋𝐼𝐶 𝑢𝑛𝑑𝑒𝑟𝑝𝑟𝑜𝑝𝑖𝑜𝑛𝑦𝑙𝑎𝑡𝑒𝑑
𝑋𝐼𝐶 𝑑𝑒𝑠𝑖𝑟𝑒𝑑 + 𝑋𝐼𝐶 𝑢𝑛𝑑𝑒𝑟𝑝𝑟𝑜𝑝𝑖𝑜𝑛𝑦𝑙𝑎𝑡𝑒𝑑 + 𝑋𝐼𝐶 𝑜𝑣𝑒𝑟𝑝𝑟𝑜𝑝𝑖𝑜𝑛𝑦𝑙𝑎𝑡𝑒𝑑 + 𝑋𝐼𝐶 𝐶𝑂𝑂𝐻 − 𝑎𝑚𝑖𝑑𝑎𝑡𝑒𝑑 + 𝑋𝐼𝐶 𝐶𝑂𝑂𝐻 − 𝑚𝑒𝑡ℎ𝑦𝑙𝑎𝑡𝑒𝑑
 
The area under the curve (AUC) itself was defined in two different manners, depending on the LCMS 
platform used. Both approaches are described into more detail below.  
MS data acquired by the TripleTOF 5600 was processed as follows. Generated wiff-files were thoroughly 
searched using Protein Pilot 4.5 (Sciex), implementing the following special factors: purified histones, 
propionylation pre-digestion and propionylation post-digestion. Enzyme specificity was set to Arg-C 
and an FDR analysis was performed. The data were exported to Excel and filtered using 5% distinct 
peptide local FDR as cut-off value. The different peptide forms of eight peptides (underpropionylated, 
desired, overpropionylated) were isolated and XICs of these forms throughout all runs were made using 
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PiekView 1.2. To confirm correct annotation and localization of the propionyl groups, the same dataset 
was also searched using a Mascot 2.5 in house server (Matrix Science) and only spectra assigned to the 
same peptide by both ProteinPilot and Mascot were taken into account. Mascot parameters were the 
following: mass error tolerances for the precursor ions and its fragment ions were set at 15 ppm and 
0.01 Da respectively, enzyme semi-specificity was set to Arg-C, allowing for up to two missed cleavage 
sites. Variable modifications included acetylation, dimethylation, trimethylation and propionylation on 
lysine (K), methylation and dimethylation on arginine (R) and oxidation of methionine. Lysine 
monomethylation was searched as the sum of propionylation and methylation since monomethylated 
lysine residues can still be propionylated. Propionylation was set as a variable modification at the N-
terminus, serine (S), threonine (T) and tyrosine (Y). Only peptides with an expectancy value < 0.01 were 
considered correctly annotated. 
Progenesis QI for Proteomics software and Mascot Deamon 2.5 were used to process raw MS data 
coming from Synapt G2Si and for further in-depth analysis of the samples. After alignment of the 
different runs to a single reference run (QC run, made from every sample of the experiment), raw data 
of all runs were processed using the default peak picking parameters with regard to sensitivity and 
chromatographic peak width. Features were filtered based on retention time and charge state (2+ to 5+) 
and the data were normalized to all features. Before exporting the data as an MGF-file, a top 5 MS/MS 
selection was taken to reduce the number of redundant spectra exported. These MGF files were searched 
using Mascot Daemon with following parameter set: decoy database, MS/MS tolerance of 0.3 Da, 
enzyme semi-specificity was set to Arg-C, allowing for up to two missed cleavage sites. Regarding 
modifications, the defined variables were: acetyl (K), amidated (C-term), amidated (DE), methyl (C-term), 
methyl (DE), methyl (K), methylpropionyl (K), propionyl (K), propionyl (N-term), propionyl (S), propionyl 
(T), and propionyl (Y). The data, obtained in Mascot, was filtered with an expectancy value of 0.01 and 
was exported as an XML-file and imported back into Progenesis QI software in order to link peptide 
identifications with peak areas. Then, the data was exported to Excel and the conversion rates were 
calculated as stated above. 
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6.3. Results 
In the previous chapter several pitfalls in propionylating histones for bottom-up MS were disclosed: 
incomplete derivatization, aspecific propionylation and side reactions on carboxyl groups. During 
acquisition, considerable amounts of time are lost to these redundant peptide species and adding in 
vitro induced modifications in the search impedes identification of in vivo modifications. Equally, only 
relative abundance is robust enough not be affected by these modifications, making other methods such 
as direct inter-run relative quantification of AUCs imprecise. We thus set out to address these known 
issues by making adjustments to known protocols. An overview of the effects thereof is given in Table 
6.1. 
 An attempt to tackle amidation of carboxyl groups in method A 
As decribed in Chapter 5, propionylation method A suffers from unexpected amidation of carboxyl 
groups, next to the desired N-acylation at primary amines (Figure 6.2 A). This side reaction has not been 
described before and the exact nature of the reaction mechanism remains unclear. In Figure 6.2 B we 
make a suggestion of what this amidation mechanism may look like on a peptide C-terminus. In this 
representation, the carboxyl group itself becomes an anhydride, due to a side reaction between 
propionic anhydride and the peptide C-terminus. Hence, this reactive “mixed anhydride” can react whith 
ammonium hydroxide, when added to the reaction in a second step. As such, this will result in an 
amidated C-terminus and the formation of propionic acid. We tried to prevent this reaction from 
happening by changing the order in which reagentia were added in method A.reversed (method A.r) 
and method A.together (method A.t) or simply omitting ammonium hydroxide: method A.no NH4OH 
(method A.n). 
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Figure 6.2 Amidation of carboxyl groups 
A: Correct chemical derivatization of lysine containing peptides by propionic anhydride (K, Kme and N-termini). R1 
and R2 represent amino acid side chains. After derivatization, the amine group on the unmodified K residue is 
modified with a propionyl group. Propionic acid is the side product of this reaction. B: Suggested reaction 
mechanism of the amidation of carboxyl groups (D, E and C-termini), which can occur as a side reaction during the 
chemical derivatization of histones by means of propionic anhydride and ammonium hydroxide. Hereby a mixed 
anhydride is formed, which reacts with ammonia and thereby generates an amidated carboxyl group.  
 Changing the order of adding reagents can turn amidation at COOH into 
underpropionylation – method A.r and A.t 
In order to avoid amidation of carboxyl groups, we made some adjustments to method A and examined 
whether or not the amount of amidated peptides was reduced. We assumed (based on Figure 6.2) that 
by preventing the conversion of a carboxyl group in a very reactive “mixed anhydride”, subsequent 
amidation would be circumvented as well. Therefore, we decided not to change the reagents used, only 
the order in which they were added to vacuum dried bovine histone. We reasoned that by mixing the 
same amount of ammonium hydroxide and bovine histones prior to (method A.r) or simultaneous with 
(method A.t) propionic anhydride, the latter would no longer react with carboxylgroups, since it will 
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readily react with the amines coming from the bovine histones as well as ammonium hydroxide to form 
correctly propionylated peptides and propionamide, respectively. 
As anticipated, both customized methods no longer show any form of amidation at carboxyl groups. 
Unfortunately, besides hindering amidation, changing the order of adding reagents also affects efficient 
propionylation of primary amines on bovine histones, leading to a drastic increase in underpropionylated 
peptides. Just like amidation, this impaires identification as well as relative inter-run quantification of 
histone PTMs. We thus concluded that both methods are insufficient. 
 Omitting ammonium hydroxide can result in overpropionylation and turn amidation 
into methylation at COOH groups – method A.n 
Knowing that nitrogen is needed as a nucleophile for the amidation of COOH groups, it seems 
reasonable not to add any nitrogen donors to the reaction when trying to avert amidation as a side 
reaction. Accordingly, we developed a method - based on method A - that no longer includes the 
addition of ammonium hydroxide: method A.no NH4OH (method A.n). Only, if the reaction mechanism 
as suggested in Figure 6.2 is correct, leaving out the addition of ammonium hydroxide would result in 
the reactive “mixed-anhydride” intermediate as a final product. For this reason, water was added to 
further hydrolyze this anhydride into the original peptide (ending on a carboxyl group) and propionic 
acid. Taken into account our previous train of thought (Figure 6.2), the overall reaction mechanism of 
this propionylation method would be as depicted in Figure 6.3 A. However, the results did not confirm 
our assumption. Data analysis revealed another side reaction occurring: formation of methylesters on 
COOH groups and overpropionylation on S, T and Y. The former is probably caused by the use of 
methanol, which can react with the “mixed anhydride” intermediate (Figure 6.3 B). The hydroxylgroups 
of S, T and Y can also react with the excess of propionic anhydride, even though their reactivity is less 
compared to primary amines (Figure 6.3 C). 
We thus conclude that omitting ammonium hydroxide in method A indeed stops amidation at carboxyl 
groups, but introduces other unwanted side reactions such as COOH-methylation and 
overpropionylation.  
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Figure 6.3 Hydrolysis and methylation of the “mixed anhydride”; aspecific propionylation 
A: Addition of propionic anhydride to histone peptides can generate a “mixed anhydride” intermediate. This 
anhydride can be hydrolyzed by addition of water, thereby regenerating a the original COOH group. B: In the 
presence of methanol, hydrolysis as depicted in panel A is displaced by the reaction between the “mixed anhydride” 
and methanol itself. This results in the formation of methylesters at carboxyl groups of D, E and the C-termini. C: 
Aspecific propionylation can take place on the hydroxylgroups of S, T and Y by means of O-acylation. Panel C 
displays this reaction for both S and T residues. Y residues contain a phenyl group and are therefore less reactive, 
but they can react likewise. 
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Of interest, substituting methanol for isopropylalcohol in method A.n could stop the formation of 
methylesters on carboxyl groups. When we applied this, additionally no isopropylesters were detected. 
This was also described in the publication of Olcott et al., who studied the esterification of proteins by 
low molecular weight alcohols [214]. They report that primary alcohols other than methanol react more 
sluggishly with proteins, and ispropylacohol does not react appreciably. Overpropionylation on the other 
hand remained present when isopropanol was used. Moreover, we were surprised to see amidation 
recurring, even though no ammonium hydroxide was used in this method. This side product is potentially 
generated during digestion in ABC buffer.  
 An attempt to tackle inefficient propionylation of primary amines in method B and C – 
method B.s 
Since amidation of carboxyl groups is a new phenomenon with an unknown reaction mechanism, it is 
difficult to control this side reaction. Hence, we equally set out to further improve a known 
propionylation protocol that does not suffer from amidation. As described in Chapter 5, both methods 
based on the protocol of Garcia et al. [128] (method B and C) were hindered by underpropionylation. In 
order to optimize the reaction efficiency, we developed method B.separate (method B.s), where two 
major adjustments were made compared to methods B and C (Chapter 5). First, ammonium hydroxide 
is now added as a final step during propionylation, in stead of prior to propionic anhydride. The reason 
therefore is that the large amount of primary amines coming from ammonium hydroxide could compete 
with the primary amines on the bovine histones themselves, hindering proper derivatization. Also, 
methanol and propionic anhydride were no longer mixed prior to the propionylation reaction, but 
instead were added separately. The main reason therefore is that propionic anhydride will readily react 
with methanol, once the propionylation reagent is made. This way, a lot of the reactivity of this mixture 
might be lost, even before it is added to the histone sample. Note that also other research groups 
acknowledge this to be an issue, as they recommend to prepare fresh reagent every three samples and 
equally stress the importance of working in a streamlined manner, without any interruptions [128,179].  
As we reached our objective of limiting the amount of underpropionylation (on average < 2%), other 
side reactions emerged instead. We now found overpropionylation (up to 18%) and amidation (up to 
31%) to be the main problems. The latter can be due to the presence of ABC and ammonium hydroxide 
in the reaction. Even though methanol was used, no significant amount of methylesterification was 
detected. In conclusion, we were able to improve propionylation efficiency on primary amines by making 
some small adjustments to method B, but this was at the cost of a loss in specificity. Besides, amidation 
of carboxyl groups appeared as an unwanted side reaction. 
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 An attempt to improve specificity and efficiency by omitting or changing the buffering 
system 
Since avoiding amidation at COOH groups, as well as preventing underpropionylation proved to result 
in other side reactions, we tried some new approaches for the derivatization of histones. Method E is 
based on literature, methods F till H are new, according to our knowledge. 
 Propionylation without buffering system – method E 
In a first attempt, histones were propionylated by use of a protocol mentioned in a publication of Smith 
et al. [130]. This method (method E) includes no buffers (such as ABC or ammonium hydroxide) that are 
typically used to maintain a pH between 8 and 10. The only reagent used, next to propionic anhydride, 
is propionic acid. For a detailed description, see section Methods (section 6.2).  
Even though the primary amines on the histones were all adequately propionylated, this derivatization 
method was far from specific. A large amount of the peptides appeared in their overpropionylated form 
(up to 89%).  
 Propionylation with ethanolamine, triethanolamine or TEAB – method F, G and H 
Because the use of ammoniumhydroxide or ABC was associated with amidation at carboxyl groups and 
the use of methanol could lead to the generation of carboxymethylesters we decided to test whether or 
not omitting methanol and at the same time using another buffering system could prevent these side 
reactions from happening. We investigated the use of ethanolamine (pKa = 9.5), triethanolamine (pKa = 
7.74) and TEAB (pKa = 10.75) (Figure 6.4). The methods (methods F, G and H respectively) are described 
in detail in section 6.2.  
 
Figure 6.4 Chemical structure of ethanolamine, triethanolamine and TEAB 
 
Indeed, no amidation nor formation of methylesters could be detected on carboxylgroups for either of 
these protocols. Also, the reaction was efficient on primary amines as no underpropionylated peptides 
were identified. Nevertheless, all three methods struggle with a lack of specificity as each of them shows 
EFFICIENT AND SPECIFIC CHEMICAL DERIVATIZATION OF HISTONES BY MEANS OF PROPIONIC ANHYDRIDE 
119 
 
a lot of overpropionylation: 43% (method F), 61% (method G) and 62% (method H) on average. As such, 
these methods do not suffice for the propionylation of histones. 
 Dealing with aspecific overpropionylation by preventing or reversing it 
Foregoing methods illustrate that avoiding inefficient propionylation (underpropionylation), often goes 
at the cost of introducing aspecific overpropionylation. Nevertheless, some propionylation strategies 
(method D, E, F, G and H) only have overpropionylation as an unwanted side effect and could thus result 
in a proper method if this issue is addressed. Therefore, three different strategies were performed on 
aforementioned protocol H, which – based on our analysis - suffered from no other issues than 
overpropionylation. (i) At first, we tried to prevent overpropionylation by lowering the molar excess of 
propionic anhydride, compared to the average amount of primary amines on bovine histones. We thus 
lowered the volume of propionic anhydride added to the reaction. Next, we verified two different 
approaches for reversing overpropionylation, after the final propionylation reaction post digestion: (ii) 
boiling of propionylated peptides during 1 h and (iii) adding hydroxylamine. 
 Lowering propionic anhydride concentration down to a 5-fold molar excess 
One approach to circumvent aspecific propionylation is lowering the concentration of propionic 
anhydride from the estimated 420-fold molar excess used in method H to a 42-fold (method H 42x), 20-
fold (method H 20x) and 5-fold (method H 5x) molar excess (per primary amine group). Also, 
propionylation of the samples was only performed once prior to and post digestion instead of twice. 
This drastic decrease is based on literature where the molar excess of anhydride reagents ranges from 
5x over 200x up to 1000x [215–219]. 
As can be seen in Figure 6.5, reducing the surplus of propionic anhydride decreases the amount of 
overpropionylated peptides. While the portion of peptides with propionyl groups at S, T and Y is still 
high for a 42x molar excess of propionic anhydride, there is a significant decrease for a 20x surplus and 
overpropionylation is almost reduced to zero for 5x molar excess. Nevertheless, these methods still do 
not meet expectations as they simultaneously display an increase in underpropionylated peptides.  
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Figure 6.5 Lowering the molar excess (42x, 20x and 5x) of propionic anhydride per primary amine prevents 
most overpropionylation but increases underpropionylation 
Each method is represented by a radar chart showing the average contribution of over-, under- and desired 
propionylation for 7 peptides monitored. Each peptide is located on one angle of the radar chart and each peptide 
form is represented by another color. The abundance of a specific peptide form is shown on the radius, whereby a 
conversion rate of 0 is located in the center, increasing outwards. 
In conclusion, we can state that lowering the molar excess of propionic anhydride per primary amine 
helps in preventing overpropionylation but at the same time hinders efficient propionylation on the 
targeted primary amines. 
 Reversing overpropionylation through boiling or adding hydroxylamine 
Given the latter conclusion, we set out to reverse this overpropionylation, instead of avoiding it. Based 
on literature we found two strategies: (i) boiling of propionylated peptides during 1h (method H42x 
boil) [220] and (ii) adding hydroxylamine (method H 42x ha) [221–223], and implemented these on 
method H 42x since overpropionylation is the only known side reaction for this approach. The reaction 
mechanism of the latter is displayed in Figure 6.6. 
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Figure 6.6 Reversing overpropionylation by means of hydroxylamine 
 
As illustrated by Figure 6.7, both boiling and the addition of hydroxylamine result in the reversing 
overpropionylation, without a substantial increase in underpropionylated peptides. Boiling the samples 
decreases aspecific propionylation of all 7 peptides monitored, but it appears to be less efficient for 
some peptides, such as DAVTYTEHAKR. Treatment with hydroxylamine on the other hand was very 
effective with a negligible discrepancy for peptide sequence. The average conversion into correctly 
propionylated peptides increased up to 95 %. The only disadvantage of using this method is the loss of 
acetylation at S, T and Y residues as a biological modification. This PTM will most probably be removed 
simultaneously with the propionylgroups and can thus no longer be identified, nor quantified. However, 
this modification is very rare compared to other PTMs that can now be characterized more reliable. 
Additionally, it is a very challenging modification to be annotated correctly by MS, as it is extremely 
difficult to distinguish it from neighboring and more abundant K acetylations. 
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Figure 6.7 Overpropionylation can be (partially) reversed by boiling the sample for 1h or adding 
hydroxylamine 
Each method is represented by a radar chart showing the average contribution of over- (blue), under- (yellow) and 
desired propionylation for 7 peptides monitored. Each peptide is located on one angle of the radar chart and each 
peptide form is represented by another color. The abundance of a specific peptide form is shown on the radius, 
whereby a conversion rate of 0 is located in the center, increasing outwards. 
Thus, both methods seem promising as a new strategy to reverse overpropionylation without causing 
underpropionylation. At this point, adding hydroxylamine is the method of choice as it can generate on 
average 95% of correctly propionylated peptides. 
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6.4. Discussion 
Histone analysis by bottom-up MS requires an additional step during sample preparation as compared 
to the traditional proteomics strategy: chemical derivatization by acylation reaction at amine groups. 
This is mainly because histones are highly enriched in basic Aa residues (K and R), which comes as an 
advantage for the proper binding to DNA but results in generation of very short peptides for LCMS 
analysis after trypsin digestion. Therefore, histones are mostly derivatized prior to and after trypsin-
mediated cleavage by means of propionylation of accessible amine groups. However, the technical 
framework of this propionylation step should not induce additional variation that obscures biological 
changes. 
In Chapter 5 we performed an extensive investigation of side reactions for 4 commonly used 
propionylation protocols (method A till D), using DDA and peptide quantification performed via XIC after 
precursor alignment. This analysis disclosed several pitfalls: side reactions on carboxyl groups 
(amidation, methylation), incomplete derivatization and aspecific propionylation at S, T and Y residues. 
These pitfalls hinder identification and impair direct comparison of precursor intensities of biological 
modified peptides. However, relative abundance proved to be a very robust relative measurement, that 
quantified PTM very similarly independent of the propionylation protocol applied. This implies that 
research groups using one or the other protocol are likely to provide equally results when using this 
measurement to quantify changes between different biological samples [224]. Note that correction 
factors for ionization efficiency are required when aiming at quantifying the true relative abundance in 
a single sample and that the robustness here applies only to the comparison of different relative 
abundance values. Nevertheless, in order not to generate large amounts of uninformative new 
precursors that are being selected for MSMS during DDA and at the same time enable “inter-run relative 
quantification”, we set out to address these pitfalls in propionylation and develop a protocol that only 
leads to correctly propionylated peptides. The results are summarized in Table 6.1. 
First, we tried to avoid amidation of carboxyl groups by making some adjustments to method A. In 
method A.r and A.t, we mixed the same amount of ammonium hydroxide prior to or simultaneous with 
propionic anhydride, which no longer led to the generation of amidated carboxyl groups. However, due 
to increase in underpropionylated peptides we refrained from further developing this strategy. Leaving 
out ammonium hydroxide as such, as done in method A.n, could also prevent amidation of carboxyl 
groups, but on the other hand induced methylation of these groups and led to aspecific propionylation 
at S, T and Y residues. The former is probably due to an O-acylation reaction between the very reactive 
“mixed anhydride” and methanol. This reaction did not occur in the presence of ammonium hydroxide 
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(method A, A.r and A.t) because amine groups are more reactive than hydroxyl groups. In conclusion, 
the adjustments made to method A failed to provide an optimal propionylation method. 
Next, we tried to convert the underpropionylation in method B and C. Despite the fact that all 
underpropionylation was countered by omitting the mixing of methanol and propionic anhydride prior 
to the reaction, as well as by adding the ammonium hydroxide after the propionylation reagent, new 
pitfalls (amidation and overpropionylation) shut the door on this protocol. 
Subsequent, we investigated the effect of interfering with the buffer system, either by using no buffer at 
all or changing the buffer system (ethanolamine, triethanolamine and TEAB): method E till H. 
Unfortunately, all methods led to an increase in overpropionylation. The reason therefore probably is 
the reactivity of an anhydride towards hydroxylgroups. While primary amines are more reactive, acylation 
of hydroxyl groups becomes favorable once these are all propionylated. Nevertheless, if 
overpropionylation is the only pitfall and these methods are not hindered by any other unwanted 
reactions, it is worth trying to address this issue specifically. 
Hence, we tried to tackle this aspecific propionylation in two ways: (i) preventing it from happening by 
lowering the molar excess of propionic anhydride or (ii) reversing it by means of boiling or the addition 
of hydroxylamine. The first approach was partially successfull given that overpropionylation decreased 
in correlation to the reduction in propionic anhydride added to the samples. Yet, underpropionylation 
started to increase simultaneously, and finding the optimal molar excess to balance between both pitfalls 
is difficult. Furthermore, researchers often do not know the exact amount of sample – let alone primary 
amines- they have on their hands, which would be required for converting an ideal molar excess into a 
specific volume of propionic anhydride. Taking this into account, reversing propionylation of 
hydroxylgroups on S, T and Y might be a better strategy. This goal could be achieved by both boiling 
and by the addition of hydroxylamine. Heating the sample was able to break the ester bond on most 
peptides but unfortunately the amount of overpropionylated peptides remained too high for some 
peptides, such as DAVTYTEHAKR where 41% of the peptides were left overpropionylated. The 
hydroxylamine mediated acyl removal on the other hand was more efficient with an average conversion 
rate of 95%. The addition of this very reactive nucleophile can reverse overpropionylation, without 
removing propionylation on primary amines. Hence, all protocols generating only overpropionylated 
products as unwanted side products can be turned into good propionylation protocols by addition of 
hydroxylamine post propionylation. Yet, when using a method for reversing ovepropionylation, one 
should always take into account that acetylgroups on S and T residues will no longer be identified. 
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Table 6.1 Customizing a method in order to tackle known pitfalls 
In order to address the known pitfalls, methods were customized. The effect of these adjustments on the average 
contribution of each peptide form was monitored. This contribution could be none (/), increase (↑), decrease (↓) or 
the adjustment could lead to complete reduction (↡) of the peptide form. 
Based on 
- pitfall 
Method 
name 
Adjustments made Pitfall 
Amid Meth Und Over 
Method A 
- Amid 
A.r Reverse order of adding NH4OH 
and PA reagent 
↡ / ↑ / 
A.t Add NH4OH and PA reagent 
together 
↡ / ↑ / 
A.n Do not add any NH4OH ↡ ↑ / ↑ 
Method B and C 
- Under 
B.s Do not mix methanol and 
propionic anhydride in advance 
Add NH4OH at the end 
↑ / ↡ ↑ 
NEW E No buffer / / / ↑ 
 F Ethanolamine buffer ↑ / / ↑ 
 G Triethanolamine buffer / / / ↑ 
 H TEAB buffer / / / ↑ 
Method H 
- Over 
H 42x 42x molar excess of propionic 
anhydride 
/ / / ↓ 
H 20x 20x molar excess of propionic 
anhydride 
/ / ↑ ↓ 
H 5x 5x molar excess of propionic 
anhydride 
/ / ↑ ↡ 
Method H 42x 
- Over 
H 42x 
boil 
Boil sample for 1h after 
propionylation 
/ / / ↓ 
H 42x ha Reaction with hydroxylamine 
after propionylation 
/ / / ↡ 
 
In conclusion, we were able to develop a protocol (method H 42x ha) that attains efficient propionylation 
on primary amines, has no remaining aspecific propionylation of S, T and Y residues and displays no side 
reactions such as amidation or methylation of carboxyl groups. Despite the loss of information on in 
vivo acetylated S and T residus, this propionylation protocol has several advantages over other methods. 
First of all, sensitivity will rise as the MS signal of the same peptide is no longer spread over different MS 
precursors, generated by unwanted side reactions or inefficient propionylation. Additionally, no precious 
acquisition time will be lost by generating MSMS spectra of these differentially in vitro modified peptides 
instead of spectra belonging to peptides with the interesting in vivo modifications. But not only data 
acquisition will benefit from using both efficient and specific propionylation protocol: also the 
confidence of peptide identifications will increase, considering that less variable modifications such as 
propionylation on S, T and Y have to be taken into account when performing a database search. 
Alternatively, more in vivo modifications can be permitted before causing a combinatorial explosion. 
This in turn will lead to more biologically relevant conclusions. Finally, sample preparation will require 
less time as only one round of propionylation is required prior to as well as post digestion.  
  
“A scientist is not a person who gives the right answers, he's the one who asks the right questions.”  
— Claude Lévi-Strauss 
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 FINAL DISCUSSION AND GENERAL CONCLUSIONS 
This thesis aimed at studying histone PTMs from both a biological and technical point of view. 
Throughout the first part, we report histone H3 cleavage, mediated by a serine protease, as a new PTM 
in hESC and investigate its occurrence in a biological context. In the second part we further elaborate on 
the technical pitfalls associated with uncovering such histone PTMs by bottom-up MS. 
7.1. Histone clipping: the pursuit of an epigenetic outcast 
 Oct4 expression is not directly related to H3 clipping activity 
In the first part of this dissertation we focused on the N-terminal truncation of histone H3 during early 
hESC differentiation. A similar event was reported earlier in 2008 by Duncan et al. in mESC [184]. This 
manuscript strongly implies a cause-and-effect relationship between H3 clipping and differentiation. In 
order to disclose a similar link between both this clipping event and and the expression of the 
pluripotency marker Oct4, we set out to monitor the hESC over a longer period of time (14 days) and 
subjected them to three different types of differentiation: (i) stem cells were maintained in their 
undifferentiated status by culturing the cells in E8 medium, (ii) spontaneous differentiation was induced 
by omitting bFGF from the culture medium and (iii) addition of RA directed enforced differentiation. 
Despite the clear decline in Oct4 expression, no change in H3 proteolysis activity could be observed. 
Even though these results seem to be conflicting with the findings of Duncan et al. – who claim that H3 
clipping to be differentiation-related - a thorough analysis of their results leads us to believe otherwise. 
In one of the cathepsin L inhibition experiments, the authors monitored H3 clipping together with Oct4 
expression. While the Oct4 expression kept on following the same trend, with or without cathepsin L 
inhibition, the clipping event was clearly influenced by this inhibition. Thus, similar Oct4 expression, but 
nevertheless H3 cleavage was affected [184]. Still, our findings seem to suggest that cells require a 
certain degree of multipotency for the clipping to occur. This was illustrated by the fact that terminally 
differentiated Raji cells are incapable of H3 clipping in contrast to multipotent THP-I cells. A possible 
explanation for this is the more loosened chromatin structure associated with pluripotent cells, which 
increases the susceptibility for histone clipping. However, more cell types need to be investigated to 
exclude the possibility that this finding simply comes down to a difference in enzyme expression 
between different cell lineages. 
 The truncation of H3 is not cell cycle regulated 
Next, the undulating pattern of cH3 seen when hESC are cultured on MEFs (Figure 4.9), together with 
the known effect of RA addition on the cell cycle itself [225], drove us to hypothesis that the event 
instead is cell cycle-dependent. Duncan and co-workers considered this theory as well, based on flow 
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cytometry data that revealed a prolonged S phase of the mESC upon differentiation. Moreover, the 
preferred clipping of the H3.2 isoform, whose expression is tightly replication-coupled, might indicate a 
preference of histone proteolysis towards the S phase. However, synchronized cells showed no change 
in H3 clipping in neither of the cell cycle phases. We thus conclude there is no direct link between the 
cell cycle and histone clipping. 
 Culture conditions alter H3 clipping pattern in differentiating hESC 
To further extend the context of histone clipping, we investigated two different hESC cell lines under two 
different culturing conditions. Surprisingly, the latter variable had a major impact on the H3 clipping 
pattern in differentiating hESC. While both cell lines showed continuous clipping under feeder-free 
culturing conditions, this no longer applies to hESC cultured on a MEF feeder layer. In this setting, hESC 
cleave H3 in an identical temporary window compared to mESC: the clipping process starts on day 2 
after RA addition and reaches a maximum at day 4. Henceforth, the cH3 intensity fades towards the end 
of the experiment. Even though Duncan et al. do not specifically mention the effect of culturing 
conditions on the cleavage pattern, they saw a similar phenomenon during EB formation, where the cH3 
band appeared early and remained until 14 days after the start of differentiation. Nevertheless, when 
monolayer differentiation was induced by means of RA, H3 proteolysis appeared to be temporary, arising 
at day 2 and 3 and disappearing thereafter [184]. Only very recently the group of Jensen also noted that 
culture conditions can impact histone proteolysis [226]. Histone clipping was induced during the 
cultivation of human hepatocarcinoma cell line in 3D culture but not in 2D culture. The dissimilarity in 
proteolytic activity between culture conditions for both this cell line and hESC might be explained by the 
difference in composition, in hESC colony architecture, in cell signaling, and in the biomechanics of the 
cellular microenvironment [227]. In general, these features act in concert to provide the necessary cues, 
regulating cell function in both developing and adult organisms. Substrate-cell, as well as cell-cell 
interactions can activate specific mechanotransduction pathways that are involved in the regulation of 
the stem cell fate. Mechanical factors and geometrical properties can thus have significant influence on 
regulating stem cell activities [228]. Also histone H3 clipping might one of those affected processes. 
Moreover, one can doubt whether the 2D culturing system for hESC (MEF feeder layer or feeder free) 
even comes close to representing the 3D in vivo conditions, rendering the biological relevance of 
processes such as histone clipping less trustworthy. Additionally, to eliminate the possibility that this 
clipping event is actually a technical in vitro artefact, we included several controles: adding a spike-in of 
(i) biotinylated and (ii) non-biotinylated calf H3 during extraction, (iii) whether or not omitting protease 
inhibitors at the time of sample preparation and (iv) the application of direct boiling after cell harvesting. 
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Each of these measures confirmed our assumption that H3 proteolysis is not merely an in vitro side 
effect, but takes place in the nucleus itself prior to extraction. 
 A broader context: categorizing histone proteolysis into histone clipping and histone 
degradation 
When fitting these results into a broader context one can remark that also other research groups have 
linked histone disintegration and developmental processes. However, the autors often do not state 
whether complete degradation or specific clipping was studied. Therefore, we have categorized earlier 
reports linking histone proteolysis and development into two different functional classes: (complete) 
histone degradation on one hand and the epigenetically connoted histone clipping on the other.  
First, the following events illustrate that overall histone degradation occurs predominantly during 
important developmental transitions. (i) Both through enzymatic degradation and mediated by the 
proteasome histones are degraded during spermatogenesis [229]. (ii) These sperm histones 
(protamines) then have to be degraded once again during early embryogenesis. The enzyme responsible 
for this was recently found to be cathepsin L. (iii) Also earlier eukaryotes go through complete histone 
degradation during specific stages of development. For example, H3 is degraded during Tetrahymena 
macronucleus formation, with H3A21 being the most abundant fragment [230]. (iv) Some intracellular 
pathogens such as Chlamydia seem to be able to selectively degrade their own histones upon infection 
[231]. Taken together, developmental histone degradation can be expected to be an omnipresent 
phenomenon in eukaryotic organisms, especially during reproduction. However, the relative lack of 
studies focusing on the mechanisms underlying these histone turnover events also conceals its relation 
to histone clipping. 
More specifically, next to these events of (complete) histone degradation, H3-specific clipping has been 
raised as being of potential epigenetic importance in various biological processes. Here, we report these 
findings in a chronological order (summarized in Table 7.1). (i) In 1979, Allis et al. demonstrated that the 
micronuclei of Tetrahymena thermophila contain two electrophoretically distinct forms of histone H3. 
The faster species is derived from H3 by a proteolytic cleavage which removes six residues from the 
amino terminus [192,193,232]. (ii) Falk and co-workers were among the first to report the occurrence of 
histone H3 clipping in infection and dissease when they showed that the FMDV expresses the so-called 
protease 3C in host cells, which mediates clipping at H3L20 [187,188,233,234]. (iii) As mentioned earlier, 
the N-terminus of H3 is clipped from A21 to K27 during mESC differentiation [184]. (iv) Almost 
simultaneously with the publication of H3 trunctation in differentiating mESC in 2008, Santos-Rosa et al. 
reported a protease activity in yeast that was induced under conditions of nutrient deprivation and 
sporulation [191]. Five years later, Xue et al. appointed PRB1 as an enzyme responsible for this event 
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[205]. Similar to cathepsin L activity, the yeast endopeptidase cleavage of H3 occurred in a PTM-
dependent matter. The authors showed that H3 truncation precedes H3 eviction from induced 
promotors, by removing repressive marks. (v) Moreover, glutamate dehydrogenase was discovered to 
also have H3 protease specificity in chicken liver [195]. Given that the truncated H3 form was only 
observed in adult chicken livers and remained absent in young chickens, a role for H3 clipping in aging 
has been suggested [194,235]. Within the same context, Kanungo and co-workers reported earlier the 
H3 truncation in aging quail liver [190,236]. Yet, they have not been able to pinpoint the responsible 
enzyme, nor could they unravel the epigenetic mechanism involved. (vi) Recently, histone H3.1 was 
demonstrated to be a potential legumain substrate in colorectal cancer, but the in vivo functional 
implications of this legumain nuclear activity are yet to be explored [237]. (vii) In 2014, a study of the 
post-lactational regression of the mammary gland revealed that PTMs drive cathepsin D into the nucleus 
to cleave H3. One year later, Arnandis et al. revealed enzyme redundancy when they showed that also 
Calpain-1 was internalized within nuclei and found to be present in the nuclear chromatin-enriched 
fraction, associated with histone H3. This developmental regression stage is an intriguing biological 
phenomenon, and its further elucidation is of great relevance to breast cancer research [238].  
Based on this overview of histone clipping events, we can agree with the notion that H3 clipping could 
very well represent a common feature during developmental processes, such as differentiation and 
aging. Nevertheless, since the link between histone proteolysis and epigenetics only started to emerge 
during the last decade, conclusive evidence is still lacking. Uncoupeling controlled histone clipping from 
continuous histone degradation will probably prove to be the biggest challenge. 
 N-terminal cleavage sites are targeted by a serine protease 
If we acknowledge H3 clipping during early hESC differentiation as a potential epigenetic mark, two key 
questions remain. First, where does this clipping take place in the chain of AA? Second, which enzyme 
mediates this event?  
The former was addressed by implementing complementary techniques. Western blotting enabled to 
confirm the N-terminal nature of cH3 and could moreover pinpoint A21 as a first cleavage site. MS based 
analysis revealed residue 31 as an additional location for proteolysis. Finally, R26 was appointed by 
means of edman degradation, at least for the H3.1 and/or H3.2 isoforms.  
For the identification of the enzyme mediating this N-terminal H3 truncation, we applied a targeted as 
well as a general approach, using both specific inhibitors for cathepsin L and general inhibitors for a 
specific enzyme class. (i) We assumed cathepsin L to be a major candidate as this enzyme is responsible 
for the clipping in mESC and has been proven to be able to clip H3 in vitro. Nonetheless, none of the 
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specific cathepsin L inhibitors nor the inhibitors for cysteine proteases in general could counter the 
truncation of purified calf H3 when incubated with nuclear extract (NE) that already had been proved to 
contain clipping ability. We thus conclude that cathepsin L is not the main H3 clipping mediator in hESC, 
even though Duncan et al. have proven otherwise in mESC. At least this finding is rather remarkable, 
given that both the biological context (stem cell differentiation) and cleavage sites are very similar. (ii) 
In analogy, we also subjected the in vitro H3 clipping capacity of the NE to several broad spectrum 
protease inhibitors (serine proteases, cysteine proteases, metalloproteases, aminopeptidases and/or 
aspartyl proteases). Out of all these inhibitors only AEBSF, a serine protease inhibitor, was able to 
intervene with H3 proteolysis. Hence, the proteolytic activity in hESC seems to be carried out by a serine 
protease. 
Since H3 cleavage is extensively studied as an epigenetic template in general, we compare our findings 
concerning the cleavage site and the enzyme involved to previously published research. As displayed in 
Table 7.1, up until now all H3 clipping reported was located in the N-terminus. This is in contrast with 
the truncation of H2A, that occurs at the C-terminus in e.g. chronic lymhocytic leukemia and the myeloid 
THP-I cell line [171]. The specific localization of the H3 cleavage site itself differs, depending on the 
biological context involved. The same can be said for the enzyme mediating the clipping event. 
Moreover, only during the past decade convincing evidence was found for some of these enzymes 
concerning their ability to migrate to the nucleus where they maintain enzymatic activity [195,205,239–
244]. This forces researchers to keep an open mind towards alternative functions of known proteins 
[245]. Both cathepsin L and cathepsin D were intitially described in cytoplasmic vesicles as proteinases 
that degrade protein substrates with broad specificity [246,247]. PRB1 in yeast also has yet been 
associated with vacuolar degradation for a long time [248], and GDH is mainly known as a metabolic 
enzyme.  
CHAPTER 7 
134 
 
Table 7.1 Overview of the known H3 clipping events: organism, biological context, cleavage site, enzyme 
and protease class 
Organism/tissue Biological context Cleavage site Enzyme Protease 
class 
S. Cerevisiae  Sporulation or 
starvation 
A21-T22  Serine [191] 
K23-A24 PRB1 [205]  
T. thermophila/ 
micronuclei 
[192,193,232] 
Demethylation 
mechanism 
T6-A7 / / 
Neisseria meningitidis 
[249] 
Virulence factors / App and MspA Serine 
FMDV/infected BHK 
cells [188] 
Host cell transcription L20-A21 Protease 3C Serine 
Chicken/liver 
[194,195] 
Aging K23-A24 
K27-S28 
Glutamate 
dehydrogenase 
Cysteine 
Mouse/ESC [184] Differentiation A21-T22 
T22-K23 
K23-A24 
A24-A25 
R26-K27 
K27-S28 
Cathepsin L Cysteine 
Mouse/ mammary 
glands 
Post lactational 
regression 
K23-A24 Cathepsin D [238] Aspartyl 
K9-S10 Calpain 1 [250] Cysteine 
Human/tumor [237] Colorectal cancer / Legumain Cysteine 
Human/ ESC Differentiation A21-T22 
R26-K27 
A/S 31-T32 
/ Serine 
 
 Histone proteolysis: an epigenetic outcast 
Histone proteolysis has a long history of disregard. The implications thereof on scientific research are 
twofold. First, many more proteolysis events have most probably been encountered in the past, but 
remained outside the scope of the authors at that time. One very remarkable recent case shows 
additional histone H3 bands in HIV latency infected cell lines [251]. Besides, when looking back at the 
publications concerning histone proteolysis over the last 50 years, it has always been treated in a 
stephmotherly fashion by the scientific community. Although the first papers started to suggest that 
histone truncation might greatly impact transcription in the 70s and 80s, the interest in this biological 
event seemed to completely fade away during the 90s and early 21st century. Nevertheless, 10 years 
later, a second wave if interest seemed to be upon us with the publication of the first evidence of 
epigenetic potential for histone clipping in mouse and yeast. Surprisingly however, this promise was 
again not fulfilled and histone clipping is still not picked up as a relevant PTM by the broader scientific 
community, at a time where over 5000 papers are published on histones every year.  
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Next to the immediate effect of brushing aside histone clipping as a potentially important process in 
biology, the disregard of this event can also have indirect effects on experiments aiming other processes 
involving histones. Any experimental approach that targets histone tails and their modifications is prone 
to the effects of both in vivo and in vitro histone proteolysis. Epigenetic screening techniques such as 
the detection of modifications by means of specific antibodies or the immunoprecipitation of modified 
tails are entirely blind to these effects. Considering the intensity of the cleaved fragment of H3 in 
differentiating ESC from mouse and human, it is fair to state that up to half of the whole histone H3 
content can be clipped at certain time points in ESC differentiation [184,252]. It is thus definitely not a 
secondary phenomenon, whose impact can be treated with disregard. According to our knowledge 
however, researchers have rarely taken specific care to avoid this technical pitfall while studying histones.  
7.2. Properly reading the histone code through bottom-up MS 
MS analysis of histone PTMs is typically carried out by a bottom-up approach. In this workflow, histones 
are often chemically derivatized on K residues prior to and post digestion to make sure enzymatic 
cleavage occurs only at R residues and thus yield sufficient usable peptides. The specificity and effiency 
of this procedure will have an influence on different aspects of the histone analysis pipeline. Therefore 
it is crucial to fully understand the nature of this chemical derivatization prior to solving biological 
questions. We investigated different approaches for propionylation and examined the efficiency on 
primary amines (underpropionylation), the specificity of the reaction (overpropionylation) as well as the 
occurrence of unwanted side reactions such as methylation and amidation at carboxylgroups. In the 
following paragraphs, we will discuss the different pitfalls that emerged, their implications on data 
acquisition and data analysis, and elaborate on the efforts made in trying to tackle these problems. A 
summary thereof is given in Figure 7.1. 
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Figure 7.1 Overview of the implications for data acquisition and data analysis, related to several pitfalls that 
can emerge during propionylation of histones 
 
First, amidation of carboxyl groups can occur when using ammonium hydroxide and/or ABC as a buffer 
system during the propionylation or digestion procedure. Nevertheless, not all methods using these 
products showed amidation, such as is the case for e.g. method B and C. This mainly depends on the 
order in which the propionylation reagent and buffer system are added. If propionic anhydride can react 
with the carboxyl groups in the histone sample and form a “mixed anhydride”, prior to the addition of 
ammonium hydroxide, the latter will react with this “mixed anhydride” resulting in an amidated carboxyl 
group (Figure 6.2). This leads to the distribution of one former MS precursor over several amidated forms 
thereof. Consequently, these less intense peptide forms can co-elute, leading to chimeric spectra and 
take up valuable time during MSMS acquisition. Moreover, the subsequent identification and 
quantification will be hindered as well.  
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Another unwanted side reaction that can occur at carboxyl groups is methylation. This reaction occurs 
when methanol reacts with the “mixed anhydride” peptide form in stead of ammonium hydroxide. 
However, this side effect is of minor relevance as the reaction with ammonium hydroxide is favored.  
Next, inefficient propionylation was observed in several methods. The main reason for this is the 
presence of other primary amines (coming from ammonium hydroxide or ABC), that are competing for 
propionylation with histones. A second cause can be lowering the molar excess of propionic anhydride 
from 420x to 20x or lower, which also results in underpropionylated peptides. Just as for amidation, 
underpropionylation can result in the original precursor being distributed over several peptide forms, 
although no chimeric spectra are expected since there is no co-elution of identical m/z ratio’s. 
Nevertheless, an additional problem is the inadequate LC retention of non-propionylated tryptic 
peptides. The identification of in vivo PTMs will be hampered by the additional amount of variable “in 
vitro induced” PTMs and by impaired enzyme specificity. Finally, the inconsistent derivatization efficiency 
in between samples makes relative quantification unreliable. 
Further, aspecific propionylation at hydroxyl groups of S, T and Y residues will result in the same issues 
as underpropionylation, except for the decrease in LC retention and increase in semi-ArgC specificity. 
Breaking this ester bond by boiling or hydroxylamine mediated acyl removal will undo all of these 
complications, as depicted in Figure 7.1. Nevertheless, this is at the cost of identifying one specific type 
of biological PTM at these residues: acetylation. As the chemical bond of the latter is the same as for the 
chemically induced propionylgroup, both will most probably be removed simultaneously. Still, we 
believe this method is arguably a very good candidate since the acetylation of S and T is a sproradic 
event compared to other PTMs which can now be more easily identified and quantified.  
In conclusion, chemical derivatization of histones prior to bottom-up MS is not as straight forward as it 
was considered to be. Many pitfalls can interfere with data acquisition as well as data analysis, which 
were already quite demanding to start with, given the large amount of PTMs present on these histones. 
After examining various approaches, we put forward a new propionylation strategy whereby 
overpropionylation on S, T and Y residues is reversed by the addition of hydroxylamine, resulting in only 
correctly propionylated peptides. This protocol will facilitate both identification and quantification of all 
biological histone PTMs – apart from acetylation at S and T.
  
“Prediction is very difficult, especially about the future”  
― Niels Bohr 
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 BROADER INTERNATIONAL CONTEXT, RELEVANCE AND FUTURE PERSPECTIVES 
“We now have the possibility of achieving all we ever hoped for from medicine”. This statement of the 
UK science minister in June 2000 seemed to mark a new era, where the origin of each disease could be 
uncovered. The trigger for this remarkable announcement was the report that the Human Genome 
Project public consortium assembled a working draft of the sequence of the human genome - the 
genetic blueprint of a human being. Over a decade and thousands of human genomes later, this 
statement has proven at best premature, since reality turned out to be somewhat more complicated. 
Epigenetics might be able to fill up at least some of the remaining gaps. The term epigenetics, which 
was coined by Waddington in 1942, was derived from the Greek word “epigenesis”. Waddington 
presented his metaphorical “epigenetic landscape” to exemplify the concepts of developmental biology. 
Nowadays, it includes all heritable changes in gene expression (active versus inactive genes) that do not 
involve changes to the underlying DNA sequence; a change in phenotype without a change in genotype. 
Biologists offer the following metaphor as an explanation: if the genome is the hardware, then the 
epigenome is the software. Or as Joseph Ecker, a Salk Institute biologist puts it: "I can load Windows, if 
I want, on my Mac. You're going to have the same chip in there, the same genome, but different software. 
And the outcome is a different cell type."  
Epigenetics is one of the fastest growing areas in science these days and is now a key issue in studies 
concerning development and disease. The amount of publications per year concerning this topic have 
increased from about 300 around the turn of the century, to over 7000 for the year 2015. While many 
epigenetic scientists have devoted a great part of their research to DNA methylation, in the meantime 
also many other different types of epigenetic processes were identified. Histone PTMs are one of them. 
The combinatorial nature of these histone modifications reveals a "histone code" that considerably 
extends the information potential of the genetic code. Just like for epigenetics in general, the amount 
of publications on histone PTMs in specific has massively increased from a humble 72 in the year 2000 
to over 1700 the past year. Throughout this dissertation, we tried to color one small area of the biological 
picture related to the histone code (histone clipping in hESC) and also made some suggestions to 
strengthen the technical procedures that provide the framework for studying biology (chemical 
derivatization prior to bottom-up MS analysis). 
First, we zoomed in on histone H3 proteolysis as a new type of PTM in hESC. We found this event to be 
dependent on the conditions hESC were cultured in (feeder-free or MEF feeder layer). This is in 
accordance with the findings in mESC, where the cleavage pattern altered during embryonic body 
formation [184]. Only very recently the group of Jensen published a paper where they state histones 
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H2B and H3 undergo proteolytic processing in primary human hepatocytes and the hepatocellular 
carcinoma cell line HepG2/C3A when grown in spheroid (3D) culture, but not in a flat (2D) culture [226]. 
These examples underline the relevance of our findings and the need for further research, as currently a 
full understanding of this process is lacking. In general, the concept of histone proteolysis has had a long 
history of disregard ever since the first reports occured during the 70s and 80s. The revival started around 
2010 with the first evidence of epigenetic potential of histone clipping in yeast and mouse 
[184,191][253]. However, up to now this phenomenom of histone proteolysis is still not being picked up 
by the broader scientific community. Moreover, the papers that do appear, often do not indicate whether 
degradation or clipping was studied. Given the importance of histone modifications in epigenetic 
regulation, we proposed to divide histone proteolysis into histone degradation and the epigenetically 
connoted histone clipping. As such, readers can hopefully find their way more easily through the 
confusing amalgam of recent reports in which findings of often little biological coherence are 
continuously being cross-referenced.  
Prudence in drawing immediate biological conclusion is also called for during the study of other PTMs 
than histone proteolysis. Mass spectrometry currently is the only technique holding the promise of 
simultaneously annotating and quantifying enough different hPTM combinations to considerably mine 
the histone code to a depth that is required for interpreting the biology underlying this histone code. 
The second part of this thesis however surfaces several pitfalls in the standard methodology applied in 
MS-based histone study, as we came across different types of unexpected PTMs that were induced 
during chemical derivatization of histones for subsequent bottom-up MS analysis. Our results have 
implications on data analysis for all MS based histone research and more specifically on quantitation: 
current findings are only correct when using relative abundances as a metric to find changes between 
different samples. The relevance of this notion was stressed in a commentary article on our findings, 
written by the group of Garcia [224]. Because of these and other inconveniences - such as loss of MSMS 
acquisition time on in vitro generated precursors – we developed a new strategy for derivatizing these 
histones. This propionylation procedure is now efficient as well as specific, with the only drawback being 
that acetylations on S, T or Y residues can no longer be identified. We hope this derivatization protocol 
will be implemented by the growing amount of research groups using bottom-up MS when investigating 
histones. 
When looking at future perspectives, we would like to distinguish between the goals of our own research 
group in particular and the more broad-shouldered ambitions of epigenetic research in general. At 
present, our research group is focusing on further deciphering the histone code in differentiating hESC. 
(i) On the one hand, experiments are carried out to identify the enzyme mediating the previously 
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disclosed H3 clipping in hESC. Therefore, the nuclear extract of clipping hESC is fractionated and the 
different fractions are tested for their H3 clipping ability. Subsequently all fractions will be analyzed by 
MS in order to detect an enzyme unique for the clipping fractions. (ii) On the other hand, we will 
continue investigating histone PTMs through MS. In order to mine the histone epigenome of 
differentiating hESC, we will apply two new DIA strategies, HDMSE (Waters) and SWATH (Sciex). In a first 
step, we will focus on data analysis of histone PTMs in terms of identification and quantification. Some 
very concrete challeges still remain for data analysis platforms to be addressed concerning MS 
identification of histone PTMs. First, mass spectra need to be preprocessed, which can be difficult for 
middle down and top down anlysis due to the limitations in resolution. Moreover, chimeric spectra 
originating from isobaricly modified peptides make interpration at the MSMS level more complex. The 
next challenge is to increase the identification rate at a certain FDR. The wide variety of PTMs can lead 
to a combinatorial explosion and in increasing risk of false positive identifications. How to fast and 
accurately process them is the key for accurate identification. Finally, correct localization of a PTM 
remains difficult, as typically not all fragment ion are available. Subsequently, the DIA analysis platform 
will be used to start developing an “epigenetic toxicology screening test” for monitoring the changes in 
histone PTMs upon treatment with different pharmacological compounds. Toxic agents could act at 
different levels, either directly on enzymes controlling epigenetic changes or indirectly to activate or 
block signalling pathways causing long-term alterations in chromatin structure that may or may not be 
heritable. The extensive list of drugs withdrawn from the market because of unwanted side effect calls 
for some consideration [254]. A broad descriptive analysis made clear that among 121 prescription 
drugs, 42.1% were withdrawn from the European markets alone between 1960 and 1999 [256]. The 
current preclinical and clinical studies often do not succeed in tracing all possible side effect, not even 
taking into account the effects on pregnant women or children that are hardly ever investigated. 
Therefore it is important broaden our knowledge on the epigenetic changes involved when cells or 
organisms are exposed to chemicals. With the increasing introduction of DNA-methylation patterns in 
toxicology screenings, it might be that histone modification analysis makes its entry in the near future 
[255]. With the inclusion of hESC, the guidelines formulated by “Toxicity Testing in the 21st Century: A 
Vision and a Strategy” are taken into account as well [257]. By means of developing a DIA MS based 
screening test our research groups aims at further extending the knowledge on toxicology induced 
changes in histone PTMs. The final goal is for research groups and drug developers to be able to 
anticipate possible side effect of new drug targets. 
These objectives partly overlay with the goals set by the NIH Roadmap Epigenomics Mapping 
Consortium, launched in 2008. This latter project set out to generate a public resource of human 
epigenomic data from 111 different types of human cells and tissues: stem cells, mature cells from a 
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variety of different tissues from healthy people and from patients with diseases such as cancer, 
neurodegenerative conditions and autoimmune disease. In February 2015, the journal Nature published 
a suite of papers that serve as a joint update of the consortium’s findings and the ongoing progress. In 
general, these findings collectively provide insights into three fundamental aspects of epigenetics: how 
the epigenome affects gene expression, the epigenetic changes during stem cell differentiation, and the 
interplay between epigenetics and disease. Over the next 7 to 10 years, the consortium aims to expand 
on this work by deciphering 1000 human epigenomes. So far, it is still hard to predict where this 
epigenome roadmap will lead us, but joint efforts might bring the statement of the UK Science minster 
in 2000 to live after all.  
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 SUMMARY  
All cells in the human body contain the same DNA. In contrast, they do not all fulfill the same function. 
Hence, it is clear that DNA is not our only destiny. In the 1940’s, Waddington brought up the term 
“epigenotype” for the first time [32] and ever since it has been used to connect genotype and 
environment to phenotype and disease. This thesis focusses on histone-related epigenetics from two 
different perspectives. On the one hand, we investigated the biology of histone cleavage as a potential 
epigenetic mechanisms during hESC differentiation. On the other, the technical challenges involved in 
studying posttranslational histone modifications through bottom-up mass spectrometry (MS) are 
addressed, whereupon suggestions for better sample preparation are made.  
Chapter 1 provides the biological framework as a basis for enabling the interpretation of the following 
chapters of this thesis. Thereby we begin by discussing the origin of hESC, available culture methods, 
differentiation possibilities and characterization of this specific cell type. Next, we put forward two 
different types of stem cells and consider the transition from bench to bedside from an ethical point of 
view. This section on stem cells is followed by a brief definition of the term epigenetics and the 
categorization into the different biological processes involved in the epigenetic landscape and changes 
thereof. Because of the ample technical optimization for MS analysis on histone PTMs described in this 
thesis, Chapter 2 offers a technical background. Some basic principles of proteomics in general and of 
MS specifically are discussed, followed by a section dedicated to the different possible MS strategies for 
studying histone PTMs.  
Being different from most studies regarding histone PTMs, the first part of the research (Chapter 4) does 
not describe the specific introduction or removal of a single functional group on the amino acid chain, 
but focuses on a phenomenon called histone proteolysis, in the setting of early stem cell differentiation. 
This type of PTM has received only little attention in the field even though its occurrence may lead to 
drastic epigenetic changes. If an amino- or carboxy-terminal histone tail gets clipped, all accompanying 
PTMs, both transcription-activating and -inhibiting ones, are erased simultaneously. Chapter 4 outlines 
in more detail that also in hESC the aminoterminal tail of histone H3 can be cleaved. We investigated 
the effect of the culture condition on this events and report that clipping of histone H3 can be found 
both in feeder-free as well as MEF feeder layer culturing condition, albeit in a dissimilar pattern. Whilst 
the H3 clipping was a continuous process for feeder-free cultured stem cells, it appeared to be more of 
a fluctuating event if these hESC were cultured on a MEF feeder layer during differentiation. The reason 
for this discrepancy is not clear, but it might be explained by the difference in composition, in hESC 
colony architecture, in cell signaling, and in the biomechanics of the cellular microenvironment. All our 
subsequent attempts to disclose this clipping event as an in vitro artefact did confirm our assumption 
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that this event takes place prior to extraction, in the nucleus itself. Next, we also report that there is no 
direct link between H3 clipping and the expression of Oct4 - a hallmark pluripotency factor – or the cell 
cycle. By the use of different complementary techniques, we then found three different cleavage sites: 
A21 (western blotting), R26 (Edman degradation) and residue 31 (MS). Finally, by means of a protease 
inhibitor panel, we were able to identify the enzyme responsible for the clipping event as a serine 
protease. To date, the lack of evidence for transcriptional implications of H3 clipping during hESC 
differentiation calls for prudence in categorizing H3 proteolysis as an epigenetic event. Therefore, as 
described in the first part of Chapter 7, a proposal is given to divide histone proteolysis into histone 
degradation on the one hand and the epigenetically connoted histone clipping on the other.  
Next to the biological complexity involved in histone epigenetics, there are also various technical 
challenges. MS stands at the heart of proteome research and is also the method of choice for the large-
scale PTM-analysis. However, the most commonly used strategy - bottom-up MS analysis - requires 
derivatization of lysine residues prior to the trypsin digest, in order to obtain sufficient hydrophobic 
peptides of an appropriate length. Generally, the primary amines are propionylated by use of propionic 
anhydride. Unfortunately, the technical variation introduced by this additional step during sample 
preparation might hinder drawing the correct biological conclusions. In this context, we focused on the 
issues concerning both propionylation efficiency as well as specificity that need to be overcome. 
In Chapter 5 we examined different propionylation strategies found in literature and encountered 
several side reactions hindering the specificity or efficiency of the derivatization process. The main pitfalls 
are amidation and methylation of carboxy residues, aspecific overpropionylation on S, T and Y and 
inefficient propionylation of the primary amines on K-residues as well as peptide N-termini. In order to 
address each of these issues, we made several adjustments to these methods and developed some new 
propionylation strategies in Chapter 6. Unfortunately, many adjustments made seemed to exchange 
one problem for another, rendering most methods unfit for future MS analysis. Nevertheless, one 
specific strategy does meet the criteria of a specific and efficient propionylation strategy. In this method, 
overpropionylation on all monitored peptides was reversed by hydroxylamine-mediated acyl removal, 
resulting in correctly propionylated peptides. The average conversion rate of this approach was 95%. 
The only drawback when using this method is that the acetylation at S and/or T residues can no longer 
be identified or quantified, as this ester bond is broken as well. This appears to be the small price we 
need to pay to be able to identify and quantify all other PTMs that in a more reliable manner. The 
implications on data acquisition and data analysis of all methods investigated are considered in the 
second part of Chapter 7. 
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To sum up, this dissertation has unraveled some layers of histone proteomics both from a biological and 
a technical point of view. In the first section, we were able to characterize histone H3 clipping in hESC. 
In the second part, we disclosed various pitfalls during chemical derivatization of histones prior to 
bottom-up MS analysis and put forward an optimized method for future analysis. However, to get to the 
core of true histone epigenetics, many layers still need to be peeled off. On the bright side, each 
contribution can be considered an additional pen stroke to design an epigenome roadmap, as directed 
by the US National Institutes of Health. Let’s hope this roadmap will be able to guide us through the 
epigenetic jungle in the near future, and provide crucial information to connect genetic variation and 
disease.  
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 SAMENVATTING  
Alle cellen in een menselijk lichaam beschikken over hetzelfde DNA, niettegenstaande ze niet allemaal 
dezelfde functie vervullen. Klaarblijkelijk beslist het DNA dus niet als enige over de eindbestemming van 
een cel. Rond 1940 opperde Waddington voor het eerst de term “epigenotype” [32] en van toen af aan 
gebruikt men dit begrip om de link te maken vanuit genotype en omgeving naar fenotype en ziekte. 
Deze thesis focust op histon gerelateerde epigenetica vanuit twee verschillende invalshoeken. Enerzijds 
stellen we een onderzoek in naar de biologische context van histon klieving als een mogelijk 
epigenetisch proces tijdens stemceldifferentiatie. Anderzijds leggen we ons toe op de technische 
uitdagingen die gepaard gaan met het bestuderen van posttranslationele histon modificaties (PTMs) 
aan de hand van bottom-up massaspectrometrie (MS), waarbij we enkele suggesties maken voor een 
betere staalvoorbereiding. 
Hoofdstuk 1 omvat de biologische omkadering die dient als basis om de daaropvolgende hoofdstukken 
te interpeteren. Daarbij starten we met het bespreken van de herkomst van humane embryonale 
stamcellen (hESC), de beschikbare cultuursystemen, de differentiatiemogelijkheden en de karakterisatie 
van dit speciefieke celtype. Vervolgens brengen we twee verschillende types stamcellen ter sprake en 
beschouwen we de overgang vanuit de ondezoekslaboratoria naar de patient vanuit een ethisch 
oogpunt. Dit onderdeel rond stamcellen wordt gevolgd door een korte definitie van de term epigenetica 
en de onderverdeling daarvan in verscheidene biologische processen die betrekking hebben op dit 
epigentische landschap en de veranderingen ervan. Gezien de uitvoerige beschrijving van de technische 
optimalisatie voor MS analyse in dit werk, biedt hoofdstuk 2 de nodige technische achtergrond. Enkele 
basisprincipes van eiwitonderzoek in het algemeen en MS in het bijzonder worden hierin toegelicht, 
alsook de verschillende benaderingen om histon PTMs te bestuderen aan de hand van MS. 
In tegenstelling tot de meeste studies naar histon PTMs, legt het eerste deel van dit onderzoek 
(hoofdstuk 4) zich niet toe op de specifieke aan- dan wel afwezigheid van een bepaalde functionele 
groep op de keten van aminozuren. Het focust daarentegen op een fenomeen tijdens vroege 
stamceldifferentiatie dat histon proteolyse wordt genoemd. Dit type PTM kreeg tot op heden nog maar 
weinig aandacht, ondanks de grote epigentische veranderingen die het met zich mee kan brengen. Als 
de histonstaart amino- of carboxyterminaal ingekort wordt dan zullen namelijk gelijktijdig alle 
bijhorende PTMs op deze staarten verwijderd worden. Hoofdstuk 4 beschrijft in detail hoe zo een N-
terminale klieving van histon H3 ook in hESC kan plaatsvinden. We onderzochten het effect van 
cultuurcondities op dit process en rapporteren dat histon H3 kllieving zich zowel mét als zonder MEF 
feeder layer manifesteert, zij het volgens een ander patroon. Hoewel deze klieving doorlopend 
plaatsgrijpt in een stamcelcultuur zonder feeder laag, blijkt de aanwezigheid van MEFs als feeder laag 
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ervoor te zorgen dat dit proces een golvend patroon volgt tijdens differentiatie. De oorzaak voor deze 
discrepantie is nog niet gekend, maar een mogelijke verklaring is het verschil in compositie, architectuur, 
cel signalisatie en biomechanica in het micromilieu rondom de cellen. Alle voorafgaandelijke pogingen 
om aan te tonen dat deze klieving zich in vitro voordoet, bevestigden ons vermoeden dat dit verschijnsel 
wel degelijk in de celkern zelf plaatsvindt, voorafgaandelijk aan extractie. Vervolgens rapporteren we 
tevens dat noch de expressie van Oct4 – een pluripotentiemerker – noch de celcyclus in verband kon 
worden gebracht met deze H3 klieving. Aan de hand van verscheidene complementaire technieken 
konden we drie verschillende klievingsplaatsen aanduiden: A21 (western blot), R26 (Edman degradatie) 
en residue 31 (MS). Ten slotte hebben we met behulp van een verzameling aan protease inhibitoren 
kunnen aantonen dat het enzyme verantwoordelijk voor deze klieving tot de serine proteases behoort. 
Echter, tot op heden dwingt het gebrek aan bewijzen betreffende het belang van H3 klieving op 
transcriptie-niveau ons tot voorzichtigheid wanneer we H3 proteolyse als een epigenetisch concept 
beschouwen. Daarom doen we in het eerste deel van hoofdstuk 7 een voorstel tot het onderverdelen 
van histon proteolyse in “histon afbraak” enerzijds en een meer epigenetisch getinte “histon klieving” 
anderzijds.  
Naast de biologische complexiteit van histon epigentica, brengt het ook verschillende technische 
uitdagingen met zich mee. MS vormt de basis van eiwitonderzoek en is tevens eerste keuze bij de 
grootschalige analyse van PTMs. Echter, om de meest gebruikte strategie – bottom-up MS analyse- te 
hanteren is het noodzakelijk de lysines (K) chemisch te derivatiseren voorafgaandelijk aan incubatie met 
trypsine, opdat er voldoende hydrofobe peptiden van geschikte lengte zouden gegenereerd worden. 
Meestal worden de primaire amines gederivatiseerd door middel van propionzuuranhydride. Helaas 
wordt er heel wat technische variatie geïntroduceerd tijdens deze stap in de staalvoorbereiding, wat het 
trekken van de juiste biologische conclusies kan hinderen. Binnen deze context, legden we ons toe op 
de problemen gerelateerd aan zowel de efficiëntie als specificiteit van deze propionylatiereactie. 
In hoofdstuk 5 bestudeerden we verscheidene propionylatie methoden die terug te vinden zijn in de 
literatuur en stootten daarbij op ettelijke nevenreacties die zowel de efficiëntie als de specificiteit van 
deze derivatisaties kunnen verstoren. De voornaamste struikelblokken zijn amidatie en methylatie van 
carboxylgroepen, aspecifieke overpropionylatie op serine (S) threonine (T) en tyrosine (Y), en inefficiënte 
propionylatie van de primaire amines op K en de N-termini van peptiden. Om aan deze problemen 
tegemoet te komen werden verschillende aanpassingen doorgevoerd en eveneens enkele nieuwe 
propionylatie methodes ontwikkeld, zoals beschreven in hoofdstuk 6. Jammer genoeg zorgden heel 
wat aanpassingen voor het uitwisselen van het ene probleem met een ander, waardoor de methode 
ongeschikt bleef voor verder gebruik. Desalniettemin voldoet één methode aan de vooropgestelde 
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criteria betreffende efficiëntie en specificiteit. Hierbij wordt de overpropionylatie op alle bestudeerde 
peptiden teniet gedaan onder invloed van hydroxylamine gestuurde verwijdering van de acyl groep, 
waardoor enkel nog correct gepropionyleerde peptides overbijven. De gemiddelde derivatisatiegraad 
voor deze methode bedraagt meer dan 95%. Het enige minpunt bij het aanwenden van deze strategie 
is dat acetylatie op S en/of T residuen niet langer geïndentifceerd of gekwantificeerd kan worden, gezien 
de ester binding tussen beide eveneens verbroken zal worden. Dit blijkt echter het kleine offer dat we 
moeten maken opdat alle andere PTMs op een meer betrouwbare wijze geïdentificeerd en 
gekwantificeerd kunnen worden. De consequenties ten aanzien van data acquisitie en data analyse 
worden voor alle methoden verder uitgediept in het tweede deel van hoofdstuk 7.  
Kortom, deze thesis heeft binnen het histoneiwit-onderzoek verschillende knopen ontward, zowel vanuit 
een biologisch als technisch oogpunt. In het eerste deel omschrijven we histon H3 klieving in hESC. 
Doorheen het tweede deel leggen we verscheidene struikelblokken bloot tijdens de chemische 
derivatisatie van histonen voorafgaand aan bottom-up MS analyse en dragen daarbij een nieuwe 
geoptimaliseerde methode aan voor toekomstige analyses. Desalniettemin, als men de histoncode 
volledig wil ontcijferen zullen nog heel wat bijkomende knopen ontward moeten worden. Het goede 
nieuws is dat elke bijdrage beschouwd kan worden als een bijkomende pennentrek om de 
“epigenetische wegenkaart” te ontwerpen, onder leiding van “the US National Institutes of health”. De 
hoop leeft dat deze kaart ons in de nabije toekomst in staat zal stellen doorheen de epigentische jungle 
te navigeren en bijgevolg cruciale informatie kan onthullen om genetische variatie en ziekte aan mekaar 
te verbinden. 
 
 
 
 
 
 
 
  
 
 
 
 
CHAPTER 11: 
ADDENDUM 
 
  
 ADDENDUM 
11.1. Supporting information Chapter 5 
Table 11.1 Propionylation methods used in Chapter 5 
 
Method 
A B C D 
Substrate (vacuum dried bovine 
histones) 
10 µg 10 µg 10 µg 10 µg 
Propionylation reagent MeOH:prop.anh (3:1) MeOH:prop.anh (3:1) MeOH:prop.anh (3:1) 
100 mM NHS-propionate 
solution:ACN (1:1) 
Propionylation reaction 
+ 20 µL prop. reagent 
+ 15 µL NH4OH 
+ 30 µL 50 mM ABC 
+ 10 µL NH4OH 
+ 10 µL prop. Reagent 
adjust pH with NH4OH (8-10) 
+ 30 µL 50 mM ABC 
+ 10 µL NH4OH 
+ 10 µL prop. Reagent 
adjust pH (8-10) 
+ 50 mM TEAB 
+ prop. Reagent at 10 mM 
Incubate * 
+ prop. Reagent at 10 mM 
Incubate * 
+ NH2OH, 10 min at 30°C 
adjust pH (3) 
Incubation 30 min at RT 15 min at 37°C 15 min at 51°C 1 h at 30°C * 
 A.1 A.2 B.1 B.2 C.1 C.2 
1x pre digest 
1x post digest Frequency 
1x pre digest 
1x post digest 
2x pre digest 
2x post digest 
1x pre digest 
1x post digest 
2x pre digest 
2x post digest 
1x pre digest 
1x post digest 
2x pre digest 
2x post digest 
MeOH = methanol; prop. anh = propionic anhydride; prop. reagent = propionylation reagent; ABC = ammoniumbicarbonate; ACN = acetonitrile; TEAB = 
triethylammoniumbicarbonate 
  
11.2. Supporting information Chapter 6 
Table 11.2 Propionylation methods used in Chapter 6 
 
Method 
A.r A.t A.n B.s 
Substrate (vacuum dried bovine 
histones) 
10 µg 10 µg 10 µg 10 µg 
Propionylation reagent MeOH:prop.anh (3:1) MeOH:prop.anh:NH4OH (3:1:3) MeOH:prop.anh (3:1) Prop. anh 
Propionylation reaction 
+ 15 µL NH4OH 
+ 20 µL prop. reagent 
+ 35 µL prop. reagent 
+ 20 µL prop. reagent 
+ 20 µL H2O 
+ 10 µL 25 mM ABC 
+ 10 µL MeOH 
+ 10 µL prop. reagent 
+ 20 µL NH4OH (pH 8) 
Incubation 30 min at RT 30 min at RT 30 min at RT 30 min at RT 
Frequency 
2x pre digest 
2x post digest 
2x pre digest 
2x post digest 
2x pre digest 
2x post digest 
2x pre digest 
2x post digest 
MeOH = methanol; prop. anh = propionic anhydride; prop. reagent = propionylation reagent; TEAB = triethylammonium bicarbonate 
 
 
Method 
E F G H 
Substrate (vacuum dried bovine 
histones) 
10 µg 10 µg 10 µg 20 µg 
Propionylation reagent Prop. anh Prop. anh Prop. anh IPA:prop.anh (3:1) 
Propionylation reaction 
+ 50 µL propionic acid 
+ 5µL prop. anh 
+ 15 µL 0.1 M ethanolamine 
+ 5 µL prop.anh 
+ 15 µL 0.1 M triethanolamine 
+ 5 µL prop.anh 
20 µL 1.0 M TEAB 
+ 20 µL prop. reagent 
Incubate * 
+ 20 µL H2O, 30 min at 37°C 
Incubation 6h at RT 30 min at RT 30 min at RT 30 min at RT * 
Frequency 
2x pre digest 
2x post digest 
2x pre digest 
2x post digest 
2x pre digest 
2x post digest 
2x pre digest 
2x post digest 
IPA = isopropylalcohol; prop. anh = propionic anhydride; prop. reagent = propionylation reagent; TEAB = triethylammoniumbicarbonate 
 
  
 
Method 
H 42x H 20x H 5x 
Substrate (vacuum dried bovine 
histones) 
20 µg 20 µg 20 µg 
Propionylation reagent IPA:prop.anh (79:1) IPA:prop.anh (170:1) IPA:prop.anh (680:1) 
Propionylation reaction 
20 µL 1.0 M TEAB 
+ 20 µL prop. reagent 
Incubate * 
+ 20 µL H2O, 30 min at 37°C 
20 µL 1.0 M TEAB 
+ 20 µL prop. reagent 
Incubate * 
+ 20 µL H2O, 30 min at 37°C 
20 µL 1.0 M TEAB 
+ 20 µL prop. reagent 
Incubate * 
+ 20 µL H2O, 30 min at 37°C 
Incubation 30 min at RT * 30 min at RT * 30 min at RT * 
Frequency 
1x pre digest 
1x post digest 
1x pre digest 
1x post digest 
1x pre digest 
1x post digest 
IPA = isopropylalcohol; prop. anh = propionic anhydride; prop. reagent = propionylation reagent; TEAB = triethylammonium bicarbonate 
 
 
Method for reversing overpropionylation 
Boiling mediated Hydroxylamine mediated 
Reaction 
Vacuum dry sample 
+ 50 µL 50 mM ABC 
adjust pH with NH4OH (8-10) 
Vacuum dry sample 
+ 50 µL 0.5 M NH2OH 
+ 15 µL NH4OH at pH 12 
Incubate * 
Adjust pH with formic acid (3) 
Incubation 1 h at 99°C 20 min at RT * 
ABC = ammoniumbicarbonate 
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